id	sid	tid	token	lemma	pos
dpc-4372	1	1	dermatology	dermatology	NOUN
dpc-4372	1	2	:	:	PUNCT
dpc-4372	1	3	practical	practical	ADJ
dpc-4372	1	4	and	and	CCONJ
dpc-4372	1	5	conceptual	conceptual	ADJ
dpc-4372	1	6	original	original	ADJ
dpc-4372	1	7	article	article	NOUN
dpc-4372	1	8	|	|	ADV
dpc-4372	1	9	dermatol	dermatol	ADJ
dpc-4372	1	10	pract	pract	NOUN
dpc-4372	1	11	concept	concept	NOUN
dpc-4372	1	12	.	.	PUNCT
dpc-4372	2	1	2024;14(4):e2024241	2024;14(4):e2024241	NUM
dpc-4372	2	2	1	1	NUM
dpc-4372	2	3	the	the	DET
dpc-4372	2	4	prevalence	prevalence	NOUN
dpc-4372	2	5	and	and	CCONJ
dpc-4372	2	6	clinical	clinical	ADJ
dpc-4372	2	7	significance	significance	NOUN
dpc-4372	2	8	of	of	ADP
dpc-4372	2	9	skin	skin	NOUN
dpc-4372	2	10	manifestations	manifestation	NOUN
dpc-4372	2	11	in	in	ADP
dpc-4372	2	12	parkinson	parkinson	NOUN
dpc-4372	2	13	’s	’s	PART
dpc-4372	2	14	disease	disease	NOUN
dpc-4372	2	15	patients	patient	NOUN
dpc-4372	2	16	ayşegül	ayşegül	VERB
dpc-4372	2	17	yalçınkaya	yalçınkaya	PROPN
dpc-4372	2	18	iyidal1	iyidal1	VERB
dpc-4372	2	19	,	,	PUNCT
dpc-4372	2	20	funda	funda	PROPN
dpc-4372	2	21	erduran1	erduran1	PROPN
dpc-4372	2	22	,	,	PUNCT
dpc-4372	2	23	yıldız	yıldız	PROPN
dpc-4372	2	24	hayran1	hayran1	PROPN
dpc-4372	2	25	,	,	PUNCT
dpc-4372	2	26	yeşim	yeşim	PROPN
dpc-4372	2	27	sücüllü	sücüllü	NOUN
dpc-4372	2	28	karadağ2	karadağ2	PROPN
dpc-4372	2	29	1	1	NUM
dpc-4372	2	30	department	department	NOUN
dpc-4372	2	31	of	of	ADP
dpc-4372	2	32	dermatology	dermatology	NOUN
dpc-4372	2	33	,	,	PUNCT
dpc-4372	2	34	ankara	ankara	PROPN
dpc-4372	2	35	bilkent	bilkent	PROPN
dpc-4372	2	36	city	city	PROPN
dpc-4372	2	37	hospital	hospital	PROPN
dpc-4372	2	38	,	,	PUNCT
dpc-4372	2	39	çankaya	çankaya	PROPN
dpc-4372	2	40	/	/	SYM
dpc-4372	2	41	ankara	ankara	PROPN
dpc-4372	2	42	,	,	PUNCT
dpc-4372	2	43	türkiye	türkiye	PROPN
dpc-4372	2	44	2	2	NUM
dpc-4372	2	45	department	department	NOUN
dpc-4372	2	46	of	of	ADP
dpc-4372	2	47	neurology	neurology	NOUN
dpc-4372	2	48	,	,	PUNCT
dpc-4372	2	49	university	university	NOUN
dpc-4372	2	50	of	of	ADP
dpc-4372	2	51	health	health	PROPN
dpc-4372	2	52	sciences	sciences	PROPN
dpc-4372	2	53	,	,	PUNCT
dpc-4372	2	54	ankara	ankara	PROPN
dpc-4372	2	55	bilkent	bilkent	PROPN
dpc-4372	2	56	city	city	PROPN
dpc-4372	2	57	hospital	hospital	PROPN
dpc-4372	2	58	,	,	PUNCT
dpc-4372	2	59	çankaya	çankaya	PROPN
dpc-4372	2	60	/	/	SYM
dpc-4372	2	61	ankara	ankara	PROPN
dpc-4372	2	62	,	,	PUNCT
dpc-4372	2	63	türkiye	türkiye	PROPN
dpc-4372	2	64	key	key	ADJ
dpc-4372	2	65	words	word	NOUN
dpc-4372	2	66	:	:	PUNCT
dpc-4372	2	67	parkinson	parkinson	NOUN
dpc-4372	2	68	’s	’s	PART
dpc-4372	2	69	disease	disease	NOUN
dpc-4372	2	70	,	,	PUNCT
dpc-4372	2	71	dermatological	dermatological	ADJ
dpc-4372	2	72	manifestations	manifestation	NOUN
dpc-4372	2	73	,	,	PUNCT
dpc-4372	2	74	seborrheic	seborrheic	PROPN
dpc-4372	2	75	dermatitis	dermatitis	NOUN
dpc-4372	2	76	,	,	PUNCT
dpc-4372	2	77	xerosis	xerosis	NOUN
dpc-4372	2	78	,	,	PUNCT
dpc-4372	2	79	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	2	80	citation	citation	NOUN
dpc-4372	2	81	:	:	PUNCT
dpc-4372	2	82	yalçınkaya	yalçınkaya	NOUN
dpc-4372	2	83	iyidal	iyidal	NOUN
dpc-4372	2	84	a	a	PRON
dpc-4372	2	85	,	,	PUNCT
dpc-4372	2	86	erduran	erduran	ADJ
dpc-4372	2	87	f	f	NOUN
dpc-4372	2	88	,	,	PUNCT
dpc-4372	2	89	hayran	hayran	PROPN
dpc-4372	2	90	y	y	PROPN
dpc-4372	2	91	,	,	PUNCT
dpc-4372	2	92	karadağ	karadağ	NOUN
dpc-4372	2	93	sücüllü	sücüllü	PROPN
dpc-4372	2	94	y.	y.	NOUN
dpc-4372	2	95	the	the	DET
dpc-4372	2	96	prevalence	prevalence	NOUN
dpc-4372	2	97	and	and	CCONJ
dpc-4372	2	98	clinical	clinical	ADJ
dpc-4372	2	99	significance	significance	NOUN
dpc-4372	2	100	of	of	ADP
dpc-4372	2	101	skin	skin	NOUN
dpc-4372	2	102	manifestations	manifestation	NOUN
dpc-4372	2	103	in	in	ADP
dpc-4372	2	104	parkinson	parkinson	NOUN
dpc-4372	2	105	’s	’s	PART
dpc-4372	2	106	disease	disease	NOUN
dpc-4372	2	107	patients	patient	NOUN
dpc-4372	2	108	.	.	PUNCT
dpc-4372	3	1	dermatol	dermatol	NOUN
dpc-4372	3	2	pract	pract	PROPN
dpc-4372	3	3	concept	concept	NOUN
dpc-4372	3	4	.	.	PUNCT
dpc-4372	4	1	2024;14(4):e2024241	2024;14(4):e2024241	X
dpc-4372	4	2	.	.	PUNCT
dpc-4372	5	1	doi	doi	PROPN
dpc-4372	5	2	:	:	PUNCT
dpc-4372	5	3	https://doi.org/10.5826/dpc.1404a241	https://doi.org/10.5826/dpc.1404a241	NOUN
dpc-4372	5	4	accepted	accept	VERB
dpc-4372	5	5	:	:	PUNCT
dpc-4372	5	6	may	may	AUX
dpc-4372	5	7	13	13	NUM
dpc-4372	5	8	,	,	PUNCT
dpc-4372	5	9	2024	2024	NUM
dpc-4372	5	10	;	;	PUNCT
dpc-4372	5	11	published	publish	VERB
dpc-4372	5	12	:	:	PUNCT
dpc-4372	5	13	october	october	PROPN
dpc-4372	5	14	2024	2024	NUM
dpc-4372	6	1	copyright	copyright	NOUN
dpc-4372	6	2	:	:	PUNCT
dpc-4372	6	3	©	©	PROPN
dpc-4372	6	4	2024	2024	NUM
dpc-4372	6	5	yalçınkaya	yalçınkaya	NOUN
dpc-4372	6	6	iyidal	iyidal	NOUN
dpc-4372	6	7	et	et	PROPN
dpc-4372	6	8	al	al	PROPN
dpc-4372	6	9	.	.	PUNCT
dpc-4372	7	1	this	this	PRON
dpc-4372	7	2	is	be	AUX
dpc-4372	7	3	an	an	DET
dpc-4372	7	4	open	open	ADJ
dpc-4372	7	5	-	-	PUNCT
dpc-4372	7	6	access	access	NOUN
dpc-4372	7	7	article	article	NOUN
dpc-4372	7	8	distributed	distribute	VERB
dpc-4372	7	9	under	under	ADP
dpc-4372	7	10	the	the	DET
dpc-4372	7	11	terms	term	NOUN
dpc-4372	7	12	of	of	ADP
dpc-4372	7	13	the	the	DET
dpc-4372	7	14	creative	creative	ADJ
dpc-4372	7	15	commons	common	NOUN
dpc-4372	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4372	7	17	license	license	NOUN
dpc-4372	7	18	(	(	PUNCT
dpc-4372	7	19	by	by	ADP
dpc-4372	7	20	-	-	PUNCT
dpc-4372	7	21	nc-4.0	nc-4.0	NOUN
dpc-4372	7	22	)	)	PUNCT
dpc-4372	7	23	,	,	PUNCT
dpc-4372	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4372	7	25	,	,	PUNCT
dpc-4372	7	26	which	which	PRON
dpc-4372	7	27	permits	permit	VERB
dpc-4372	7	28	unrestricted	unrestricted	ADJ
dpc-4372	7	29	noncommercial	noncommercial	ADJ
dpc-4372	7	30	use	use	NOUN
dpc-4372	7	31	,	,	PUNCT
dpc-4372	7	32	distribution	distribution	NOUN
dpc-4372	7	33	,	,	PUNCT
dpc-4372	7	34	and	and	CCONJ
dpc-4372	7	35	reproduction	reproduction	NOUN
dpc-4372	7	36	in	in	ADP
dpc-4372	7	37	any	any	DET
dpc-4372	7	38	medium	medium	NOUN
dpc-4372	7	39	,	,	PUNCT
dpc-4372	7	40	provided	provide	VERB
dpc-4372	7	41	the	the	DET
dpc-4372	7	42	original	original	ADJ
dpc-4372	7	43	authors	author	NOUN
dpc-4372	7	44	and	and	CCONJ
dpc-4372	7	45	source	source	NOUN
dpc-4372	7	46	are	be	AUX
dpc-4372	7	47	credited	credit	VERB
dpc-4372	7	48	.	.	PUNCT
dpc-4372	8	1	funding	funding	NOUN
dpc-4372	8	2	:	:	PUNCT
dpc-4372	8	3	none	none	NOUN
dpc-4372	8	4	.	.	PUNCT
dpc-4372	9	1	competing	compete	VERB
dpc-4372	9	2	interests	interest	NOUN
dpc-4372	9	3	:	:	PUNCT
dpc-4372	9	4	none	none	NOUN
dpc-4372	9	5	.	.	PUNCT
dpc-4372	10	1	authorship	authorship	NOUN
dpc-4372	10	2	:	:	PUNCT
dpc-4372	10	3	all	all	DET
dpc-4372	10	4	authors	author	NOUN
dpc-4372	10	5	have	have	AUX
dpc-4372	10	6	contributed	contribute	VERB
dpc-4372	10	7	significantly	significantly	ADV
dpc-4372	10	8	to	to	ADP
dpc-4372	10	9	this	this	DET
dpc-4372	10	10	publication	publication	NOUN
dpc-4372	10	11	.	.	PUNCT
dpc-4372	11	1	corresponding	correspond	VERB
dpc-4372	11	2	author	author	NOUN
dpc-4372	11	3	:	:	PUNCT
dpc-4372	11	4	ayşegül	ayşegül	PROPN
dpc-4372	11	5	yalçınkaya	yalçınkaya	NOUN
dpc-4372	11	6	iyidal	iyidal	NOUN
dpc-4372	11	7	,	,	PUNCT
dpc-4372	11	8	md	md	PROPN
dpc-4372	11	9	,	,	PUNCT
dpc-4372	11	10	dermatologist	dermatologist	NOUN
dpc-4372	11	11	,	,	PUNCT
dpc-4372	11	12	department	department	NOUN
dpc-4372	11	13	of	of	ADP
dpc-4372	11	14	dermatology	dermatology	NOUN
dpc-4372	11	15	,	,	PUNCT
dpc-4372	11	16	ankara	ankara	PROPN
dpc-4372	11	17	bilkent	bilkent	PROPN
dpc-4372	11	18	city	city	PROPN
dpc-4372	11	19	hospital	hospital	PROPN
dpc-4372	11	20	,	,	PUNCT
dpc-4372	11	21	üniversiteler	üniversiteler	NOUN
dpc-4372	11	22	,	,	PUNCT
dpc-4372	11	23	1604	1604	NUM
dpc-4372	11	24	.	.	PUNCT
dpc-4372	12	1	cd	cd	PROPN
dpc-4372	12	2	no:9	no:9	PROPN
dpc-4372	12	3	,	,	PUNCT
dpc-4372	12	4	06800	06800	NUM
dpc-4372	12	5	,	,	PUNCT
dpc-4372	12	6	çankaya	çankaya	PROPN
dpc-4372	12	7	/	/	SYM
dpc-4372	12	8	ankara	ankara	PROPN
dpc-4372	12	9	;	;	PUNCT
dpc-4372	12	10	phone	phone	NOUN
dpc-4372	12	11	:	:	PUNCT
dpc-4372	12	12	05052720042	05052720042	NUM
dpc-4372	12	13	;	;	PUNCT
dpc-4372	12	14	e	e	X
dpc-4372	12	15	-	-	NOUN
dpc-4372	12	16	mail	mail	NOUN
dpc-4372	12	17	:	:	PUNCT
dpc-4372	12	18	draysegulyalcinkayaiyidal@gmail.com	draysegulyalcinkayaiyidal@gmail.com	X
dpc-4372	12	19	background	background	NOUN
dpc-4372	12	20	:	:	PUNCT
dpc-4372	12	21	parkinson	parkinson	NOUN
dpc-4372	12	22	’s	’s	PART
dpc-4372	12	23	disease	disease	NOUN
dpc-4372	12	24	(	(	PUNCT
dpc-4372	12	25	pd	pd	NOUN
dpc-4372	12	26	)	)	PUNCT
dpc-4372	12	27	is	be	AUX
dpc-4372	12	28	primarily	primarily	ADV
dpc-4372	12	29	characterized	characterize	VERB
dpc-4372	12	30	by	by	ADP
dpc-4372	12	31	motor	motor	NOUN
dpc-4372	12	32	symptoms	symptom	NOUN
dpc-4372	12	33	,	,	PUNCT
dpc-4372	12	34	but	but	CCONJ
dpc-4372	12	35	non	non	ADJ
dpc-4372	12	36	-	-	ADJ
dpc-4372	12	37	motor	motor	ADJ
dpc-4372	12	38	symptoms	symptom	NOUN
dpc-4372	12	39	,	,	PUNCT
dpc-4372	12	40	including	include	VERB
dpc-4372	12	41	skin	skin	NOUN
dpc-4372	12	42	manifestations	manifestation	NOUN
dpc-4372	12	43	,	,	PUNCT
dpc-4372	12	44	are	be	AUX
dpc-4372	12	45	increasingly	increasingly	ADV
dpc-4372	12	46	recognized	recognize	VERB
dpc-4372	12	47	.	.	PUNCT
dpc-4372	13	1	these	these	PRON
dpc-4372	13	2	remain	remain	VERB
dpc-4372	13	3	underexplored	underexplored	ADJ
dpc-4372	13	4	despite	despite	SCONJ
dpc-4372	13	5	their	their	PRON
dpc-4372	13	6	potential	potential	ADJ
dpc-4372	13	7	impact	impact	NOUN
dpc-4372	13	8	on	on	ADP
dpc-4372	13	9	quality	quality	NOUN
dpc-4372	13	10	of	of	ADP
dpc-4372	13	11	life	life	NOUN
dpc-4372	13	12	.	.	PUNCT
dpc-4372	14	1	objectives	objective	NOUN
dpc-4372	14	2	:	:	PUNCT
dpc-4372	14	3	this	this	DET
dpc-4372	14	4	study	study	NOUN
dpc-4372	14	5	aimed	aim	VERB
dpc-4372	14	6	to	to	PART
dpc-4372	14	7	evaluate	evaluate	VERB
dpc-4372	14	8	the	the	DET
dpc-4372	14	9	prevalence	prevalence	NOUN
dpc-4372	14	10	and	and	CCONJ
dpc-4372	14	11	clinical	clinical	ADJ
dpc-4372	14	12	features	feature	NOUN
dpc-4372	14	13	of	of	ADP
dpc-4372	14	14	skin	skin	NOUN
dpc-4372	14	15	findings	finding	NOUN
dpc-4372	14	16	in	in	ADP
dpc-4372	14	17	pd	pd	PROPN
dpc-4372	14	18	patients	patient	NOUN
dpc-4372	14	19	,	,	PUNCT
dpc-4372	14	20	with	with	ADP
dpc-4372	14	21	a	a	DET
dpc-4372	14	22	focus	focus	NOUN
dpc-4372	14	23	on	on	ADP
dpc-4372	14	24	identifying	identify	VERB
dpc-4372	14	25	potential	potential	ADJ
dpc-4372	14	26	pathogenetic	pathogenetic	ADJ
dpc-4372	14	27	links	link	NOUN
dpc-4372	14	28	between	between	ADP
dpc-4372	14	29	dermatological	dermatological	ADJ
dpc-4372	14	30	conditions	condition	NOUN
dpc-4372	14	31	and	and	CCONJ
dpc-4372	14	32	pd	pd	PROPN
dpc-4372	14	33	.	.	PROPN
dpc-4372	14	34	methods	method	NOUN
dpc-4372	14	35	:	:	PUNCT
dpc-4372	14	36	a	a	DET
dpc-4372	14	37	total	total	NOUN
dpc-4372	14	38	of	of	ADP
dpc-4372	14	39	215	215	NUM
dpc-4372	14	40	pd	pd	NOUN
dpc-4372	14	41	patients	patient	NOUN
dpc-4372	14	42	were	be	AUX
dpc-4372	14	43	included	include	VERB
dpc-4372	14	44	.	.	PUNCT
dpc-4372	15	1	comprehensive	comprehensive	ADJ
dpc-4372	15	2	dermatological	dermatological	ADJ
dpc-4372	15	3	examinations	examination	NOUN
dpc-4372	15	4	were	be	AUX
dpc-4372	15	5	performed	perform	VERB
dpc-4372	15	6	,	,	PUNCT
dpc-4372	15	7	and	and	CCONJ
dpc-4372	15	8	demographic	demographic	ADJ
dpc-4372	15	9	and	and	CCONJ
dpc-4372	15	10	clinical	clinical	ADJ
dpc-4372	15	11	data	datum	NOUN
dpc-4372	15	12	were	be	AUX
dpc-4372	15	13	collected	collect	VERB
dpc-4372	15	14	.	.	PUNCT
dpc-4372	16	1	statistical	statistical	ADJ
dpc-4372	16	2	analysis	analysis	NOUN
dpc-4372	16	3	was	be	AUX
dpc-4372	16	4	conducted	conduct	VERB
dpc-4372	16	5	using	use	VERB
dpc-4372	16	6	spss	spss	PROPN
dpc-4372	16	7	23.0	23.0	NUM
dpc-4372	16	8	,	,	PUNCT
dpc-4372	16	9	with	with	ADP
dpc-4372	16	10	significance	significance	NOUN
dpc-4372	16	11	set	set	VERB
dpc-4372	16	12	at	at	ADP
dpc-4372	16	13	p	p	NOUN
dpc-4372	16	14	<	<	X
dpc-4372	16	15	0.05	0.05	NUM
dpc-4372	16	16	.	.	PUNCT
dpc-4372	17	1	results	result	NOUN
dpc-4372	17	2	:	:	PUNCT
dpc-4372	17	3	skin	skin	NOUN
dpc-4372	17	4	conditions	condition	NOUN
dpc-4372	17	5	were	be	AUX
dpc-4372	17	6	found	find	VERB
dpc-4372	17	7	in	in	ADP
dpc-4372	17	8	92.1	92.1	NUM
dpc-4372	17	9	%	%	NOUN
dpc-4372	17	10	of	of	ADP
dpc-4372	17	11	pd	pd	PROPN
dpc-4372	17	12	patients	patient	NOUN
dpc-4372	17	13	.	.	PUNCT
dpc-4372	18	1	xerosis	xerosis	NOUN
dpc-4372	18	2	,	,	PUNCT
dpc-4372	18	3	seborrheic	seborrheic	ADJ
dpc-4372	18	4	dermatitis	dermatitis	NOUN
dpc-4372	18	5	,	,	PUNCT
dpc-4372	18	6	and	and	CCONJ
dpc-4372	18	7	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	18	8	were	be	AUX
dpc-4372	18	9	the	the	DET
dpc-4372	18	10	most	most	ADV
dpc-4372	18	11	common	common	ADJ
dpc-4372	18	12	findings	finding	NOUN
dpc-4372	18	13	.	.	PUNCT
dpc-4372	19	1	pre	pre	ADJ
dpc-4372	19	2	-	-	ADJ
dpc-4372	19	3	pd	pd	ADJ
dpc-4372	19	4	xerosis	xerosis	NOUN
dpc-4372	19	5	was	be	AUX
dpc-4372	19	6	associated	associate	VERB
dpc-4372	19	7	with	with	ADP
dpc-4372	19	8	an	an	DET
dpc-4372	19	9	earlier	early	ADJ
dpc-4372	19	10	stage	stage	NOUN
dpc-4372	19	11	of	of	ADP
dpc-4372	19	12	pd	pd	PROPN
dpc-4372	19	13	(	(	PUNCT
dpc-4372	19	14	p	p	NOUN
dpc-4372	19	15	=	=	NOUN
dpc-4372	19	16	0.001	0.001	NUM
dpc-4372	19	17	)	)	PUNCT
dpc-4372	19	18	.	.	PUNCT
dpc-4372	20	1	use	use	NOUN
dpc-4372	20	2	of	of	ADP
dpc-4372	20	3	pd	pd	PROPN
dpc-4372	20	4	medications	medication	NOUN
dpc-4372	20	5	,	,	PUNCT
dpc-4372	20	6	such	such	ADJ
dpc-4372	20	7	as	as	ADP
dpc-4372	20	8	levodopa	levodopa	NOUN
dpc-4372	20	9	/	/	SYM
dpc-4372	20	10	carbidopa	carbidopa	NOUN
dpc-4372	20	11	/	/	SYM
dpc-4372	20	12	entacapone	entacapone	ADJ
dpc-4372	20	13	,	,	PUNCT
dpc-4372	20	14	was	be	AUX
dpc-4372	20	15	linked	link	VERB
dpc-4372	20	16	to	to	ADP
dpc-4372	20	17	a	a	DET
dpc-4372	20	18	lower	low	ADJ
dpc-4372	20	19	incidence	incidence	NOUN
dpc-4372	20	20	of	of	ADP
dpc-4372	20	21	seborrheic	seborrheic	PROPN
dpc-4372	20	22	dermatitis	dermatitis	NOUN
dpc-4372	20	23	(	(	PUNCT
dpc-4372	20	24	p	p	NOUN
dpc-4372	20	25	=	=	NOUN
dpc-4372	20	26	0.040	0.040	NUM
dpc-4372	20	27	)	)	PUNCT
dpc-4372	20	28	.	.	PUNCT
dpc-4372	21	1	a	a	DET
dpc-4372	21	2	significant	significant	ADJ
dpc-4372	21	3	correlation	correlation	NOUN
dpc-4372	21	4	was	be	AUX
dpc-4372	21	5	also	also	ADV
dpc-4372	21	6	noted	note	VERB
dpc-4372	21	7	between	between	ADP
dpc-4372	21	8	rosacea	rosacea	NOUN
dpc-4372	21	9	and	and	CCONJ
dpc-4372	21	10	cherry	cherry	NOUN
dpc-4372	21	11	angioma	angioma	PROPN
dpc-4372	21	12	(	(	PUNCT
dpc-4372	21	13	p	p	X
dpc-4372	21	14	=	=	NOUN
dpc-4372	21	15	0.01	0.01	NUM
dpc-4372	21	16	)	)	PUNCT
dpc-4372	21	17	.	.	PUNCT
dpc-4372	22	1	conclusion	conclusion	NOUN
dpc-4372	22	2	:	:	PUNCT
dpc-4372	22	3	dermatological	dermatological	ADJ
dpc-4372	22	4	conditions	condition	NOUN
dpc-4372	22	5	are	be	AUX
dpc-4372	22	6	prevalent	prevalent	ADJ
dpc-4372	22	7	in	in	ADP
dpc-4372	22	8	pd	pd	PROPN
dpc-4372	22	9	and	and	CCONJ
dpc-4372	22	10	may	may	AUX
dpc-4372	22	11	precede	precede	VERB
dpc-4372	22	12	its	its	PRON
dpc-4372	22	13	motor	motor	NOUN
dpc-4372	22	14	symptoms	symptom	NOUN
dpc-4372	22	15	.	.	PUNCT
dpc-4372	23	1	skin	skin	NOUN
dpc-4372	23	2	assessments	assessment	NOUN
dpc-4372	23	3	could	could	AUX
dpc-4372	23	4	aid	aid	VERB
dpc-4372	23	5	early	early	ADJ
dpc-4372	23	6	diagnosis	diagnosis	NOUN
dpc-4372	23	7	and	and	CCONJ
dpc-4372	23	8	management	management	NOUN
dpc-4372	23	9	of	of	ADP
dpc-4372	23	10	pd	pd	PROPN
dpc-4372	23	11	,	,	PUNCT
dpc-4372	23	12	highlighting	highlight	VERB
dpc-4372	23	13	the	the	DET
dpc-4372	23	14	need	need	NOUN
dpc-4372	23	15	for	for	ADP
dpc-4372	23	16	further	further	ADJ
dpc-4372	23	17	research	research	NOUN
dpc-4372	23	18	on	on	ADP
dpc-4372	23	19	their	their	PRON
dpc-4372	23	20	pathogenetic	pathogenetic	ADJ
dpc-4372	23	21	mechanisms	mechanism	NOUN
dpc-4372	23	22	.	.	PUNCT
dpc-4372	24	1	abstract	abstract	ADJ
dpc-4372	24	2	2	2	NUM
dpc-4372	24	3	original	original	ADJ
dpc-4372	24	4	article	article	NOUN
dpc-4372	24	5	|	|	ADV
dpc-4372	24	6	dermatol	dermatol	ADJ
dpc-4372	24	7	pract	pract	NOUN
dpc-4372	24	8	concept	concept	NOUN
dpc-4372	24	9	.	.	PUNCT
dpc-4372	25	1	2024;14(4):e2024241	2024;14(4):e2024241	NUM
dpc-4372	25	2	introduction	introduction	NOUN
dpc-4372	25	3	parkinson	parkinson	NOUN
dpc-4372	25	4	’s	’s	PART
dpc-4372	25	5	disease	disease	NOUN
dpc-4372	25	6	(	(	PUNCT
dpc-4372	25	7	pd	pd	NOUN
dpc-4372	25	8	)	)	PUNCT
dpc-4372	25	9	is	be	AUX
dpc-4372	25	10	a	a	DET
dpc-4372	25	11	progressive	progressive	ADJ
dpc-4372	25	12	neurodegenerative	neurodegenerative	ADJ
dpc-4372	25	13	disease	disease	NOUN
dpc-4372	25	14	characterized	characterize	VERB
dpc-4372	25	15	by	by	ADP
dpc-4372	25	16	the	the	DET
dpc-4372	25	17	triad	triad	PROPN
dpc-4372	25	18	of	of	ADP
dpc-4372	25	19	resting	rest	VERB
dpc-4372	25	20	tremor	tremor	NOUN
dpc-4372	25	21	,	,	PUNCT
dpc-4372	25	22	bradykinesia	bradykinesia	NOUN
dpc-4372	25	23	,	,	PUNCT
dpc-4372	25	24	and	and	CCONJ
dpc-4372	25	25	rigidity	rigidity	NOUN
dpc-4372	25	26	.	.	PUNCT
dpc-4372	26	1	in	in	ADP
dpc-4372	26	2	patients	patient	NOUN
dpc-4372	26	3	with	with	ADP
dpc-4372	26	4	pd	pd	PROPN
dpc-4372	26	5	,	,	PUNCT
dpc-4372	26	6	mainly	mainly	ADV
dpc-4372	26	7	motor	motor	NOUN
dpc-4372	26	8	disorders	disorder	NOUN
dpc-4372	26	9	are	be	AUX
dpc-4372	26	10	observed	observe	VERB
dpc-4372	26	11	;	;	PUNCT
dpc-4372	26	12	however	however	ADV
dpc-4372	26	13	,	,	PUNCT
dpc-4372	26	14	non	non	ADJ
dpc-4372	26	15	-	-	ADJ
dpc-4372	26	16	motor	motor	ADJ
dpc-4372	26	17	symptoms	symptom	NOUN
dpc-4372	26	18	can	can	AUX
dpc-4372	26	19	also	also	ADV
dpc-4372	26	20	be	be	AUX
dpc-4372	26	21	seen	see	VERB
dpc-4372	26	22	at	at	ADP
dpc-4372	26	23	all	all	DET
dpc-4372	26	24	stages	stage	NOUN
dpc-4372	26	25	of	of	ADP
dpc-4372	26	26	the	the	DET
dpc-4372	26	27	disease	disease	NOUN
dpc-4372	26	28	.	.	PUNCT
dpc-4372	27	1	the	the	DET
dpc-4372	27	2	most	most	ADV
dpc-4372	27	3	common	common	ADJ
dpc-4372	27	4	non	non	ADJ
dpc-4372	27	5	-	-	ADJ
dpc-4372	27	6	motor	motor	ADJ
dpc-4372	27	7	symptoms	symptom	NOUN
dpc-4372	27	8	are	be	AUX
dpc-4372	27	9	pain	pain	NOUN
dpc-4372	27	10	,	,	PUNCT
dpc-4372	27	11	sweating	sweating	NOUN
dpc-4372	27	12	,	,	PUNCT
dpc-4372	27	13	insomnia	insomnia	NOUN
dpc-4372	27	14	,	,	PUNCT
dpc-4372	27	15	depression	depression	NOUN
dpc-4372	27	16	,	,	PUNCT
dpc-4372	27	17	and	and	CCONJ
dpc-4372	27	18	skin	skin	NOUN
dpc-4372	27	19	manifestations	manifestation	NOUN
dpc-4372	27	20	[	[	X
dpc-4372	27	21	1	1	NUM
dpc-4372	27	22	-	-	SYM
dpc-4372	27	23	5	5	NUM
dpc-4372	27	24	]	]	PUNCT
dpc-4372	27	25	.	.	PUNCT
dpc-4372	28	1	these	these	DET
dpc-4372	28	2	symptoms	symptom	NOUN
dpc-4372	28	3	may	may	AUX
dpc-4372	28	4	occur	occur	VERB
dpc-4372	28	5	before	before	ADP
dpc-4372	28	6	the	the	DET
dpc-4372	28	7	onset	onset	NOUN
dpc-4372	28	8	or	or	CCONJ
dpc-4372	28	9	during	during	ADP
dpc-4372	28	10	the	the	DET
dpc-4372	28	11	course	course	NOUN
dpc-4372	28	12	of	of	ADP
dpc-4372	28	13	pd	pd	PROPN
dpc-4372	28	14	.	.	PUNCT
dpc-4372	29	1	recent	recent	ADJ
dpc-4372	29	2	studies	study	NOUN
dpc-4372	29	3	suggest	suggest	VERB
dpc-4372	29	4	a	a	DET
dpc-4372	29	5	close	close	ADJ
dpc-4372	29	6	relationship	relationship	NOUN
dpc-4372	29	7	between	between	ADP
dpc-4372	29	8	neurological	neurological	ADJ
dpc-4372	29	9	symptoms	symptom	NOUN
dpc-4372	29	10	and	and	CCONJ
dpc-4372	29	11	skin	skin	NOUN
dpc-4372	29	12	findings	finding	NOUN
dpc-4372	29	13	in	in	ADP
dpc-4372	29	14	pd	pd	PROPN
dpc-4372	29	15	[	[	X
dpc-4372	29	16	1,2,6,7	1,2,6,7	NUM
dpc-4372	29	17	]	]	PUNCT
dpc-4372	29	18	.	.	PUNCT
dpc-4372	30	1	these	these	DET
dpc-4372	30	2	studies	study	NOUN
dpc-4372	30	3	have	have	AUX
dpc-4372	30	4	reported	report	VERB
dpc-4372	30	5	a	a	DET
dpc-4372	30	6	higher	high	ADJ
dpc-4372	30	7	incidence	incidence	NOUN
dpc-4372	30	8	of	of	ADP
dpc-4372	30	9	seborrheic	seborrheic	PROPN
dpc-4372	30	10	dermatitis	dermatitis	NOUN
dpc-4372	30	11	(	(	PUNCT
dpc-4372	30	12	sd	sd	NOUN
dpc-4372	30	13	)	)	PUNCT
dpc-4372	30	14	,	,	PUNCT
dpc-4372	30	15	rosacea	rosacea	NOUN
dpc-4372	30	16	,	,	PUNCT
dpc-4372	30	17	and	and	CCONJ
dpc-4372	30	18	sweating	sweat	VERB
dpc-4372	30	19	dysfunction	dysfunction	NOUN
dpc-4372	30	20	in	in	ADP
dpc-4372	30	21	patients	patient	NOUN
dpc-4372	30	22	with	with	ADP
dpc-4372	30	23	pd	pd	PROPN
dpc-4372	31	1	[	[	X
dpc-4372	31	2	1–10	1–10	NOUN
dpc-4372	31	3	]	]	PUNCT
dpc-4372	31	4	.	.	PUNCT
dpc-4372	32	1	in	in	ADP
dpc-4372	32	2	this	this	DET
dpc-4372	32	3	context	context	NOUN
dpc-4372	32	4	,	,	PUNCT
dpc-4372	32	5	there	there	PRON
dpc-4372	32	6	is	be	VERB
dpc-4372	32	7	a	a	DET
dpc-4372	32	8	need	need	NOUN
dpc-4372	32	9	for	for	ADP
dpc-4372	32	10	further	further	ADJ
dpc-4372	32	11	studies	study	NOUN
dpc-4372	32	12	on	on	ADP
dpc-4372	32	13	the	the	DET
dpc-4372	32	14	relationship	relationship	NOUN
dpc-4372	32	15	between	between	ADP
dpc-4372	32	16	skin	skin	NOUN
dpc-4372	32	17	diseases	disease	NOUN
dpc-4372	32	18	and	and	CCONJ
dpc-4372	32	19	pd	pd	NOUN
dpc-4372	32	20	in	in	ADP
dpc-4372	32	21	order	order	NOUN
dpc-4372	32	22	to	to	PART
dpc-4372	32	23	elucidate	elucidate	VERB
dpc-4372	32	24	the	the	DET
dpc-4372	32	25	pathogenesis	pathogenesis	NOUN
dpc-4372	32	26	of	of	ADP
dpc-4372	32	27	these	these	DET
dpc-4372	32	28	diseases	disease	NOUN
dpc-4372	32	29	.	.	PUNCT
dpc-4372	33	1	nevertheless	nevertheless	ADV
dpc-4372	33	2	,	,	PUNCT
dpc-4372	33	3	skin	skin	NOUN
dpc-4372	33	4	problems	problem	NOUN
dpc-4372	33	5	associated	associate	VERB
dpc-4372	33	6	with	with	ADP
dpc-4372	33	7	pd	pd	PROPN
dpc-4372	33	8	that	that	PRON
dpc-4372	33	9	worsen	worsen	VERB
dpc-4372	33	10	the	the	DET
dpc-4372	33	11	quality	quality	NOUN
dpc-4372	33	12	of	of	ADP
dpc-4372	33	13	life	life	NOUN
dpc-4372	33	14	of	of	ADP
dpc-4372	33	15	pd	pd	PROPN
dpc-4372	33	16	patients	patient	NOUN
dpc-4372	33	17	go	go	VERB
dpc-4372	33	18	unnoticed	unnoticed	ADJ
dpc-4372	33	19	or	or	CCONJ
dpc-4372	33	20	are	be	AUX
dpc-4372	33	21	underestimated	underestimate	VERB
dpc-4372	33	22	by	by	ADP
dpc-4372	33	23	both	both	CCONJ
dpc-4372	33	24	the	the	DET
dpc-4372	33	25	patient	patient	NOUN
dpc-4372	33	26	and	and	CCONJ
dpc-4372	33	27	the	the	DET
dpc-4372	33	28	doctor	doctor	NOUN
dpc-4372	33	29	who	who	PRON
dpc-4372	33	30	follows	follow	VERB
dpc-4372	33	31	the	the	DET
dpc-4372	33	32	patient	patient	NOUN
dpc-4372	33	33	.	.	PUNCT
dpc-4372	34	1	objectives	objective	NOUN
dpc-4372	34	2	in	in	ADP
dpc-4372	34	3	view	view	NOUN
dpc-4372	34	4	of	of	ADP
dpc-4372	34	5	the	the	DET
dpc-4372	34	6	foregoing	foregoing	NOUN
dpc-4372	34	7	,	,	PUNCT
dpc-4372	34	8	the	the	DET
dpc-4372	34	9	objective	objective	NOUN
dpc-4372	34	10	of	of	ADP
dpc-4372	34	11	this	this	DET
dpc-4372	34	12	study	study	NOUN
dpc-4372	34	13	was	be	AUX
dpc-4372	34	14	to	to	PART
dpc-4372	34	15	investigate	investigate	VERB
dpc-4372	34	16	the	the	DET
dpc-4372	34	17	prevalence	prevalence	NOUN
dpc-4372	34	18	and	and	CCONJ
dpc-4372	34	19	clinical	clinical	ADJ
dpc-4372	34	20	features	feature	NOUN
dpc-4372	34	21	of	of	ADP
dpc-4372	34	22	skin	skin	NOUN
dpc-4372	34	23	findings	finding	NOUN
dpc-4372	34	24	in	in	ADP
dpc-4372	34	25	pd	pd	PROPN
dpc-4372	34	26	in	in	ADP
dpc-4372	34	27	order	order	NOUN
dpc-4372	34	28	to	to	PART
dpc-4372	34	29	reveal	reveal	VERB
dpc-4372	34	30	the	the	DET
dpc-4372	34	31	relationships	relationship	NOUN
dpc-4372	34	32	,	,	PUNCT
dpc-4372	34	33	if	if	SCONJ
dpc-4372	34	34	any	any	PRON
dpc-4372	34	35	,	,	PUNCT
dpc-4372	34	36	between	between	ADP
dpc-4372	34	37	the	the	DET
dpc-4372	34	38	skin	skin	NOUN
dpc-4372	34	39	and	and	CCONJ
dpc-4372	34	40	the	the	DET
dpc-4372	34	41	nervous	nervous	ADJ
dpc-4372	34	42	system	system	NOUN
dpc-4372	34	43	.	.	PUNCT
dpc-4372	35	1	materials	material	NOUN
dpc-4372	35	2	and	and	CCONJ
dpc-4372	35	3	methods	method	NOUN
dpc-4372	35	4	study	study	VERB
dpc-4372	35	5	population	population	NOUN
dpc-4372	35	6	the	the	DET
dpc-4372	35	7	population	population	NOUN
dpc-4372	35	8	of	of	ADP
dpc-4372	35	9	this	this	DET
dpc-4372	35	10	cross	cross	ADJ
dpc-4372	35	11	-	-	ADJ
dpc-4372	35	12	sectional	sectional	ADJ
dpc-4372	35	13	observational	observational	ADJ
dpc-4372	35	14	study	study	NOUN
dpc-4372	35	15	consisted	consist	VERB
dpc-4372	35	16	of	of	ADP
dpc-4372	35	17	patients	patient	NOUN
dpc-4372	35	18	who	who	PRON
dpc-4372	35	19	were	be	AUX
dpc-4372	35	20	followed	follow	VERB
dpc-4372	35	21	up	up	ADP
dpc-4372	35	22	with	with	ADP
dpc-4372	35	23	pd	pd	NOUN
dpc-4372	35	24	diagnosis	diagnosis	NOUN
dpc-4372	35	25	in	in	ADP
dpc-4372	35	26	the	the	DET
dpc-4372	35	27	hospital	hospital	NOUN
dpc-4372	35	28	neurology	neurology	NOUN
dpc-4372	35	29	outpatient	outpatient	NOUN
dpc-4372	35	30	clinic	clinic	NOUN
dpc-4372	35	31	and	and	CCONJ
dpc-4372	35	32	for	for	ADP
dpc-4372	35	33	whom	whom	PRON
dpc-4372	35	34	the	the	DET
dpc-4372	35	35	dermatology	dermatology	NOUN
dpc-4372	35	36	outpatient	outpatient	NOUN
dpc-4372	35	37	clinic	clinic	NOUN
dpc-4372	35	38	was	be	AUX
dpc-4372	35	39	consulted	consult	VERB
dpc-4372	35	40	between	between	ADP
dpc-4372	35	41	march	march	PROPN
dpc-4372	35	42	2022	2022	NUM
dpc-4372	35	43	and	and	CCONJ
dpc-4372	35	44	march	march	PROPN
dpc-4372	35	45	2023	2023	NUM
dpc-4372	35	46	.	.	PUNCT
dpc-4372	36	1	demographic	demographic	ADJ
dpc-4372	36	2	and	and	CCONJ
dpc-4372	36	3	clinical	clinical	ADJ
dpc-4372	36	4	characteristics	characteristic	NOUN
dpc-4372	36	5	patients	patient	NOUN
dpc-4372	36	6	’	'	PUNCT
dpc-4372	36	7	demographic	demographic	ADJ
dpc-4372	36	8	and	and	CCONJ
dpc-4372	36	9	clinical	clinical	ADJ
dpc-4372	36	10	characteristics	characteristic	NOUN
dpc-4372	36	11	,	,	PUNCT
dpc-4372	36	12	including	include	VERB
dpc-4372	36	13	age	age	NOUN
dpc-4372	36	14	,	,	PUNCT
dpc-4372	36	15	sex	sex	NOUN
dpc-4372	36	16	,	,	PUNCT
dpc-4372	36	17	known	know	VERB
dpc-4372	36	18	dermatological	dermatological	ADJ
dpc-4372	36	19	diseases	disease	NOUN
dpc-4372	36	20	,	,	PUNCT
dpc-4372	36	21	pd	pd	PROPN
dpc-4372	36	22	duration	duration	NOUN
dpc-4372	36	23	,	,	PUNCT
dpc-4372	36	24	pd	pd	PROPN
dpc-4372	36	25	stage	stage	NOUN
dpc-4372	36	26	according	accord	VERB
dpc-4372	36	27	to	to	ADP
dpc-4372	36	28	hoehn	hoehn	PROPN
dpc-4372	36	29	&	&	CCONJ
dpc-4372	36	30	yahr	yahr	PROPN
dpc-4372	36	31	staging	staging	NOUN
dpc-4372	36	32	system	system	NOUN
dpc-4372	36	33	(	(	PUNCT
dpc-4372	36	34	stage	stage	NOUN
dpc-4372	36	35	1	1	NUM
dpc-4372	36	36	:	:	PUNCT
dpc-4372	36	37	unilateral	unilateral	ADJ
dpc-4372	36	38	involvement	involvement	NOUN
dpc-4372	36	39	only	only	ADV
dpc-4372	36	40	,	,	PUNCT
dpc-4372	36	41	usually	usually	ADV
dpc-4372	36	42	with	with	ADP
dpc-4372	36	43	minimal	minimal	ADJ
dpc-4372	36	44	or	or	CCONJ
dpc-4372	36	45	no	no	DET
dpc-4372	36	46	functional	functional	ADJ
dpc-4372	36	47	disability	disability	NOUN
dpc-4372	36	48	;	;	PUNCT
dpc-4372	36	49	stage	stage	NOUN
dpc-4372	36	50	2	2	NUM
dpc-4372	36	51	:	:	PUNCT
dpc-4372	36	52	bilateral	bilateral	ADJ
dpc-4372	36	53	or	or	CCONJ
dpc-4372	36	54	midline	midline	NOUN
dpc-4372	36	55	involvement	involvement	NOUN
dpc-4372	36	56	,	,	PUNCT
dpc-4372	36	57	without	without	ADP
dpc-4372	36	58	impairment	impairment	NOUN
dpc-4372	36	59	of	of	ADP
dpc-4372	36	60	balance	balance	NOUN
dpc-4372	36	61	;	;	PUNCT
dpc-4372	36	62	stage	stage	NOUN
dpc-4372	36	63	3	3	NUM
dpc-4372	36	64	:	:	PUNCT
dpc-4372	36	65	bilateral	bilateral	ADJ
dpc-4372	36	66	disease	disease	NOUN
dpc-4372	36	67	,	,	PUNCT
dpc-4372	36	68	mild	mild	ADJ
dpc-4372	36	69	to	to	ADP
dpc-4372	36	70	moderate	moderate	ADJ
dpc-4372	36	71	disability	disability	NOUN
dpc-4372	36	72	with	with	ADP
dpc-4372	36	73	impaired	impaired	ADJ
dpc-4372	36	74	postural	postural	ADJ
dpc-4372	36	75	reflexes	reflex	NOUN
dpc-4372	36	76	;	;	PUNCT
dpc-4372	36	77	physical	physical	ADJ
dpc-4372	36	78	independence	independence	NOUN
dpc-4372	36	79	,	,	PUNCT
dpc-4372	36	80	stage	stage	NOUN
dpc-4372	36	81	4	4	NUM
dpc-4372	36	82	:	:	PUNCT
dpc-4372	36	83	severely	severely	ADV
dpc-4372	36	84	disabling	disable	VERB
dpc-4372	36	85	disease	disease	NOUN
dpc-4372	36	86	,	,	PUNCT
dpc-4372	36	87	ability	ability	NOUN
dpc-4372	36	88	to	to	PART
dpc-4372	36	89	walk	walk	VERB
dpc-4372	36	90	or	or	CCONJ
dpc-4372	36	91	stand	stand	VERB
dpc-4372	36	92	unassisted	unassiste	VERB
dpc-4372	36	93	,	,	PUNCT
dpc-4372	36	94	stage	stage	NOUN
dpc-4372	36	95	5	5	NUM
dpc-4372	36	96	:	:	PUNCT
dpc-4372	36	97	confinement	confinement	NOUN
dpc-4372	36	98	to	to	ADP
dpc-4372	36	99	bed	bed	NOUN
dpc-4372	36	100	or	or	CCONJ
dpc-4372	36	101	wheelchair	wheelchair	NOUN
dpc-4372	36	102	unless	unless	SCONJ
dpc-4372	36	103	aided	aid	VERB
dpc-4372	36	104	)	)	PUNCT
dpc-4372	36	105	,	,	PUNCT
dpc-4372	36	106	additional	additional	ADJ
dpc-4372	36	107	chronic	chronic	ADJ
dpc-4372	36	108	diseases	disease	NOUN
dpc-4372	36	109	,	,	PUNCT
dpc-4372	36	110	regularly	regularly	ADV
dpc-4372	36	111	used	use	VERB
dpc-4372	36	112	pd	pd	NOUN
dpc-4372	36	113	medications	medication	NOUN
dpc-4372	36	114	and	and	CCONJ
dpc-4372	36	115	other	other	ADJ
dpc-4372	36	116	regularly	regularly	ADV
dpc-4372	36	117	used	use	VERB
dpc-4372	36	118	medications	medication	NOUN
dpc-4372	36	119	were	be	AUX
dpc-4372	36	120	recorded	record	VERB
dpc-4372	36	121	.	.	PUNCT
dpc-4372	37	1	physical	physical	ADJ
dpc-4372	37	2	examinations	examination	NOUN
dpc-4372	37	3	whole	whole	ADJ
dpc-4372	37	4	-	-	PUNCT
dpc-4372	37	5	body	body	NOUN
dpc-4372	37	6	skin	skin	NOUN
dpc-4372	37	7	,	,	PUNCT
dpc-4372	37	8	scalp	scalp	NOUN
dpc-4372	37	9	,	,	PUNCT
dpc-4372	37	10	nail	nail	NOUN
dpc-4372	37	11	,	,	PUNCT
dpc-4372	37	12	and	and	CCONJ
dpc-4372	37	13	oral	oral	ADJ
dpc-4372	37	14	mucosa	mucosa	NOUN
dpc-4372	37	15	examinations	examination	NOUN
dpc-4372	37	16	were	be	AUX
dpc-4372	37	17	performed	perform	VERB
dpc-4372	37	18	on	on	ADP
dpc-4372	37	19	all	all	DET
dpc-4372	37	20	patients	patient	NOUN
dpc-4372	37	21	,	,	PUNCT
dpc-4372	37	22	and	and	CCONJ
dpc-4372	37	23	the	the	DET
dpc-4372	37	24	resulting	result	VERB
dpc-4372	37	25	skin	skin	NOUN
dpc-4372	37	26	findings	finding	NOUN
dpc-4372	37	27	were	be	AUX
dpc-4372	37	28	noted	note	VERB
dpc-4372	37	29	.	.	PUNCT
dpc-4372	38	1	pathology	pathology	NOUN
dpc-4372	38	2	investigations	investigation	NOUN
dpc-4372	38	3	it	it	PRON
dpc-4372	38	4	was	be	AUX
dpc-4372	38	5	investigated	investigate	VERB
dpc-4372	38	6	whether	whether	SCONJ
dpc-4372	38	7	these	these	DET
dpc-4372	38	8	pathologies	pathology	NOUN
dpc-4372	38	9	started	start	VERB
dpc-4372	38	10	before	before	ADV
dpc-4372	38	11	,	,	PUNCT
dpc-4372	38	12	after	after	SCONJ
dpc-4372	38	13	,	,	PUNCT
dpc-4372	38	14	or	or	CCONJ
dpc-4372	38	15	simultaneously	simultaneously	ADV
dpc-4372	38	16	with	with	ADP
dpc-4372	38	17	pd	pd	PROPN
dpc-4372	38	18	and	and	CCONJ
dpc-4372	38	19	whether	whether	SCONJ
dpc-4372	38	20	they	they	PRON
dpc-4372	38	21	progressed	progress	VERB
dpc-4372	38	22	with	with	ADP
dpc-4372	38	23	pd	pd	PROPN
dpc-4372	38	24	.	.	PUNCT
dpc-4372	38	25	ethical	ethical	ADJ
dpc-4372	38	26	approval	approval	NOUN
dpc-4372	38	27	the	the	DET
dpc-4372	38	28	study	study	NOUN
dpc-4372	38	29	protocol	protocol	NOUN
dpc-4372	38	30	was	be	AUX
dpc-4372	38	31	approved	approve	VERB
dpc-4372	38	32	by	by	ADP
dpc-4372	38	33	the	the	DET
dpc-4372	38	34	hospital	hospital	NOUN
dpc-4372	38	35	ethics	ethic	NOUN
dpc-4372	38	36	committee	committee	PROPN
dpc-4372	38	37	(	(	PUNCT
dpc-4372	38	38	approval	approval	NOUN
dpc-4372	38	39	no	no	INTJ
dpc-4372	38	40	:	:	PUNCT
dpc-4372	38	41	e1	e1	NOUN
dpc-4372	38	42	-	-	PUNCT
dpc-4372	38	43	22	22	NUM
dpc-4372	38	44	-	-	PUNCT
dpc-4372	38	45	2404	2404	NUM
dpc-4372	38	46	)	)	PUNCT
dpc-4372	38	47	.	.	PUNCT
dpc-4372	39	1	statistical	statistical	ADJ
dpc-4372	39	2	analysis	analysis	NOUN
dpc-4372	39	3	statistical	statistical	ADJ
dpc-4372	39	4	analyses	analysis	NOUN
dpc-4372	39	5	of	of	ADP
dpc-4372	39	6	the	the	DET
dpc-4372	39	7	collected	collect	VERB
dpc-4372	39	8	data	datum	NOUN
dpc-4372	39	9	were	be	AUX
dpc-4372	39	10	conducted	conduct	VERB
dpc-4372	39	11	using	use	VERB
dpc-4372	39	12	the	the	DET
dpc-4372	39	13	spss	spss	PROPN
dpc-4372	39	14	23.0	23.0	NUM
dpc-4372	39	15	(	(	PUNCT
dpc-4372	39	16	statistical	statistical	ADJ
dpc-4372	39	17	product	product	NOUN
dpc-4372	39	18	and	and	CCONJ
dpc-4372	39	19	service	service	NOUN
dpc-4372	39	20	solutions	solution	NOUN
dpc-4372	39	21	for	for	ADP
dpc-4372	39	22	windows	window	NOUN
dpc-4372	39	23	,	,	PUNCT
dpc-4372	39	24	version	version	NOUN
dpc-4372	39	25	23.0	23.0	NUM
dpc-4372	39	26	,	,	PUNCT
dpc-4372	39	27	ibm	ibm	PROPN
dpc-4372	39	28	corp	corp	PROPN
dpc-4372	39	29	.	.	PROPN
dpc-4372	39	30	,	,	PUNCT
dpc-4372	39	31	armonk	armonk	PROPN
dpc-4372	39	32	,	,	PUNCT
dpc-4372	39	33	ny	ny	PROPN
dpc-4372	39	34	,	,	PUNCT
dpc-4372	39	35	us	we	PRON
dpc-4372	39	36	,	,	PUNCT
dpc-4372	39	37	2015	2015	NUM
dpc-4372	39	38	)	)	PUNCT
dpc-4372	39	39	software	software	NOUN
dpc-4372	39	40	package	package	NOUN
dpc-4372	39	41	.	.	PUNCT
dpc-4372	40	1	percentages	percentage	NOUN
dpc-4372	40	2	and	and	CCONJ
dpc-4372	40	3	proportions	proportion	NOUN
dpc-4372	40	4	were	be	AUX
dpc-4372	40	5	used	use	VERB
dpc-4372	40	6	to	to	PART
dpc-4372	40	7	express	express	VERB
dpc-4372	40	8	categorical	categorical	ADJ
dpc-4372	40	9	variables	variable	NOUN
dpc-4372	40	10	,	,	PUNCT
dpc-4372	40	11	and	and	CCONJ
dpc-4372	40	12	mean	mean	ADJ
dpc-4372	40	13	(	(	PUNCT
dpc-4372	40	14	standard	standard	ADJ
dpc-4372	40	15	deviation	deviation	NOUN
dpc-4372	40	16	,	,	PUNCT
dpc-4372	40	17	sd	sd	NOUN
dpc-4372	40	18	)	)	PUNCT
dpc-4372	40	19	or	or	CCONJ
dpc-4372	40	20	median	median	NOUN
dpc-4372	40	21	(	(	PUNCT
dpc-4372	40	22	interquartile	interquartile	NOUN
dpc-4372	40	23	range	range	PROPN
dpc-4372	40	24	,	,	PUNCT
dpc-4372	40	25	iqr	iqr	NOUN
dpc-4372	40	26	)	)	PUNCT
dpc-4372	40	27	values	value	NOUN
dpc-4372	40	28	were	be	AUX
dpc-4372	40	29	used	use	VERB
dpc-4372	40	30	to	to	PART
dpc-4372	40	31	express	express	VERB
dpc-4372	40	32	numerical	numerical	ADJ
dpc-4372	40	33	variables	variable	NOUN
dpc-4372	40	34	.	.	PUNCT
dpc-4372	41	1	categorical	categorical	ADJ
dpc-4372	41	2	variables	variable	NOUN
dpc-4372	41	3	were	be	AUX
dpc-4372	41	4	analyzed	analyze	VERB
dpc-4372	41	5	using	use	VERB
dpc-4372	41	6	the	the	DET
dpc-4372	41	7	chi	chi	ADJ
dpc-4372	41	8	-	-	PUNCT
dpc-4372	41	9	square	square	ADJ
dpc-4372	41	10	test	test	NOUN
dpc-4372	41	11	,	,	PUNCT
dpc-4372	41	12	and	and	CCONJ
dpc-4372	41	13	numerical	numerical	ADJ
dpc-4372	41	14	variables	variable	NOUN
dpc-4372	41	15	were	be	AUX
dpc-4372	41	16	analyzed	analyze	VERB
dpc-4372	41	17	using	use	VERB
dpc-4372	41	18	the	the	DET
dpc-4372	41	19	student	student	NOUN
dpc-4372	41	20	’s	’s	PART
dpc-4372	41	21	t	t	PROPN
dpc-4372	41	22	-	-	PUNCT
dpc-4372	41	23	test	test	NOUN
dpc-4372	41	24	or	or	CCONJ
dpc-4372	41	25	mann	mann	PROPN
dpc-4372	41	26	-	-	PUNCT
dpc-4372	41	27	whitney	whitney	PROPN
dpc-4372	41	28	u	u	PROPN
dpc-4372	41	29	test	test	NOUN
dpc-4372	41	30	.	.	PUNCT
dpc-4372	42	1	probability	probability	NOUN
dpc-4372	42	2	(	(	PUNCT
dpc-4372	42	3	p	p	NOUN
dpc-4372	42	4	)	)	PUNCT
dpc-4372	42	5	statistics	statistic	NOUN
dpc-4372	42	6	of	of	ADP
dpc-4372	42	7	<	<	X
dpc-4372	42	8	0.05	0.05	NUM
dpc-4372	42	9	were	be	AUX
dpc-4372	42	10	deemed	deem	VERB
dpc-4372	42	11	to	to	PART
dpc-4372	42	12	indicate	indicate	VERB
dpc-4372	42	13	statistical	statistical	ADJ
dpc-4372	42	14	significance	significance	NOUN
dpc-4372	42	15	.	.	PUNCT
dpc-4372	43	1	results	result	VERB
dpc-4372	43	2	demographic	demographic	ADJ
dpc-4372	43	3	and	and	CCONJ
dpc-4372	43	4	clinical	clinical	ADJ
dpc-4372	43	5	characteristics	characteristic	NOUN
dpc-4372	43	6	of	of	ADP
dpc-4372	43	7	patients	patient	NOUN
dpc-4372	43	8	the	the	DET
dpc-4372	43	9	study	study	NOUN
dpc-4372	43	10	sample	sample	NOUN
dpc-4372	43	11	consisted	consist	VERB
dpc-4372	43	12	of	of	ADP
dpc-4372	43	13	215	215	NUM
dpc-4372	43	14	pd	pd	NOUN
dpc-4372	43	15	patients	patient	NOUN
dpc-4372	43	16	:	:	PUNCT
dpc-4372	43	17	143	143	NUM
dpc-4372	43	18	(	(	PUNCT
dpc-4372	43	19	66.5	66.5	NUM
dpc-4372	43	20	%	%	NOUN
dpc-4372	43	21	)	)	PUNCT
dpc-4372	43	22	male	male	NOUN
dpc-4372	43	23	and	and	CCONJ
dpc-4372	43	24	72	72	NUM
dpc-4372	43	25	(	(	PUNCT
dpc-4372	43	26	33.5	33.5	NUM
dpc-4372	43	27	%	%	NOUN
dpc-4372	43	28	)	)	PUNCT
dpc-4372	43	29	female	female	NOUN
dpc-4372	43	30	.	.	PUNCT
dpc-4372	44	1	the	the	DET
dpc-4372	44	2	mean	mean	ADJ
dpc-4372	44	3	age	age	NOUN
dpc-4372	44	4	of	of	ADP
dpc-4372	44	5	the	the	DET
dpc-4372	44	6	sample	sample	NOUN
dpc-4372	44	7	was	be	AUX
dpc-4372	44	8	65.15	65.15	NUM
dpc-4372	44	9	±	±	NUM
dpc-4372	44	10	9.8	9.8	NUM
dpc-4372	44	11	years	year	NOUN
dpc-4372	44	12	.	.	PUNCT
dpc-4372	45	1	of	of	ADP
dpc-4372	45	2	the	the	DET
dpc-4372	45	3	pd	pd	PROPN
dpc-4372	45	4	patients	patient	NOUN
dpc-4372	45	5	followed	follow	VERB
dpc-4372	45	6	at	at	ADP
dpc-4372	45	7	the	the	DET
dpc-4372	45	8	neurology	neurology	NOUN
dpc-4372	45	9	polyclinic	polyclinic	ADJ
dpc-4372	45	10	and	and	CCONJ
dpc-4372	45	11	for	for	ADP
dpc-4372	45	12	whom	whom	PRON
dpc-4372	45	13	dermatology	dermatology	NOUN
dpc-4372	45	14	outpatient	outpatient	NOUN
dpc-4372	45	15	clinic	clinic	NOUN
dpc-4372	45	16	was	be	AUX
dpc-4372	45	17	consulted	consult	VERB
dpc-4372	45	18	,	,	PUNCT
dpc-4372	45	19	skin	skin	NOUN
dpc-4372	45	20	diseases	disease	NOUN
dpc-4372	45	21	were	be	AUX
dpc-4372	45	22	detected	detect	VERB
dpc-4372	45	23	in	in	ADP
dpc-4372	45	24	16.3	16.3	NUM
dpc-4372	45	25	%	%	NOUN
dpc-4372	45	26	,	,	PUNCT
dpc-4372	45	27	scalp	scalp	NOUN
dpc-4372	45	28	disease	disease	NOUN
dpc-4372	45	29	in	in	ADP
dpc-4372	45	30	5.1	5.1	NUM
dpc-4372	45	31	%	%	NOUN
dpc-4372	45	32	,	,	PUNCT
dpc-4372	45	33	nail	nail	NOUN
dpc-4372	45	34	disorders	disorder	NOUN
dpc-4372	45	35	in	in	ADP
dpc-4372	45	36	2.8	2.8	NUM
dpc-4372	45	37	%	%	NOUN
dpc-4372	45	38	,	,	PUNCT
dpc-4372	45	39	and	and	CCONJ
dpc-4372	45	40	no	no	DET
dpc-4372	45	41	dermatological	dermatological	ADJ
dpc-4372	45	42	problem	problem	NOUN
dpc-4372	45	43	was	be	AUX
dpc-4372	45	44	detected	detect	VERB
dpc-4372	45	45	in	in	ADP
dpc-4372	45	46	75.8	75.8	NUM
dpc-4372	45	47	%	%	NOUN
dpc-4372	45	48	.	.	PUNCT
dpc-4372	46	1	additionally	additionally	ADV
dpc-4372	46	2	,	,	PUNCT
dpc-4372	46	3	systemic	systemic	ADJ
dpc-4372	46	4	disease	disease	NOUN
dpc-4372	46	5	was	be	AUX
dpc-4372	46	6	detected	detect	VERB
dpc-4372	46	7	in	in	ADP
dpc-4372	46	8	43.3	43.3	NUM
dpc-4372	46	9	%	%	NOUN
dpc-4372	46	10	of	of	ADP
dpc-4372	46	11	the	the	DET
dpc-4372	46	12	patients	patient	NOUN
dpc-4372	46	13	.	.	PUNCT
dpc-4372	47	1	patients	patient	NOUN
dpc-4372	47	2	’	'	PUNCT
dpc-4372	47	3	demographic	demographic	ADJ
dpc-4372	47	4	and	and	CCONJ
dpc-4372	47	5	clinical	clinical	ADJ
dpc-4372	47	6	characteristics	characteristic	NOUN
dpc-4372	47	7	are	be	AUX
dpc-4372	47	8	summarized	summarize	VERB
dpc-4372	47	9	in	in	ADP
dpc-4372	47	10	table	table	NOUN
dpc-4372	47	11	1	1	NUM
dpc-4372	47	12	.	.	PUNCT
dpc-4372	48	1	findings	finding	NOUN
dpc-4372	48	2	from	from	ADP
dpc-4372	48	3	dermatological	dermatological	ADJ
dpc-4372	48	4	examination	examination	NOUN
dpc-4372	48	5	skin	skin	NOUN
dpc-4372	48	6	,	,	PUNCT
dpc-4372	48	7	scalp	scalp	NOUN
dpc-4372	48	8	,	,	PUNCT
dpc-4372	48	9	nail	nail	NOUN
dpc-4372	48	10	,	,	PUNCT
dpc-4372	48	11	and	and	CCONJ
dpc-4372	48	12	oral	oral	ADJ
dpc-4372	48	13	mucosa	mucosa	NOUN
dpc-4372	48	14	findings	finding	NOUN
dpc-4372	48	15	obtained	obtain	VERB
dpc-4372	48	16	in	in	ADP
dpc-4372	48	17	dermatological	dermatological	ADJ
dpc-4372	48	18	examination	examination	NOUN
dpc-4372	48	19	revealed	reveal	VERB
dpc-4372	48	20	at	at	ADP
dpc-4372	48	21	least	least	ADV
dpc-4372	48	22	one	one	NUM
dpc-4372	48	23	skin	skin	NOUN
dpc-4372	48	24	disease	disease	NOUN
dpc-4372	48	25	in	in	ADP
dpc-4372	48	26	92.1	92.1	NUM
dpc-4372	48	27	%	%	NOUN
dpc-4372	48	28	of	of	ADP
dpc-4372	48	29	the	the	DET
dpc-4372	48	30	patients	patient	NOUN
dpc-4372	48	31	,	,	PUNCT
dpc-4372	48	32	at	at	ADV
dpc-4372	48	33	least	least	ADV
dpc-4372	48	34	one	one	NUM
dpc-4372	48	35	scalp	scalp	NOUN
dpc-4372	48	36	disease	disease	NOUN
dpc-4372	48	37	in	in	ADP
dpc-4372	48	38	39.1	39.1	NUM
dpc-4372	48	39	%	%	NOUN
dpc-4372	48	40	,	,	PUNCT
dpc-4372	48	41	original	original	ADJ
dpc-4372	48	42	article	article	NOUN
dpc-4372	48	43	|	|	ADV
dpc-4372	48	44	dermatol	dermatol	ADJ
dpc-4372	48	45	pract	pract	NOUN
dpc-4372	48	46	concept	concept	NOUN
dpc-4372	48	47	.	.	PUNCT
dpc-4372	49	1	2024;14(4):e2024241	2024;14(4):e2024241	NUM
dpc-4372	49	2	3	3	NUM
dpc-4372	49	3	table	table	NOUN
dpc-4372	49	4	1	1	NUM
dpc-4372	49	5	.	.	PUNCT
dpc-4372	49	6	demographic	demographic	ADJ
dpc-4372	49	7	and	and	CCONJ
dpc-4372	49	8	clinical	clinical	ADJ
dpc-4372	49	9	characteristics	characteristic	NOUN
dpc-4372	49	10	of	of	ADP
dpc-4372	49	11	patients	patient	NOUN
dpc-4372	49	12	participating	participate	VERB
dpc-4372	49	13	in	in	ADP
dpc-4372	49	14	the	the	DET
dpc-4372	49	15	study	study	NOUN
dpc-4372	49	16	.	.	PUNCT
dpc-4372	50	1	sex	sex	NOUN
dpc-4372	50	2	frequency	frequency	NOUN
dpc-4372	50	3	(	(	PUNCT
dpc-4372	50	4	%	%	INTJ
dpc-4372	50	5	)	)	PUNCT
dpc-4372	50	6	female	female	ADJ
dpc-4372	50	7	33.5	33.5	NUM
dpc-4372	50	8	male	male	NOUN
dpc-4372	50	9	66.5	66.5	NUM
dpc-4372	50	10	age	age	NOUN
dpc-4372	50	11	,	,	PUNCT
dpc-4372	50	12	average	average	ADJ
dpc-4372	50	13	(	(	PUNCT
dpc-4372	50	14	sd	sd	NOUN
dpc-4372	50	15	)	)	PUNCT
dpc-4372	50	16	65.15	65.15	NUM
dpc-4372	50	17	(	(	PUNCT
dpc-4372	50	18	±9.8	±9.8	NOUN
dpc-4372	50	19	)	)	PUNCT
dpc-4372	50	20	reason	reason	NOUN
dpc-4372	50	21	for	for	ADP
dpc-4372	50	22	attending	attend	VERB
dpc-4372	50	23	the	the	DET
dpc-4372	50	24	dermatology	dermatology	NOUN
dpc-4372	50	25	polyclinic	polyclinic	ADJ
dpc-4372	50	26	frequency	frequency	NOUN
dpc-4372	50	27	(	(	PUNCT
dpc-4372	50	28	%	%	NOUN
dpc-4372	50	29	)	)	PUNCT
dpc-4372	50	30	skin	skin	NOUN
dpc-4372	50	31	disease	disease	NOUN
dpc-4372	50	32	16.3	16.3	NUM
dpc-4372	50	33	scalp	scalp	NOUN
dpc-4372	50	34	disease	disease	NOUN
dpc-4372	50	35	5.1	5.1	NUM
dpc-4372	50	36	nail	nail	NOUN
dpc-4372	50	37	disease	disease	NOUN
dpc-4372	50	38	2.8	2.8	NUM
dpc-4372	50	39	no	no	DET
dpc-4372	50	40	complaint	complaint	NOUN
dpc-4372	50	41	75.8	75.8	NUM
dpc-4372	50	42	pd	pd	NOUN
dpc-4372	50	43	duration	duration	NOUN
dpc-4372	50	44	median	median	NOUN
dpc-4372	50	45	,	,	PUNCT
dpc-4372	50	46	years	year	NOUN
dpc-4372	50	47	(	(	PUNCT
dpc-4372	50	48	iqr	iqr	NOUN
dpc-4372	50	49	)	)	PUNCT
dpc-4372	50	50	4	4	NUM
dpc-4372	50	51	(	(	PUNCT
dpc-4372	50	52	2	2	NUM
dpc-4372	50	53	-	-	SYM
dpc-4372	50	54	7	7	NUM
dpc-4372	50	55	)	)	PUNCT
dpc-4372	50	56	pd	pd	NOUN
dpc-4372	50	57	stage	stage	NOUN
dpc-4372	50	58	frequency	frequency	NOUN
dpc-4372	50	59	(	(	PUNCT
dpc-4372	50	60	%	%	NOUN
dpc-4372	50	61	)	)	PUNCT
dpc-4372	50	62	1	1	NUM
dpc-4372	50	63	17.2	17.2	NUM
dpc-4372	50	64	2	2	NUM
dpc-4372	50	65	51.6	51.6	NUM
dpc-4372	50	66	3	3	NUM
dpc-4372	50	67	20.1	20.1	NUM
dpc-4372	50	68	4	4	NUM
dpc-4372	50	69	8.8	8.8	NUM
dpc-4372	50	70	5	5	NUM
dpc-4372	50	71	2.3	2.3	NUM
dpc-4372	50	72	pd	pd	NOUN
dpc-4372	50	73	treatment	treatment	NOUN
dpc-4372	50	74	frequency	frequency	NOUN
dpc-4372	50	75	(	(	PUNCT
dpc-4372	50	76	%	%	INTJ
dpc-4372	50	77	)	)	PUNCT
dpc-4372	50	78	levodopa+dk	levodopa+dk	PUNCT
dpc-4372	50	79	inhibitor	inhibitor	NOUN
dpc-4372	50	80	73	73	NUM
dpc-4372	50	81	mao	mao	NOUN
dpc-4372	50	82	b	b	PROPN
dpc-4372	50	83	inhibitor	inhibitor	NOUN
dpc-4372	50	84	83.3	83.3	NUM
dpc-4372	50	85	non	non	ADJ
dpc-4372	50	86	-	-	ADJ
dpc-4372	50	87	ergot	ergot	ADJ
dpc-4372	50	88	dopamine	dopamine	NOUN
dpc-4372	50	89	agonist	agonist	NOUN
dpc-4372	50	90	81.4	81.4	NUM
dpc-4372	50	91	levodopa+dk	levodopa+dk	PART
dpc-4372	50	92	inhibitor	inhibitor	NOUN
dpc-4372	50	93	+	+	NOUN
dpc-4372	50	94	comt	comt	PROPN
dpc-4372	50	95	inhibitor	inhibitor	NOUN
dpc-4372	50	96	25.1	25.1	NUM
dpc-4372	50	97	amantadine	amantadine	NOUN
dpc-4372	50	98	21.4	21.4	NUM
dpc-4372	50	99	levodopa	levodopa	NOUN
dpc-4372	50	100	/	/	SYM
dpc-4372	50	101	carbidopa	carbidopa	NOUN
dpc-4372	50	102	intestinal	intestinal	ADJ
dpc-4372	50	103	gel	gel	NOUN
dpc-4372	50	104	5.6	5.6	NUM
dpc-4372	50	105	deep	deep	ADJ
dpc-4372	50	106	brain	brain	NOUN
dpc-4372	50	107	stimulation	stimulation	NOUN
dpc-4372	50	108	(	(	PUNCT
dpc-4372	50	109	dbs	dbs	ADJ
dpc-4372	50	110	-	-	PUNCT
dpc-4372	50	111	brain	brain	NOUN
dpc-4372	50	112	stimulator	stimulator	NOUN
dpc-4372	50	113	)	)	PUNCT
dpc-4372	50	114	0.9	0.9	NUM
dpc-4372	50	115	pd	pd	PROPN
dpc-4372	50	116	treatment	treatment	NOUN
dpc-4372	50	117	duration	duration	NOUN
dpc-4372	50	118	median	median	NOUN
dpc-4372	50	119	,	,	PUNCT
dpc-4372	50	120	years	year	NOUN
dpc-4372	50	121	(	(	PUNCT
dpc-4372	50	122	iqr	iqr	NOUN
dpc-4372	50	123	)	)	PUNCT
dpc-4372	50	124	3	3	NUM
dpc-4372	50	125	(	(	PUNCT
dpc-4372	50	126	1	1	NUM
dpc-4372	50	127	-	-	SYM
dpc-4372	50	128	6	6	NUM
dpc-4372	50	129	)	)	PUNCT
dpc-4372	50	130	previously	previously	ADV
dpc-4372	50	131	known	know	VERB
dpc-4372	50	132	dermatological	dermatological	ADJ
dpc-4372	50	133	disease	disease	NOUN
dpc-4372	50	134	in	in	ADP
dpc-4372	50	135	the	the	DET
dpc-4372	50	136	patient	patient	ADJ
dpc-4372	50	137	frequency	frequency	NOUN
dpc-4372	50	138	(	(	PUNCT
dpc-4372	50	139	%	%	INTJ
dpc-4372	50	140	)	)	PUNCT
dpc-4372	51	1	yes	yes	INTJ
dpc-4372	51	2	5.2	5.2	NUM
dpc-4372	51	3	seborrheic	seborrheic	VERB
dpc-4372	51	4	dermatitis	dermatitis	NOUN
dpc-4372	51	5	3.3	3.3	NUM
dpc-4372	51	6	rosacea	rosacea	NOUN
dpc-4372	51	7	1.4	1.4	NUM
dpc-4372	51	8	vitiligo	vitiligo	PROPN
dpc-4372	51	9	0.5	0.5	NUM
dpc-4372	51	10	duration	duration	NOUN
dpc-4372	51	11	median	median	NOUN
dpc-4372	51	12	,	,	PUNCT
dpc-4372	51	13	years	year	NOUN
dpc-4372	51	14	(	(	PUNCT
dpc-4372	51	15	iqr	iqr	NOUN
dpc-4372	51	16	)	)	PUNCT
dpc-4372	51	17	7	7	NUM
dpc-4372	51	18	(	(	PUNCT
dpc-4372	51	19	5	5	NUM
dpc-4372	51	20	-	-	SYM
dpc-4372	51	21	15	15	NUM
dpc-4372	51	22	)	)	PUNCT
dpc-4372	51	23	no	no	DET
dpc-4372	51	24	94.8	94.8	NUM
dpc-4372	51	25	systemic	systemic	ADJ
dpc-4372	51	26	disease	disease	NOUN
dpc-4372	51	27	frequency	frequency	NOUN
dpc-4372	51	28	(	(	PUNCT
dpc-4372	51	29	%	%	INTJ
dpc-4372	51	30	)	)	PUNCT
dpc-4372	52	1	yes	yes	INTJ
dpc-4372	53	1	43.3	43.3	NUM
dpc-4372	53	2	no	no	DET
dpc-4372	53	3	56.7	56.7	NUM
dpc-4372	53	4	the	the	DET
dpc-4372	53	5	three	three	NUM
dpc-4372	53	6	most	most	ADV
dpc-4372	53	7	common	common	ADJ
dpc-4372	53	8	systemic	systemic	ADJ
dpc-4372	53	9	diseases	disease	NOUN
dpc-4372	53	10	frequency	frequency	NOUN
dpc-4372	53	11	(	(	PUNCT
dpc-4372	53	12	%	%	INTJ
dpc-4372	53	13	)	)	PUNCT
dpc-4372	53	14	hypertension	hypertension	NOUN
dpc-4372	53	15	29.3	29.3	NUM
dpc-4372	53	16	diabetes	diabetes	NOUN
dpc-4372	53	17	mellitus	mellitus	NOUN
dpc-4372	53	18	type	type	VERB
dpc-4372	53	19	2	2	NUM
dpc-4372	53	20	19.5	19.5	NUM
dpc-4372	53	21	hypothyroidism	hypothyroidism	NOUN
dpc-4372	53	22	3.8	3.8	NUM
dpc-4372	53	23	abbreviations	abbreviation	NOUN
dpc-4372	53	24	used	use	VERB
dpc-4372	53	25	in	in	ADP
dpc-4372	53	26	this	this	DET
dpc-4372	53	27	table	table	NOUN
dpc-4372	53	28	include	include	VERB
dpc-4372	53	29	sd	sd	NOUN
dpc-4372	53	30	for	for	ADP
dpc-4372	53	31	standard	standard	ADJ
dpc-4372	53	32	deviation	deviation	NOUN
dpc-4372	53	33	,	,	PUNCT
dpc-4372	53	34	iqr	iqr	PROPN
dpc-4372	53	35	for	for	ADP
dpc-4372	53	36	interquartile	interquartile	ADJ
dpc-4372	53	37	range	range	NOUN
dpc-4372	53	38	,	,	PUNCT
dpc-4372	53	39	pd	pd	PROPN
dpc-4372	53	40	for	for	ADP
dpc-4372	53	41	parkinson	parkinson	NOUN
dpc-4372	53	42	’s	’s	PART
dpc-4372	53	43	disease	disease	NOUN
dpc-4372	53	44	,	,	PUNCT
dpc-4372	53	45	dk	dk	PROPN
dpc-4372	53	46	inhibitor	inhibitor	NOUN
dpc-4372	53	47	for	for	ADP
dpc-4372	53	48	decarboxylase	decarboxylase	NOUN
dpc-4372	53	49	inhibitor	inhibitor	NOUN
dpc-4372	53	50	,	,	PUNCT
dpc-4372	53	51	mao	mao	NOUN
dpc-4372	53	52	b	b	NOUN
dpc-4372	53	53	inhibitor	inhibitor	NOUN
dpc-4372	53	54	for	for	ADP
dpc-4372	53	55	monoamine	monoamine	ADJ
dpc-4372	53	56	oxidase	oxidase	NOUN
dpc-4372	53	57	b	b	NOUN
dpc-4372	53	58	inhibitor	inhibitor	NOUN
dpc-4372	53	59	,	,	PUNCT
dpc-4372	53	60	comt	comt	NOUN
dpc-4372	53	61	inhibitor	inhibitor	NOUN
dpc-4372	53	62	for	for	ADP
dpc-4372	53	63	catechol	catechol	NOUN
dpc-4372	53	64	-	-	PUNCT
dpc-4372	53	65	o	o	NOUN
dpc-4372	53	66	-	-	NOUN
dpc-4372	53	67	methyltransferase	methyltransferase	NOUN
dpc-4372	53	68	inhibitor	inhibitor	NOUN
dpc-4372	53	69	,	,	PUNCT
dpc-4372	53	70	and	and	CCONJ
dpc-4372	53	71	dbs	dbs	NOUN
dpc-4372	53	72	for	for	ADP
dpc-4372	53	73	deep	deep	ADJ
dpc-4372	53	74	brain	brain	NOUN
dpc-4372	53	75	stimulation	stimulation	NOUN
dpc-4372	53	76	.	.	PUNCT
dpc-4372	54	1	the	the	DET
dpc-4372	54	2	percentages	percentage	NOUN
dpc-4372	54	3	indicate	indicate	VERB
dpc-4372	54	4	the	the	DET
dpc-4372	54	5	proportion	proportion	NOUN
dpc-4372	54	6	of	of	ADP
dpc-4372	54	7	patients	patient	NOUN
dpc-4372	54	8	with	with	ADP
dpc-4372	54	9	each	each	DET
dpc-4372	54	10	characteristic	characteristic	ADJ
dpc-4372	54	11	or	or	CCONJ
dpc-4372	54	12	treatment	treatment	NOUN
dpc-4372	54	13	,	,	PUNCT
dpc-4372	54	14	and	and	CCONJ
dpc-4372	54	15	the	the	DET
dpc-4372	54	16	median	median	ADJ
dpc-4372	54	17	years	year	NOUN
dpc-4372	54	18	(	(	PUNCT
dpc-4372	54	19	with	with	ADP
dpc-4372	54	20	iqr	iqr	NOUN
dpc-4372	54	21	)	)	PUNCT
dpc-4372	54	22	reflect	reflect	VERB
dpc-4372	54	23	the	the	DET
dpc-4372	54	24	duration	duration	NOUN
dpc-4372	54	25	of	of	ADP
dpc-4372	54	26	pd	pd	PROPN
dpc-4372	54	27	and	and	CCONJ
dpc-4372	54	28	pd	pd	PROPN
dpc-4372	54	29	treatment	treatment	NOUN
dpc-4372	54	30	as	as	ADV
dpc-4372	54	31	well	well	ADV
dpc-4372	54	32	as	as	ADP
dpc-4372	54	33	the	the	DET
dpc-4372	54	34	duration	duration	NOUN
dpc-4372	54	35	of	of	ADP
dpc-4372	54	36	previously	previously	ADV
dpc-4372	54	37	known	know	VERB
dpc-4372	54	38	dermatological	dermatological	ADJ
dpc-4372	54	39	diseases	disease	NOUN
dpc-4372	54	40	,	,	PUNCT
dpc-4372	54	41	where	where	SCONJ
dpc-4372	54	42	applicable	applicable	ADJ
dpc-4372	54	43	.	.	PUNCT
dpc-4372	55	1	4	4	NUM
dpc-4372	55	2	original	original	ADJ
dpc-4372	55	3	article	article	NOUN
dpc-4372	55	4	|	|	ADV
dpc-4372	55	5	dermatol	dermatol	ADJ
dpc-4372	55	6	pract	pract	NOUN
dpc-4372	55	7	concept	concept	NOUN
dpc-4372	55	8	.	.	PUNCT
dpc-4372	56	1	2024;14(4):e2024241	2024;14(4):e2024241	NUM
dpc-4372	56	2	table	table	NOUN
dpc-4372	56	3	2	2	NUM
dpc-4372	56	4	.	.	PUNCT
dpc-4372	57	1	summary	summary	NOUN
dpc-4372	57	2	of	of	ADP
dpc-4372	57	3	dermatological	dermatological	ADJ
dpc-4372	57	4	examination	examination	NOUN
dpc-4372	57	5	of	of	ADP
dpc-4372	57	6	skin	skin	NOUN
dpc-4372	57	7	,	,	PUNCT
dpc-4372	57	8	scalp	scalp	NOUN
dpc-4372	57	9	,	,	PUNCT
dpc-4372	57	10	nail	nail	NOUN
dpc-4372	57	11	,	,	PUNCT
dpc-4372	57	12	and	and	CCONJ
dpc-4372	57	13	oral	oral	ADJ
dpc-4372	57	14	mucosa	mucosa	NOUN
dpc-4372	57	15	.	.	PUNCT
dpc-4372	58	1	duration	duration	NOUN
dpc-4372	58	2	,	,	PUNCT
dpc-4372	58	3	median	median	ADJ
dpc-4372	58	4	months	month	NOUN
dpc-4372	58	5	(	(	PUNCT
dpc-4372	58	6	iqr	iqr	NOUN
dpc-4372	58	7	)	)	PUNCT
dpc-4372	58	8	appearance	appearance	NOUN
dpc-4372	58	9	of	of	ADP
dpc-4372	58	10	skin	skin	NOUN
dpc-4372	58	11	,	,	PUNCT
dpc-4372	58	12	scalp	scalp	NOUN
dpc-4372	58	13	,	,	PUNCT
dpc-4372	58	14	and	and	CCONJ
dpc-4372	58	15	nail	nail	NOUN
dpc-4372	58	16	mucosa	mucosa	NOUN
dpc-4372	58	17	findings	finding	NOUN
dpc-4372	58	18	freq	freq	ADJ
dpc-4372	58	19	%	%	NOUN
dpc-4372	58	20	before	before	ADP
dpc-4372	58	21	pd	pd	PROPN
dpc-4372	58	22	,	,	PUNCT
dpc-4372	58	23	freq	freq	ADJ
dpc-4372	58	24	%	%	NOUN
dpc-4372	58	25	with	with	ADP
dpc-4372	58	26	pd	pd	PROPN
dpc-4372	58	27	,	,	PUNCT
dpc-4372	58	28	freq	freq	ADJ
dpc-4372	58	29	%	%	NOUN
dpc-4372	58	30	after	after	ADP
dpc-4372	58	31	pd	pd	PROPN
dpc-4372	58	32	,	,	PUNCT
dpc-4372	58	33	freq	freq	ADJ
dpc-4372	58	34	%	%	NOUN
dpc-4372	58	35	skin	skin	NOUN
dpc-4372	58	36	findings	finding	NOUN
dpc-4372	58	37	xerosis	xerosis	NOUN
dpc-4372	58	38	60.9	60.9	NUM
dpc-4372	58	39	60	60	NUM
dpc-4372	58	40	(	(	PUNCT
dpc-4372	58	41	36	36	NUM
dpc-4372	58	42	-	-	SYM
dpc-4372	58	43	60	60	NUM
dpc-4372	58	44	)	)	PUNCT
dpc-4372	58	45	57.3	57.3	NUM
dpc-4372	58	46	29.7	29.7	NUM
dpc-4372	58	47	13.0	13.0	NUM
dpc-4372	58	48	cherry	cherry	NOUN
dpc-4372	58	49	angioma	angioma	NOUN
dpc-4372	58	50	45.1	45.1	NUM
dpc-4372	58	51	60	60	NUM
dpc-4372	58	52	(	(	PUNCT
dpc-4372	58	53	36	36	NUM
dpc-4372	58	54	-	-	SYM
dpc-4372	58	55	60	60	NUM
dpc-4372	58	56	)	)	PUNCT
dpc-4372	58	57	79.3	79.3	NUM
dpc-4372	58	58	18.6	18.6	NUM
dpc-4372	58	59	2.1	2.1	NUM
dpc-4372	58	60	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	58	61	37.2	37.2	NUM
dpc-4372	58	62	48	48	NUM
dpc-4372	58	63	(	(	PUNCT
dpc-4372	58	64	24	24	NUM
dpc-4372	58	65	-	-	SYM
dpc-4372	58	66	60	60	NUM
dpc-4372	58	67	)	)	PUNCT
dpc-4372	58	68	56.2	56.2	NUM
dpc-4372	58	69	26.3	26.3	NUM
dpc-4372	58	70	17.5	17.5	NUM
dpc-4372	58	71	seborrheic	seborrheic	VERB
dpc-4372	58	72	dermatitis	dermatitis	NOUN
dpc-4372	58	73	27.4	27.4	NUM
dpc-4372	58	74	48	48	NUM
dpc-4372	58	75	(	(	PUNCT
dpc-4372	58	76	24	24	NUM
dpc-4372	58	77	-	-	SYM
dpc-4372	58	78	60	60	NUM
dpc-4372	58	79	)	)	PUNCT
dpc-4372	58	80	66.1	66.1	NUM
dpc-4372	58	81	28.8	28.8	NUM
dpc-4372	58	82	5.1	5.1	NUM
dpc-4372	58	83	rosacea	rosacea	NOUN
dpc-4372	58	84	27.4	27.4	NUM
dpc-4372	58	85	48	48	NUM
dpc-4372	58	86	(	(	PUNCT
dpc-4372	58	87	36	36	NUM
dpc-4372	58	88	-	-	SYM
dpc-4372	58	89	60	60	NUM
dpc-4372	58	90	)	)	PUNCT
dpc-4372	58	91	55.9	55.9	NUM
dpc-4372	58	92	37.3	37.3	NUM
dpc-4372	58	93	6.8	6.8	NUM
dpc-4372	58	94	erythema	erythema	ADV
dpc-4372	58	95	intertrigo	intertrigo	VERB
dpc-4372	58	96	16.3	16.3	NUM
dpc-4372	58	97	4	4	NUM
dpc-4372	58	98	(	(	PUNCT
dpc-4372	58	99	2	2	NUM
dpc-4372	58	100	-	-	SYM
dpc-4372	58	101	5	5	NUM
dpc-4372	58	102	)	)	PUNCT
dpc-4372	58	103	xerotic	xerotic	ADJ
dpc-4372	58	104	eczema	eczema	NOUN
dpc-4372	58	105	13	13	NUM
dpc-4372	58	106	60	60	NUM
dpc-4372	58	107	(	(	PUNCT
dpc-4372	58	108	36	36	NUM
dpc-4372	58	109	-	-	SYM
dpc-4372	58	110	60	60	NUM
dpc-4372	58	111	)	)	PUNCT
dpc-4372	58	112	tinea	tinea	NOUN
dpc-4372	58	113	pedis	pedi	VERB
dpc-4372	58	114	14.4	14.4	NUM
dpc-4372	58	115	4	4	NUM
dpc-4372	58	116	(	(	PUNCT
dpc-4372	58	117	2	2	NUM
dpc-4372	58	118	-	-	SYM
dpc-4372	58	119	6	6	NUM
dpc-4372	58	120	)	)	PUNCT
dpc-4372	58	121	actinic	actinic	ADJ
dpc-4372	58	122	keratosis	keratosis	NOUN
dpc-4372	58	123	9.8	9.8	NUM
dpc-4372	58	124	60	60	NUM
dpc-4372	58	125	(	(	PUNCT
dpc-4372	58	126	36	36	NUM
dpc-4372	58	127	-	-	SYM
dpc-4372	58	128	60	60	NUM
dpc-4372	58	129	)	)	PUNCT
dpc-4372	58	130	hand	hand	NOUN
dpc-4372	58	131	eczema	eczema	NOUN
dpc-4372	58	132	4.1	4.1	NUM
dpc-4372	58	133	60	60	NUM
dpc-4372	58	134	(	(	PUNCT
dpc-4372	58	135	36	36	NUM
dpc-4372	58	136	-	-	SYM
dpc-4372	58	137	60	60	NUM
dpc-4372	58	138	)	)	PUNCT
dpc-4372	58	139	stasis	stasis	NOUN
dpc-4372	58	140	dermatitis	dermatitis	NOUN
dpc-4372	58	141	2.3	2.3	NUM
dpc-4372	58	142	24	24	NUM
dpc-4372	58	143	(	(	PUNCT
dpc-4372	58	144	24	24	NUM
dpc-4372	58	145	-	-	SYM
dpc-4372	58	146	36	36	NUM
dpc-4372	58	147	)	)	PUNCT
dpc-4372	58	148	p	p	NOUN
dpc-4372	58	149	versicolor	versicolor	NOUN
dpc-4372	58	150	1.9	1.9	NUM
dpc-4372	58	151	2	2	NUM
dpc-4372	58	152	(	(	PUNCT
dpc-4372	58	153	2	2	NUM
dpc-4372	58	154	-	-	SYM
dpc-4372	58	155	5	5	NUM
dpc-4372	58	156	)	)	PUNCT
dpc-4372	58	157	scalp	scalp	NOUN
dpc-4372	58	158	disease	disease	NOUN
dpc-4372	58	159	seborrheic	seborrheic	PROPN
dpc-4372	58	160	dermatitis	dermatitis	NOUN
dpc-4372	58	161	31.6	31.6	NUM
dpc-4372	58	162	48	48	NUM
dpc-4372	58	163	(	(	PUNCT
dpc-4372	58	164	24	24	NUM
dpc-4372	58	165	-	-	SYM
dpc-4372	58	166	60	60	NUM
dpc-4372	58	167	)	)	PUNCT
dpc-4372	58	168	50.8	50.8	NUM
dpc-4372	58	169	44.4	44.4	NUM
dpc-4372	58	170	4.8	4.8	NUM
dpc-4372	58	171	actinic	actinic	ADJ
dpc-4372	58	172	keratosis	keratosis	NOUN
dpc-4372	58	173	11.6	11.6	NUM
dpc-4372	58	174	36	36	NUM
dpc-4372	58	175	(	(	PUNCT
dpc-4372	58	176	30	30	NUM
dpc-4372	58	177	-	-	SYM
dpc-4372	58	178	60	60	NUM
dpc-4372	58	179	)	)	PUNCT
dpc-4372	58	180	folliculitis	folliculitis	NOUN
dpc-4372	58	181	4.7	4.7	NUM
dpc-4372	58	182	12	12	NUM
dpc-4372	58	183	(	(	PUNCT
dpc-4372	58	184	12	12	NUM
dpc-4372	58	185	-	-	SYM
dpc-4372	58	186	15	15	NUM
dpc-4372	58	187	)	)	PUNCT
dpc-4372	58	188	nail	nail	NOUN
dpc-4372	58	189	disease	disease	NOUN
dpc-4372	58	190	tinea	tinea	PROPN
dpc-4372	58	191	ungium	ungium	NOUN
dpc-4372	58	192	14.9	14.9	NUM
dpc-4372	58	193	longitudinal	longitudinal	ADJ
dpc-4372	58	194	ridges	ridge	NOUN
dpc-4372	58	195	9.3	9.3	NUM
dpc-4372	58	196	terry	terry	PROPN
dpc-4372	58	197	’s	’s	PART
dpc-4372	58	198	nail	nail	NOUN
dpc-4372	58	199	1.4	1.4	NUM
dpc-4372	58	200	subungual	subungual	ADJ
dpc-4372	58	201	hyperkeratosis	hyperkeratosis	VERB
dpc-4372	58	202	1.4	1.4	NUM
dpc-4372	58	203	muehrcke	muehrcke	NOUN
dpc-4372	58	204	’s	’s	PART
dpc-4372	58	205	nails	nail	NOUN
dpc-4372	58	206	0.9	0.9	NUM
dpc-4372	58	207	oral	oral	ADJ
dpc-4372	58	208	mucosa	mucosa	NOUN
dpc-4372	58	209	atrophic	atrophic	ADJ
dpc-4372	58	210	glossitis	glossitis	PROPN
dpc-4372	58	211	0.9	0.9	NUM
dpc-4372	58	212	black	black	ADJ
dpc-4372	58	213	tongue	tongue	NOUN
dpc-4372	58	214	0.5	0.5	NUM
dpc-4372	58	215	this	this	DET
dpc-4372	58	216	table	table	NOUN
dpc-4372	58	217	presents	present	VERB
dpc-4372	58	218	the	the	DET
dpc-4372	58	219	findings	finding	NOUN
dpc-4372	58	220	from	from	ADP
dpc-4372	58	221	dermatological	dermatological	ADJ
dpc-4372	58	222	examinations	examination	NOUN
dpc-4372	58	223	focusing	focus	VERB
dpc-4372	58	224	on	on	ADP
dpc-4372	58	225	skin	skin	NOUN
dpc-4372	58	226	,	,	PUNCT
dpc-4372	58	227	scalp	scalp	NOUN
dpc-4372	58	228	,	,	PUNCT
dpc-4372	58	229	nail	nail	NOUN
dpc-4372	58	230	,	,	PUNCT
dpc-4372	58	231	and	and	CCONJ
dpc-4372	58	232	oral	oral	ADJ
dpc-4372	58	233	mucosa	mucosa	NOUN
dpc-4372	58	234	conditions	condition	NOUN
dpc-4372	58	235	in	in	ADP
dpc-4372	58	236	parkinson	parkinson	NOUN
dpc-4372	58	237	’s	’s	PART
dpc-4372	58	238	disease	disease	NOUN
dpc-4372	58	239	(	(	PUNCT
dpc-4372	58	240	pd	pd	NOUN
dpc-4372	58	241	)	)	PUNCT
dpc-4372	58	242	patients	patient	NOUN
dpc-4372	58	243	.	.	PUNCT
dpc-4372	59	1	“	"	PUNCT
dpc-4372	59	2	freq	freq	ADJ
dpc-4372	59	3	%	%	NOUN
dpc-4372	59	4	”	"	PUNCT
dpc-4372	59	5	indicates	indicate	VERB
dpc-4372	59	6	the	the	DET
dpc-4372	59	7	percentage	percentage	NOUN
dpc-4372	59	8	of	of	ADP
dpc-4372	59	9	patients	patient	NOUN
dpc-4372	59	10	exhibiting	exhibit	VERB
dpc-4372	59	11	each	each	DET
dpc-4372	59	12	condition	condition	NOUN
dpc-4372	59	13	.	.	PUNCT
dpc-4372	60	1	“	"	PUNCT
dpc-4372	60	2	duration	duration	NOUN
dpc-4372	60	3	,	,	PUNCT
dpc-4372	60	4	median	median	ADJ
dpc-4372	60	5	months	month	NOUN
dpc-4372	60	6	(	(	PUNCT
dpc-4372	60	7	iqr	iqr	NOUN
dpc-4372	60	8	)	)	PUNCT
dpc-4372	60	9	”	"	PUNCT
dpc-4372	60	10	provides	provide	VERB
dpc-4372	60	11	the	the	DET
dpc-4372	60	12	median	median	ADJ
dpc-4372	60	13	duration	duration	NOUN
dpc-4372	60	14	of	of	ADP
dpc-4372	60	15	each	each	DET
dpc-4372	60	16	condition	condition	NOUN
dpc-4372	60	17	in	in	ADP
dpc-4372	60	18	months	month	NOUN
dpc-4372	60	19	,	,	PUNCT
dpc-4372	60	20	along	along	ADP
dpc-4372	60	21	with	with	ADP
dpc-4372	60	22	the	the	DET
dpc-4372	60	23	interquartile	interquartile	ADJ
dpc-4372	60	24	range	range	NOUN
dpc-4372	60	25	(	(	PUNCT
dpc-4372	60	26	iqr	iqr	NOUN
dpc-4372	60	27	)	)	PUNCT
dpc-4372	60	28	,	,	PUNCT
dpc-4372	60	29	reflecting	reflect	VERB
dpc-4372	60	30	variability	variability	NOUN
dpc-4372	60	31	among	among	ADP
dpc-4372	60	32	patients	patient	NOUN
dpc-4372	60	33	.	.	PUNCT
dpc-4372	61	1	“	"	PUNCT
dpc-4372	61	2	before	before	ADP
dpc-4372	61	3	pd	pd	PROPN
dpc-4372	61	4	”	"	PUNCT
dpc-4372	61	5	,	,	PUNCT
dpc-4372	61	6	“	"	PUNCT
dpc-4372	61	7	with	with	ADP
dpc-4372	61	8	pd	pd	PROPN
dpc-4372	61	9	”	"	PUNCT
dpc-4372	61	10	,	,	PUNCT
dpc-4372	61	11	and	and	CCONJ
dpc-4372	61	12	“	"	PUNCT
dpc-4372	61	13	after	after	ADP
dpc-4372	61	14	pd	pd	PROPN
dpc-4372	61	15	”	"	PUNCT
dpc-4372	61	16	percentages	percentage	NOUN
dpc-4372	61	17	denote	denote	VERB
dpc-4372	61	18	the	the	DET
dpc-4372	61	19	timing	timing	NOUN
dpc-4372	61	20	of	of	ADP
dpc-4372	61	21	onset	onset	NOUN
dpc-4372	61	22	of	of	ADP
dpc-4372	61	23	each	each	DET
dpc-4372	61	24	condition	condition	NOUN
dpc-4372	61	25	relative	relative	ADJ
dpc-4372	61	26	to	to	ADP
dpc-4372	61	27	the	the	DET
dpc-4372	61	28	diagnosis	diagnosis	NOUN
dpc-4372	61	29	of	of	ADP
dpc-4372	61	30	pd	pd	PROPN
dpc-4372	61	31	.	.	PROPN
dpc-4372	61	32	conditions	condition	NOUN
dpc-4372	61	33	without	without	ADP
dpc-4372	61	34	specified	specify	VERB
dpc-4372	61	35	percentages	percentage	NOUN
dpc-4372	61	36	for	for	ADP
dpc-4372	61	37	“	"	PUNCT
dpc-4372	61	38	before	before	ADP
dpc-4372	61	39	pd	pd	PROPN
dpc-4372	61	40	”	"	PUNCT
dpc-4372	61	41	,	,	PUNCT
dpc-4372	61	42	“	"	PUNCT
dpc-4372	61	43	with	with	ADP
dpc-4372	61	44	pd	pd	PROPN
dpc-4372	61	45	”	"	PUNCT
dpc-4372	61	46	,	,	PUNCT
dpc-4372	61	47	and	and	CCONJ
dpc-4372	61	48	“	"	PUNCT
dpc-4372	61	49	after	after	SCONJ
dpc-4372	61	50	pd	pd	PROPN
dpc-4372	61	51	”	"	PUNCT
dpc-4372	61	52	did	do	AUX
dpc-4372	61	53	not	not	PART
dpc-4372	61	54	have	have	VERB
dpc-4372	61	55	sufficient	sufficient	ADJ
dpc-4372	61	56	data	datum	NOUN
dpc-4372	61	57	for	for	ADP
dpc-4372	61	58	these	these	DET
dpc-4372	61	59	categories	category	NOUN
dpc-4372	61	60	.	.	PUNCT
dpc-4372	62	1	“	"	PUNCT
dpc-4372	62	2	tinea	tinea	PROPN
dpc-4372	62	3	ungium	ungium	NOUN
dpc-4372	62	4	”	"	PUNCT
dpc-4372	62	5	,	,	PUNCT
dpc-4372	62	6	“	"	PUNCT
dpc-4372	62	7	longitudinal	longitudinal	ADJ
dpc-4372	62	8	ridges	ridge	NOUN
dpc-4372	62	9	”	"	PUNCT
dpc-4372	62	10	,	,	PUNCT
dpc-4372	62	11	“	"	PUNCT
dpc-4372	62	12	terry	terry	PROPN
dpc-4372	62	13	’s	’s	PART
dpc-4372	62	14	nail	nail	NOUN
dpc-4372	62	15	”	"	PUNCT
dpc-4372	62	16	,	,	PUNCT
dpc-4372	62	17	“	"	PUNCT
dpc-4372	62	18	subungual	subungual	ADJ
dpc-4372	62	19	hyperkeratosis	hyperkeratosis	NOUN
dpc-4372	62	20	”	"	PUNCT
dpc-4372	62	21	,	,	PUNCT
dpc-4372	62	22	and	and	CCONJ
dpc-4372	62	23	“	"	PUNCT
dpc-4372	62	24	muehrcke	muehrcke	PROPN
dpc-4372	62	25	’s	’s	PART
dpc-4372	62	26	nails	nail	NOUN
dpc-4372	62	27	”	"	PUNCT
dpc-4372	62	28	under	under	ADP
dpc-4372	62	29	nail	nail	NOUN
dpc-4372	62	30	disease	disease	NOUN
dpc-4372	62	31	as	as	ADV
dpc-4372	62	32	well	well	ADV
dpc-4372	62	33	as	as	ADP
dpc-4372	62	34	“	"	PUNCT
dpc-4372	62	35	atrophic	atrophic	ADJ
dpc-4372	62	36	glossitis	glossitis	NOUN
dpc-4372	62	37	”	"	PUNCT
dpc-4372	62	38	and	and	CCONJ
dpc-4372	62	39	“	"	PUNCT
dpc-4372	62	40	black	black	ADJ
dpc-4372	62	41	tongue	tongue	NOUN
dpc-4372	62	42	”	"	PUNCT
dpc-4372	62	43	under	under	ADP
dpc-4372	62	44	oral	oral	ADJ
dpc-4372	62	45	mucosa	mucosa	NOUN
dpc-4372	62	46	are	be	AUX
dpc-4372	62	47	reported	report	VERB
dpc-4372	62	48	without	without	ADP
dpc-4372	62	49	specific	specific	ADJ
dpc-4372	62	50	frequency	frequency	NOUN
dpc-4372	62	51	or	or	CCONJ
dpc-4372	62	52	timing	timing	NOUN
dpc-4372	62	53	related	relate	VERB
dpc-4372	62	54	to	to	ADP
dpc-4372	62	55	pd	pd	PROPN
dpc-4372	62	56	due	due	ADP
dpc-4372	62	57	to	to	ADP
dpc-4372	62	58	the	the	DET
dpc-4372	62	59	nature	nature	NOUN
dpc-4372	62	60	of	of	ADP
dpc-4372	62	61	these	these	DET
dpc-4372	62	62	findings	finding	NOUN
dpc-4372	62	63	.	.	PUNCT
dpc-4372	63	1	nail	nail	NOUN
dpc-4372	63	2	disease	disease	NOUN
dpc-4372	63	3	in	in	ADP
dpc-4372	63	4	27.4	27.4	NUM
dpc-4372	63	5	%	%	NOUN
dpc-4372	63	6	,	,	PUNCT
dpc-4372	63	7	and	and	CCONJ
dpc-4372	63	8	oral	oral	ADJ
dpc-4372	63	9	mucosa	mucosa	NOUN
dpc-4372	63	10	disease	disease	NOUN
dpc-4372	63	11	in	in	ADP
dpc-4372	63	12	1.4	1.4	NUM
dpc-4372	63	13	%	%	NOUN
dpc-4372	63	14	.	.	PUNCT
dpc-4372	64	1	skin	skin	NOUN
dpc-4372	64	2	,	,	PUNCT
dpc-4372	64	3	scalp	scalp	NOUN
dpc-4372	64	4	,	,	PUNCT
dpc-4372	64	5	nail	nail	NOUN
dpc-4372	64	6	,	,	PUNCT
dpc-4372	64	7	and	and	CCONJ
dpc-4372	64	8	oral	oral	ADJ
dpc-4372	64	9	mucosa	mucosa	NOUN
dpc-4372	64	10	findings	finding	NOUN
dpc-4372	64	11	obtained	obtain	VERB
dpc-4372	64	12	in	in	ADP
dpc-4372	64	13	dermatological	dermatological	ADJ
dpc-4372	64	14	examination	examination	NOUN
dpc-4372	64	15	are	be	AUX
dpc-4372	64	16	summarized	summarize	VERB
dpc-4372	64	17	in	in	ADP
dpc-4372	64	18	table	table	NOUN
dpc-4372	64	19	2	2	NUM
dpc-4372	64	20	.	.	X
dpc-4372	64	21	association	association	NOUN
dpc-4372	64	22	between	between	ADP
dpc-4372	64	23	pre	pre	ADJ
dpc-4372	64	24	-	-	ADJ
dpc-4372	64	25	pd	pd	ADJ
dpc-4372	64	26	dermatological	dermatological	ADJ
dpc-4372	64	27	conditions	condition	NOUN
dpc-4372	64	28	and	and	CCONJ
dpc-4372	64	29	pd	pd	NOUN
dpc-4372	64	30	stage	stage	NOUN
dpc-4372	64	31	in	in	ADP
dpc-4372	64	32	patients	patient	NOUN
dpc-4372	64	33	with	with	ADP
dpc-4372	64	34	pre	pre	ADJ
dpc-4372	64	35	-	-	ADJ
dpc-4372	64	36	pd	pd	ADJ
dpc-4372	64	37	xerosis	xerosis	NOUN
dpc-4372	64	38	,	,	PUNCT
dpc-4372	64	39	the	the	DET
dpc-4372	64	40	pd	pd	PROPN
dpc-4372	64	41	stage	stage	NOUN
dpc-4372	64	42	was	be	AUX
dpc-4372	64	43	earlier	early	ADV
dpc-4372	64	44	(	(	PUNCT
dpc-4372	64	45	stage	stage	NOUN
dpc-4372	64	46	1	1	NUM
dpc-4372	64	47	:	:	PUNCT
dpc-4372	64	48	22.8	22.8	NUM
dpc-4372	64	49	%	%	NOUN
dpc-4372	64	50	,	,	PUNCT
dpc-4372	64	51	stage	stage	NOUN
dpc-4372	64	52	2	2	NUM
dpc-4372	64	53	:	:	PUNCT
dpc-4372	64	54	54.3	54.3	NUM
dpc-4372	64	55	%	%	NOUN
dpc-4372	64	56	,	,	PUNCT
dpc-4372	64	57	stage	stage	NOUN
dpc-4372	64	58	3	3	NUM
dpc-4372	64	59	:	:	PUNCT
dpc-4372	64	60	17.4	17.4	NUM
dpc-4372	64	61	%	%	NOUN
dpc-4372	64	62	,	,	PUNCT
dpc-4372	64	63	stage	stage	NOUN
dpc-4372	64	64	4	4	NUM
dpc-4372	64	65	:	:	SYM
dpc-4372	64	66	4.1	4.1	NUM
dpc-4372	64	67	%	%	NOUN
dpc-4372	64	68	,	,	PUNCT
dpc-4372	64	69	and	and	CCONJ
dpc-4372	64	70	stage	stage	NOUN
dpc-4372	64	71	5	5	NUM
dpc-4372	64	72	:	:	SYM
dpc-4372	64	73	1.4	1.4	NUM
dpc-4372	64	74	%	%	NOUN
dpc-4372	64	75	)	)	PUNCT
dpc-4372	64	76	than	than	ADP
dpc-4372	64	77	in	in	ADP
dpc-4372	64	78	patients	patient	NOUN
dpc-4372	64	79	without	without	ADP
dpc-4372	64	80	pre	pre	ADJ
dpc-4372	64	81	-	-	ADJ
dpc-4372	64	82	pd	pd	ADJ
dpc-4372	64	83	xerosis	xerosis	NOUN
dpc-4372	64	84	(	(	PUNCT
dpc-4372	64	85	stage	stage	NOUN
dpc-4372	64	86	1	1	NUM
dpc-4372	64	87	:	:	SYM
dpc-4372	64	88	7.2	7.2	NUM
dpc-4372	64	89	%	%	NOUN
dpc-4372	64	90	,	,	PUNCT
dpc-4372	64	91	stage	stage	NOUN
dpc-4372	64	92	2	2	NUM
dpc-4372	64	93	:	:	PUNCT
dpc-4372	64	94	44.7	44.7	NUM
dpc-4372	64	95	%	%	NOUN
dpc-4372	64	96	,	,	PUNCT
dpc-4372	64	97	stage	stage	NOUN
dpc-4372	64	98	3	3	NUM
dpc-4372	64	99	:	:	PUNCT
dpc-4372	64	100	34,1	34,1	NUM
dpc-4372	64	101	%	%	NOUN
dpc-4372	64	102	,	,	PUNCT
dpc-4372	64	103	stage	stage	NOUN
dpc-4372	64	104	4	4	NUM
dpc-4372	64	105	:	:	SYM
dpc-4372	64	106	12.5	12.5	NUM
dpc-4372	64	107	%	%	NOUN
dpc-4372	64	108	,	,	PUNCT
dpc-4372	64	109	and	and	CCONJ
dpc-4372	64	110	stage	stage	NOUN
dpc-4372	64	111	5	5	NUM
dpc-4372	64	112	:	:	SYM
dpc-4372	64	113	1.5	1.5	NUM
dpc-4372	64	114	%	%	NOUN
dpc-4372	64	115	)	)	PUNCT
dpc-4372	64	116	(	(	PUNCT
dpc-4372	64	117	p=0.001	p=0.001	NUM
dpc-4372	64	118	)	)	PUNCT
dpc-4372	64	119	(	(	PUNCT
dpc-4372	64	120	table	table	NOUN
dpc-4372	64	121	3	3	NUM
dpc-4372	64	122	)	)	PUNCT
dpc-4372	64	123	.	.	PUNCT
dpc-4372	65	1	dopalevo	dopalevo	ADJ
dpc-4372	65	2	use	use	NOUN
dpc-4372	65	3	was	be	AUX
dpc-4372	65	4	significantly	significantly	ADV
dpc-4372	65	5	lower	low	ADJ
dpc-4372	65	6	in	in	ADP
dpc-4372	65	7	patients	patient	NOUN
dpc-4372	65	8	with	with	ADP
dpc-4372	65	9	pre	pre	ADJ
dpc-4372	65	10	-	-	ADJ
dpc-4372	65	11	pd	pd	ADJ
dpc-4372	65	12	xerosis	xerosis	NOUN
dpc-4372	65	13	than	than	ADP
dpc-4372	65	14	in	in	ADP
dpc-4372	65	15	those	those	PRON
dpc-4372	65	16	without	without	ADP
dpc-4372	65	17	pre	pre	ADJ
dpc-4372	65	18	-	-	ADJ
dpc-4372	65	19	pd	pd	ADJ
dpc-4372	65	20	xerosis	xerosis	NOUN
dpc-4372	65	21	(	(	PUNCT
dpc-4372	65	22	14.7	14.7	NUM
dpc-4372	65	23	%	%	NOUN
dpc-4372	65	24	vs.	vs.	ADP
dpc-4372	65	25	39.3	39.3	NUM
dpc-4372	65	26	%	%	NOUN
dpc-4372	65	27	,	,	PUNCT
dpc-4372	65	28	p	p	X
dpc-4372	65	29	=	=	NOUN
dpc-4372	65	30	0.028	0.028	NUM
dpc-4372	65	31	)	)	PUNCT
dpc-4372	65	32	.	.	PUNCT
dpc-4372	66	1	the	the	DET
dpc-4372	66	2	rate	rate	NOUN
dpc-4372	66	3	of	of	ADP
dpc-4372	66	4	pd	pd	PROPN
dpc-4372	66	5	patients	patient	NOUN
dpc-4372	66	6	with	with	ADP
dpc-4372	66	7	sd	sd	NOUN
dpc-4372	66	8	on	on	ADP
dpc-4372	66	9	the	the	DET
dpc-4372	66	10	face	face	NOUN
dpc-4372	66	11	and	and	CCONJ
dpc-4372	66	12	body	body	NOUN
dpc-4372	66	13	was	be	AUX
dpc-4372	66	14	significantly	significantly	ADV
dpc-4372	66	15	higher	high	ADJ
dpc-4372	66	16	among	among	ADP
dpc-4372	66	17	male	male	ADJ
dpc-4372	66	18	patients	patient	NOUN
dpc-4372	66	19	than	than	ADP
dpc-4372	66	20	female	female	ADJ
dpc-4372	66	21	patients	patient	NOUN
dpc-4372	66	22	(	(	PUNCT
dpc-4372	66	23	35	35	NUM
dpc-4372	66	24	%	%	NOUN
dpc-4372	66	25	vs.	vs.	ADP
dpc-4372	66	26	12.5	12.5	NUM
dpc-4372	66	27	%	%	NOUN
dpc-4372	66	28	,	,	PUNCT
dpc-4372	66	29	p	p	X
dpc-4372	66	30	<	<	X
dpc-4372	66	31	0.001	0.001	NUM
dpc-4372	66	32	)	)	PUNCT
dpc-4372	66	33	.	.	PUNCT
dpc-4372	67	1	sd	sd	NOUN
dpc-4372	67	2	was	be	AUX
dpc-4372	67	3	significantly	significantly	ADV
dpc-4372	67	4	less	less	ADV
dpc-4372	67	5	common	common	ADJ
dpc-4372	67	6	among	among	ADP
dpc-4372	67	7	those	those	PRON
dpc-4372	67	8	using	use	VERB
dpc-4372	67	9	levodopa	levodopa	NOUN
dpc-4372	67	10	/	/	SYM
dpc-4372	67	11	carbidopa/	carbidopa/	NUM
dpc-4372	67	12	entacapone	entacapone	NOUN
dpc-4372	67	13	(	(	PUNCT
dpc-4372	67	14	p	p	NOUN
dpc-4372	67	15	=	=	NOUN
dpc-4372	67	16	0.040	0.040	NUM
dpc-4372	67	17	)	)	PUNCT
dpc-4372	67	18	.	.	PUNCT
dpc-4372	68	1	sd	sd	NOUN
dpc-4372	68	2	was	be	AUX
dpc-4372	68	3	also	also	ADV
dpc-4372	68	4	significantly	significantly	ADV
dpc-4372	68	5	less	less	ADV
dpc-4372	68	6	common	common	ADJ
dpc-4372	68	7	in	in	ADP
dpc-4372	68	8	patients	patient	NOUN
dpc-4372	68	9	who	who	PRON
dpc-4372	68	10	had	have	AUX
dpc-4372	68	11	been	be	AUX
dpc-4372	68	12	using	use	VERB
dpc-4372	68	13	dopa	dopa	NOUN
dpc-4372	68	14	agonists	agonist	NOUN
dpc-4372	68	15	than	than	ADP
dpc-4372	68	16	in	in	ADP
dpc-4372	68	17	patients	patient	NOUN
dpc-4372	68	18	who	who	PRON
dpc-4372	68	19	had	have	AUX
dpc-4372	68	20	not	not	PART
dpc-4372	68	21	been	be	AUX
dpc-4372	68	22	using	use	VERB
dpc-4372	68	23	dopa	dopa	NOUN
dpc-4372	68	24	agonists	agonist	NOUN
dpc-4372	68	25	(	(	PUNCT
dpc-4372	68	26	24.6	24.6	NUM
dpc-4372	68	27	%	%	NOUN
dpc-4372	68	28	vs.	vs.	ADP
dpc-4372	68	29	40	40	NUM
dpc-4372	68	30	%	%	NOUN
dpc-4372	68	31	,	,	PUNCT
dpc-4372	68	32	p	p	X
dpc-4372	68	33	=	=	NOUN
dpc-4372	68	34	0.049	0.049	NUM
dpc-4372	68	35	)	)	PUNCT
dpc-4372	68	36	.	.	PUNCT
dpc-4372	69	1	pre	pre	ADJ
dpc-4372	69	2	-	-	PROPN
dpc-4372	69	3	pd	pd	ADJ
dpc-4372	69	4	sd	sd	NOUN
dpc-4372	69	5	was	be	AUX
dpc-4372	69	6	significantly	significantly	ADV
dpc-4372	69	7	more	more	ADV
dpc-4372	69	8	common	common	ADJ
dpc-4372	69	9	original	original	ADJ
dpc-4372	69	10	article	article	NOUN
dpc-4372	69	11	|	|	ADV
dpc-4372	69	12	dermatol	dermatol	ADJ
dpc-4372	69	13	pract	pract	NOUN
dpc-4372	69	14	concept	concept	NOUN
dpc-4372	69	15	.	.	PUNCT
dpc-4372	70	1	2024;14(4):e2024241	2024;14(4):e2024241	NUM
dpc-4372	70	2	5	5	NUM
dpc-4372	70	3	the	the	DET
dpc-4372	70	4	patients	patient	NOUN
dpc-4372	70	5	noticed	notice	VERB
dpc-4372	70	6	the	the	DET
dpc-4372	70	7	findings	finding	NOUN
dpc-4372	70	8	in	in	ADP
dpc-4372	70	9	62.6	62.6	NUM
dpc-4372	70	10	%	%	NOUN
dpc-4372	70	11	of	of	ADP
dpc-4372	70	12	the	the	DET
dpc-4372	70	13	cases	case	NOUN
dpc-4372	70	14	and	and	CCONJ
dpc-4372	70	15	the	the	DET
dpc-4372	70	16	neurologist	neurologist	NOUN
dpc-4372	70	17	in	in	ADP
dpc-4372	70	18	4.5	4.5	NUM
dpc-4372	70	19	%	%	NOUN
dpc-4372	70	20	.	.	PUNCT
dpc-4372	71	1	conclusions	conclusion	NOUN
dpc-4372	71	2	pd	pd	PROPN
dpc-4372	71	3	,	,	PUNCT
dpc-4372	71	4	which	which	PRON
dpc-4372	71	5	affects	affect	VERB
dpc-4372	71	6	approximately	approximately	ADV
dpc-4372	71	7	0.3	0.3	NUM
dpc-4372	71	8	%	%	NOUN
dpc-4372	71	9	of	of	ADP
dpc-4372	71	10	the	the	DET
dpc-4372	71	11	general	general	ADJ
dpc-4372	71	12	population	population	NOUN
dpc-4372	71	13	,	,	PUNCT
dpc-4372	71	14	is	be	AUX
dpc-4372	71	15	a	a	DET
dpc-4372	71	16	disease	disease	NOUN
dpc-4372	71	17	that	that	PRON
dpc-4372	71	18	progresses	progress	VERB
dpc-4372	71	19	with	with	ADP
dpc-4372	71	20	the	the	DET
dpc-4372	71	21	loss	loss	NOUN
dpc-4372	71	22	of	of	ADP
dpc-4372	71	23	dopaminergic	dopaminergic	ADJ
dpc-4372	71	24	neurons	neuron	NOUN
dpc-4372	71	25	in	in	ADP
dpc-4372	71	26	the	the	DET
dpc-4372	71	27	substantia	substantia	NOUN
dpc-4372	71	28	nigra	nigra	NOUN
dpc-4372	72	1	[	[	X
dpc-4372	72	2	1,3,5,11	1,3,5,11	NOUN
dpc-4372	72	3	]	]	PUNCT
dpc-4372	72	4	.	.	PUNCT
dpc-4372	73	1	the	the	DET
dpc-4372	73	2	incidence	incidence	NOUN
dpc-4372	73	3	of	of	ADP
dpc-4372	73	4	pd	pd	PROPN
dpc-4372	73	5	,	,	PUNCT
dpc-4372	73	6	which	which	PRON
dpc-4372	73	7	is	be	AUX
dpc-4372	73	8	more	more	ADV
dpc-4372	73	9	common	common	ADJ
dpc-4372	73	10	in	in	ADP
dpc-4372	73	11	men	man	NOUN
dpc-4372	73	12	,	,	PUNCT
dpc-4372	73	13	increases	increase	NOUN
dpc-4372	73	14	after	after	ADP
dpc-4372	73	15	the	the	DET
dpc-4372	73	16	fifth	fifth	ADJ
dpc-4372	73	17	decade	decade	NOUN
dpc-4372	73	18	[	[	X
dpc-4372	73	19	2	2	NUM
dpc-4372	73	20	]	]	PUNCT
dpc-4372	73	21	.	.	PUNCT
dpc-4372	74	1	although	although	SCONJ
dpc-4372	74	2	the	the	DET
dpc-4372	74	3	pathogenesis	pathogenesis	NOUN
dpc-4372	74	4	of	of	ADP
dpc-4372	74	5	pd	pd	PROPN
dpc-4372	74	6	is	be	AUX
dpc-4372	74	7	not	not	PART
dpc-4372	74	8	fully	fully	ADV
dpc-4372	74	9	known	know	VERB
dpc-4372	74	10	,	,	PUNCT
dpc-4372	74	11	it	it	PRON
dpc-4372	74	12	has	have	AUX
dpc-4372	74	13	been	be	AUX
dpc-4372	74	14	suggested	suggest	VERB
dpc-4372	74	15	that	that	SCONJ
dpc-4372	74	16	factors	factor	NOUN
dpc-4372	74	17	such	such	ADJ
dpc-4372	74	18	as	as	ADP
dpc-4372	74	19	mitochondrial	mitochondrial	ADJ
dpc-4372	74	20	dysfunction	dysfunction	NOUN
dpc-4372	74	21	,	,	PUNCT
dpc-4372	74	22	oxidative	oxidative	ADJ
dpc-4372	74	23	stress	stress	NOUN
dpc-4372	74	24	,	,	PUNCT
dpc-4372	74	25	immune	immune	ADJ
dpc-4372	74	26	dysregulation	dysregulation	NOUN
dpc-4372	74	27	,	,	PUNCT
dpc-4372	74	28	and	and	CCONJ
dpc-4372	74	29	chronic	chronic	ADJ
dpc-4372	74	30	inflammation	inflammation	NOUN
dpc-4372	74	31	may	may	AUX
dpc-4372	74	32	lead	lead	VERB
dpc-4372	74	33	to	to	ADP
dpc-4372	74	34	pd	pd	PROPN
dpc-4372	75	1	[	[	X
dpc-4372	75	2	1	1	NUM
dpc-4372	75	3	]	]	PUNCT
dpc-4372	75	4	.	.	PUNCT
dpc-4372	76	1	despite	despite	SCONJ
dpc-4372	76	2	the	the	DET
dpc-4372	76	3	general	general	ADJ
dpc-4372	76	4	view	view	NOUN
dpc-4372	76	5	that	that	SCONJ
dpc-4372	76	6	pd	pd	PROPN
dpc-4372	76	7	cases	case	NOUN
dpc-4372	76	8	are	be	AUX
dpc-4372	76	9	sporadic	sporadic	ADJ
dpc-4372	76	10	,	,	PUNCT
dpc-4372	76	11	it	it	PRON
dpc-4372	76	12	has	have	AUX
dpc-4372	76	13	been	be	AUX
dpc-4372	76	14	reported	report	VERB
dpc-4372	76	15	that	that	SCONJ
dpc-4372	76	16	mutations	mutation	NOUN
dpc-4372	76	17	detected	detect	VERB
dpc-4372	76	18	in	in	ADP
dpc-4372	76	19	the	the	DET
dpc-4372	76	20	parkin	parkin	NOUN
dpc-4372	76	21	(	(	PUNCT
dpc-4372	76	22	park2	park2	NOUN
dpc-4372	76	23	)	)	PUNCT
dpc-4372	76	24	,	,	PUNCT
dpc-4372	76	25	pink1	pink1	NOUN
dpc-4372	76	26	(	(	PUNCT
dpc-4372	76	27	park6	park6	NOUN
dpc-4372	76	28	)	)	PUNCT
dpc-4372	76	29	,	,	PUNCT
dpc-4372	76	30	lrrk2	lrrk2	PROPN
dpc-4372	76	31	,	,	PUNCT
dpc-4372	76	32	park7	park7	NOUN
dpc-4372	76	33	,	,	PUNCT
dpc-4372	76	34	and	and	CCONJ
dpc-4372	76	35	snaca	snaca	NOUN
dpc-4372	76	36	genes	gene	NOUN
dpc-4372	76	37	may	may	AUX
dpc-4372	76	38	be	be	AUX
dpc-4372	76	39	associated	associate	VERB
dpc-4372	76	40	with	with	ADP
dpc-4372	76	41	pd	pd	PROPN
dpc-4372	77	1	[	[	X
dpc-4372	77	2	1,2,12	1,2,12	NUM
dpc-4372	77	3	]	]	PUNCT
dpc-4372	77	4	.	.	PUNCT
dpc-4372	78	1	pd	pd	PROPN
dpc-4372	78	2	is	be	AUX
dpc-4372	78	3	a	a	DET
dpc-4372	78	4	hypokinetic	hypokinetic	ADJ
dpc-4372	78	5	motor	motor	NOUN
dpc-4372	78	6	disorder	disorder	NOUN
dpc-4372	78	7	;	;	PUNCT
dpc-4372	78	8	however	however	ADV
dpc-4372	78	9	,	,	PUNCT
dpc-4372	78	10	non	non	ADJ
dpc-4372	78	11	-	-	ADJ
dpc-4372	78	12	motor	motor	ADJ
dpc-4372	78	13	symptoms	symptom	NOUN
dpc-4372	78	14	can	can	AUX
dpc-4372	78	15	also	also	ADV
dpc-4372	78	16	be	be	AUX
dpc-4372	78	17	observed	observe	VERB
dpc-4372	78	18	at	at	ADP
dpc-4372	78	19	all	all	DET
dpc-4372	78	20	stages	stage	NOUN
dpc-4372	78	21	of	of	ADP
dpc-4372	78	22	the	the	DET
dpc-4372	78	23	disease	disease	NOUN
dpc-4372	78	24	.	.	PUNCT
dpc-4372	79	1	recent	recent	ADJ
dpc-4372	79	2	studies	study	NOUN
dpc-4372	79	3	have	have	AUX
dpc-4372	79	4	suggested	suggest	VERB
dpc-4372	79	5	that	that	SCONJ
dpc-4372	79	6	the	the	DET
dpc-4372	79	7	skin	skin	NOUN
dpc-4372	79	8	is	be	AUX
dpc-4372	79	9	an	an	DET
dpc-4372	79	10	organ	organ	NOUN
dpc-4372	79	11	where	where	SCONJ
dpc-4372	79	12	non	non	ADJ
dpc-4372	79	13	-	-	ADJ
dpc-4372	79	14	motor	motor	ADJ
dpc-4372	79	15	symptoms	symptom	NOUN
dpc-4372	79	16	are	be	AUX
dpc-4372	79	17	frequently	frequently	ADV
dpc-4372	79	18	observed	observe	VERB
dpc-4372	79	19	[	[	X
dpc-4372	79	20	1,2	1,2	NUM
dpc-4372	79	21	]	]	PUNCT
dpc-4372	79	22	.	.	PUNCT
dpc-4372	80	1	pd	pd	PROPN
dpc-4372	80	2	is	be	AUX
dpc-4372	80	3	classified	classify	VERB
dpc-4372	80	4	as	as	ADP
dpc-4372	80	5	a	a	DET
dpc-4372	80	6	synucleinopathy	synucleinopathy	NOUN
dpc-4372	80	7	due	due	ADP
dpc-4372	80	8	to	to	ADP
dpc-4372	80	9	the	the	DET
dpc-4372	80	10	pathological	pathological	ADJ
dpc-4372	80	11	accumulation	accumulation	NOUN
dpc-4372	80	12	of	of	ADP
dpc-4372	80	13	alpha	alpha	NOUN
dpc-4372	80	14	-	-	PUNCT
dpc-4372	80	15	synuclein	synuclein	NOUN
dpc-4372	80	16	and	and	CCONJ
dpc-4372	80	17	the	the	DET
dpc-4372	80	18	formation	formation	NOUN
dpc-4372	80	19	of	of	ADP
dpc-4372	80	20	lewy	lewy	ADJ
dpc-4372	80	21	bodies	body	NOUN
dpc-4372	80	22	and	and	CCONJ
dpc-4372	80	23	lewy	lewy	PROPN
dpc-4372	80	24	neurites	neurite	NOUN
dpc-4372	80	25	[	[	X
dpc-4372	80	26	1,4,6,11,13	1,4,6,11,13	NUM
dpc-4372	80	27	]	]	PUNCT
dpc-4372	80	28	.	.	PUNCT
dpc-4372	81	1	it	it	PRON
dpc-4372	81	2	has	have	AUX
dpc-4372	81	3	been	be	AUX
dpc-4372	81	4	shown	show	VERB
dpc-4372	81	5	that	that	SCONJ
dpc-4372	81	6	alpha	alpha	NOUN
dpc-4372	81	7	-	-	PUNCT
dpc-4372	81	8	synuclein	synuclein	NOUN
dpc-4372	81	9	,	,	PUNCT
dpc-4372	81	10	a	a	DET
dpc-4372	81	11	small	small	ADJ
dpc-4372	81	12	protein	protein	NOUN
dpc-4372	81	13	consisting	consist	VERB
dpc-4372	81	14	of	of	ADP
dpc-4372	81	15	140	140	NUM
dpc-4372	81	16	amino	amino	NOUN
dpc-4372	81	17	acids	acid	NOUN
dpc-4372	81	18	,	,	PUNCT
dpc-4372	81	19	plays	play	VERB
dpc-4372	81	20	a	a	DET
dpc-4372	81	21	role	role	NOUN
dpc-4372	81	22	in	in	ADP
dpc-4372	81	23	some	some	DET
dpc-4372	81	24	cellular	cellular	ADJ
dpc-4372	81	25	mechanisms	mechanism	NOUN
dpc-4372	81	26	,	,	PUNCT
dpc-4372	81	27	suggesting	suggest	VERB
dpc-4372	81	28	that	that	SCONJ
dpc-4372	81	29	its	its	PRON
dpc-4372	81	30	accumulation	accumulation	NOUN
dpc-4372	81	31	in	in	ADP
dpc-4372	81	32	peripheral	peripheral	ADJ
dpc-4372	81	33	tissues	tissue	NOUN
dpc-4372	81	34	and	and	CCONJ
dpc-4372	81	35	the	the	DET
dpc-4372	81	36	brain	brain	NOUN
dpc-4372	81	37	causes	cause	VERB
dpc-4372	81	38	non	non	ADJ
dpc-4372	81	39	motor	motor	NOUN
dpc-4372	81	40	symptoms	symptom	NOUN
dpc-4372	81	41	in	in	ADP
dpc-4372	81	42	pd	pd	PROPN
dpc-4372	81	43	,	,	PUNCT
dpc-4372	81	44	including	include	VERB
dpc-4372	81	45	in	in	ADP
dpc-4372	81	46	the	the	DET
dpc-4372	81	47	skin	skin	NOUN
dpc-4372	81	48	[	[	X
dpc-4372	81	49	1,6,7,14	1,6,7,14	X
dpc-4372	81	50	]	]	X
dpc-4372	81	51	.	.	PUNCT
dpc-4372	82	1	in	in	ADP
dpc-4372	82	2	2008	2008	NUM
dpc-4372	82	3	,	,	PUNCT
dpc-4372	82	4	ikemura	ikemura	PROPN
dpc-4372	82	5	et	et	PROPN
dpc-4372	82	6	al	al	PROPN
dpc-4372	82	7	.	.	PROPN
dpc-4372	82	8	detected	detect	VERB
dpc-4372	82	9	alpha	alpha	PROPN
dpc-4372	82	10	-	-	PUNCT
dpc-4372	82	11	synuclein	synuclein	NOUN
dpc-4372	82	12	deposits	deposit	NOUN
dpc-4372	82	13	in	in	ADP
dpc-4372	82	14	the	the	DET
dpc-4372	82	15	skin	skin	NOUN
dpc-4372	82	16	samples	sample	NOUN
dpc-4372	82	17	taken	take	VERB
dpc-4372	82	18	from	from	ADP
dpc-4372	82	19	the	the	DET
dpc-4372	82	20	abdominal	abdominal	ADJ
dpc-4372	82	21	wall	wall	NOUN
dpc-4372	82	22	and	and	CCONJ
dpc-4372	82	23	upper	upper	ADJ
dpc-4372	82	24	extremities	extremity	NOUN
dpc-4372	82	25	of	of	ADP
dpc-4372	82	26	279	279	NUM
dpc-4372	82	27	pd	pd	NOUN
dpc-4372	82	28	patients	patient	NOUN
dpc-4372	82	29	who	who	PRON
dpc-4372	82	30	had	have	AUX
dpc-4372	82	31	undergone	undergo	VERB
dpc-4372	82	32	autopsy	autopsy	ADJ
dpc-4372	82	33	.	.	PUNCT
dpc-4372	83	1	they	they	PRON
dpc-4372	83	2	also	also	ADV
dpc-4372	83	3	detected	detect	VERB
dpc-4372	83	4	localized	localized	ADJ
dpc-4372	83	5	alpha	alpha	NOUN
dpc-4372	83	6	-	-	PUNCT
dpc-4372	83	7	synuclein	synuclein	NOUN
dpc-4372	83	8	immunoreactivity	immunoreactivity	NOUN
dpc-4372	83	9	in	in	ADP
dpc-4372	83	10	the	the	DET
dpc-4372	83	11	dermis	dermis	NOUN
dpc-4372	83	12	in	in	ADP
dpc-4372	83	13	23.5	23.5	NUM
dpc-4372	83	14	%	%	NOUN
dpc-4372	83	15	of	of	ADP
dpc-4372	83	16	the	the	DET
dpc-4372	83	17	patients	patient	NOUN
dpc-4372	83	18	with	with	ADP
dpc-4372	83	19	lewy	lewy	PROPN
dpc-4372	83	20	pathology	pathology	PROPN
dpc-4372	83	21	in	in	ADP
dpc-4372	83	22	the	the	DET
dpc-4372	83	23	central	central	ADJ
dpc-4372	83	24	nervous	nervous	ADJ
dpc-4372	83	25	system	system	NOUN
dpc-4372	83	26	[	[	X
dpc-4372	83	27	15	15	NUM
dpc-4372	83	28	]	]	PUNCT
dpc-4372	83	29	.	.	PUNCT
dpc-4372	84	1	in	in	ADP
dpc-4372	84	2	male	male	ADJ
dpc-4372	84	3	patients	patient	NOUN
dpc-4372	84	4	than	than	ADP
dpc-4372	84	5	in	in	ADP
dpc-4372	84	6	female	female	ADJ
dpc-4372	84	7	patients	patient	NOUN
dpc-4372	84	8	(	(	PUNCT
dpc-4372	84	9	21	21	NUM
dpc-4372	84	10	%	%	NOUN
dpc-4372	84	11	vs.	vs.	ADP
dpc-4372	84	12	8.3	8.3	NUM
dpc-4372	84	13	%	%	NOUN
dpc-4372	84	14	,	,	PUNCT
dpc-4372	84	15	p	p	X
dpc-4372	84	16	=	=	NOUN
dpc-4372	84	17	0.019	0.019	NUM
dpc-4372	84	18	)	)	PUNCT
dpc-4372	84	19	.	.	PUNCT
dpc-4372	85	1	the	the	DET
dpc-4372	85	2	pd	pd	PROPN
dpc-4372	85	3	stage	stage	NOUN
dpc-4372	85	4	at	at	ADP
dpc-4372	85	5	admission	admission	NOUN
dpc-4372	85	6	to	to	ADP
dpc-4372	85	7	our	our	PRON
dpc-4372	85	8	outpatient	outpatient	NOUN
dpc-4372	85	9	clinic	clinic	NOUN
dpc-4372	85	10	was	be	AUX
dpc-4372	85	11	significantly	significantly	ADV
dpc-4372	85	12	lower	low	ADJ
dpc-4372	85	13	in	in	ADP
dpc-4372	85	14	patients	patient	NOUN
dpc-4372	85	15	with	with	ADP
dpc-4372	85	16	pre	pre	ADJ
dpc-4372	85	17	-	-	ADJ
dpc-4372	85	18	pd	pd	ADJ
dpc-4372	85	19	sd	sd	NOUN
dpc-4372	85	20	than	than	ADP
dpc-4372	85	21	in	in	ADP
dpc-4372	85	22	patients	patient	NOUN
dpc-4372	85	23	without	without	ADP
dpc-4372	85	24	pre	pre	ADJ
dpc-4372	85	25	-	-	ADJ
dpc-4372	85	26	pd	pd	ADJ
dpc-4372	85	27	sd	sd	NOUN
dpc-4372	85	28	(	(	PUNCT
dpc-4372	85	29	stage	stage	NOUN
dpc-4372	85	30	1	1	NUM
dpc-4372	85	31	:	:	PUNCT
dpc-4372	85	32	22.2	22.2	NUM
dpc-4372	85	33	%	%	NOUN
dpc-4372	85	34	vs.	vs.	ADP
dpc-4372	85	35	16.2	16.2	NUM
dpc-4372	85	36	%	%	NOUN
dpc-4372	85	37	,	,	PUNCT
dpc-4372	85	38	stage	stage	NOUN
dpc-4372	85	39	2	2	NUM
dpc-4372	85	40	:	:	PUNCT
dpc-4372	85	41	66.7	66.7	NUM
dpc-4372	85	42	%	%	NOUN
dpc-4372	85	43	vs.	vs.	ADP
dpc-4372	85	44	48.6	48.6	NUM
dpc-4372	85	45	%	%	NOUN
dpc-4372	85	46	,	,	PUNCT
dpc-4372	85	47	stage	stage	NOUN
dpc-4372	85	48	3	3	NUM
dpc-4372	85	49	:	:	PUNCT
dpc-4372	85	50	8.3	8.3	NUM
dpc-4372	85	51	%	%	NOUN
dpc-4372	85	52	vs.	vs.	ADP
dpc-4372	85	53	22.3	22.3	NUM
dpc-4372	85	54	,	,	PUNCT
dpc-4372	85	55	stage	stage	NOUN
dpc-4372	85	56	4	4	NUM
dpc-4372	85	57	:	:	SYM
dpc-4372	85	58	2.8	2.8	NUM
dpc-4372	85	59	%	%	NOUN
dpc-4372	85	60	vs.	vs.	ADP
dpc-4372	85	61	10.1	10.1	NUM
dpc-4372	85	62	%	%	NOUN
dpc-4372	85	63	,	,	PUNCT
dpc-4372	85	64	and	and	CCONJ
dpc-4372	85	65	stage	stage	NOUN
dpc-4372	85	66	5	5	NUM
dpc-4372	85	67	:	:	SYM
dpc-4372	85	68	0	0	NUM
dpc-4372	85	69	%	%	NOUN
dpc-4372	85	70	vs.	vs.	ADP
dpc-4372	85	71	2.8	2.8	NUM
dpc-4372	85	72	%	%	NOUN
dpc-4372	85	73	;	;	PUNCT
dpc-4372	85	74	p	p	X
dpc-4372	85	75	=	=	NOUN
dpc-4372	85	76	0.011	0.011	NUM
dpc-4372	85	77	)	)	PUNCT
dpc-4372	85	78	(	(	PUNCT
dpc-4372	85	79	table	table	NOUN
dpc-4372	85	80	3	3	NUM
dpc-4372	85	81	)	)	PUNCT
dpc-4372	85	82	.	.	PUNCT
dpc-4372	86	1	specific	specific	ADJ
dpc-4372	86	2	dermatological	dermatological	ADJ
dpc-4372	86	3	conditions	condition	NOUN
dpc-4372	86	4	in	in	ADP
dpc-4372	86	5	pd	pd	PROPN
dpc-4372	86	6	patients	patient	NOUN
dpc-4372	86	7	cherry	cherry	NOUN
dpc-4372	86	8	angioma	angioma	PROPN
dpc-4372	86	9	(	(	PUNCT
dpc-4372	86	10	25	25	NUM
dpc-4372	86	11	<	<	NOUN
dpc-4372	86	12	)	)	PUNCT
dpc-4372	86	13	was	be	AUX
dpc-4372	86	14	significantly	significantly	ADV
dpc-4372	86	15	more	more	ADV
dpc-4372	86	16	common	common	ADJ
dpc-4372	86	17	in	in	ADP
dpc-4372	86	18	pd	pd	PROPN
dpc-4372	86	19	patients	patient	NOUN
dpc-4372	86	20	with	with	ADP
dpc-4372	86	21	rosacea	rosacea	NOUN
dpc-4372	86	22	than	than	ADP
dpc-4372	86	23	in	in	ADP
dpc-4372	86	24	pd	pd	PROPN
dpc-4372	86	25	patients	patient	NOUN
dpc-4372	86	26	without	without	ADP
dpc-4372	86	27	rosacea	rosacea	NOUN
dpc-4372	86	28	(	(	PUNCT
dpc-4372	86	29	59.3	59.3	NUM
dpc-4372	86	30	%	%	NOUN
dpc-4372	86	31	vs.	vs.	ADP
dpc-4372	86	32	40.3	40.3	NUM
dpc-4372	86	33	%	%	NOUN
dpc-4372	86	34	,	,	PUNCT
dpc-4372	86	35	p	p	X
dpc-4372	86	36	=	=	NOUN
dpc-4372	86	37	0.01	0.01	NUM
dpc-4372	86	38	)	)	PUNCT
dpc-4372	86	39	.	.	PUNCT
dpc-4372	87	1	in	in	ADP
dpc-4372	87	2	parallel	parallel	NOUN
dpc-4372	87	3	,	,	PUNCT
dpc-4372	87	4	rosacea	rosacea	PROPN
dpc-4372	87	5	was	be	AUX
dpc-4372	87	6	significantly	significantly	ADV
dpc-4372	87	7	more	more	ADV
dpc-4372	87	8	common	common	ADJ
dpc-4372	87	9	in	in	ADP
dpc-4372	87	10	pd	pd	PROPN
dpc-4372	87	11	patients	patient	NOUN
dpc-4372	87	12	with	with	ADP
dpc-4372	87	13	cherry	cherry	NOUN
dpc-4372	87	14	angioma	angioma	ADJ
dpc-4372	87	15	than	than	ADP
dpc-4372	87	16	in	in	ADP
dpc-4372	87	17	pd	pd	PROPN
dpc-4372	87	18	patients	patient	NOUN
dpc-4372	87	19	without	without	ADP
dpc-4372	87	20	cherry	cherry	NOUN
dpc-4372	87	21	angioma	angioma	PROPN
dpc-4372	87	22	(	(	PUNCT
dpc-4372	87	23	36.1	36.1	NUM
dpc-4372	87	24	%	%	NOUN
dpc-4372	87	25	vs.	vs.	ADP
dpc-4372	87	26	20.3	20.3	NUM
dpc-4372	87	27	%	%	NOUN
dpc-4372	87	28	,	,	PUNCT
dpc-4372	87	29	p	p	X
dpc-4372	87	30	=	=	NOUN
dpc-4372	87	31	0.01	0.01	NUM
dpc-4372	87	32	)	)	PUNCT
dpc-4372	87	33	.	.	PUNCT
dpc-4372	88	1	erythema	erythema	ADV
dpc-4372	88	2	intertrigo	intertrigo	ADJ
dpc-4372	88	3	and	and	CCONJ
dpc-4372	88	4	tinea	tinea	PROPN
dpc-4372	88	5	pedis	pedis	NOUN
dpc-4372	88	6	were	be	AUX
dpc-4372	88	7	significantly	significantly	ADV
dpc-4372	88	8	more	more	ADV
dpc-4372	88	9	common	common	ADJ
dpc-4372	88	10	in	in	ADP
dpc-4372	88	11	pd	pd	PROPN
dpc-4372	88	12	patients	patient	NOUN
dpc-4372	88	13	with	with	ADP
dpc-4372	88	14	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	88	15	than	than	ADP
dpc-4372	88	16	in	in	ADP
dpc-4372	88	17	pd	pd	PROPN
dpc-4372	88	18	patients	patient	NOUN
dpc-4372	88	19	without	without	ADP
dpc-4372	88	20	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	88	21	(	(	PUNCT
dpc-4372	88	22	p	p	X
dpc-4372	88	23	<	<	X
dpc-4372	88	24	0.001	0.001	NUM
dpc-4372	88	25	)	)	PUNCT
dpc-4372	88	26	.	.	PUNCT
dpc-4372	89	1	the	the	DET
dpc-4372	89	2	pd	pd	PROPN
dpc-4372	89	3	stage	stage	NOUN
dpc-4372	89	4	at	at	ADP
dpc-4372	89	5	admission	admission	NOUN
dpc-4372	89	6	to	to	ADP
dpc-4372	89	7	our	our	PRON
dpc-4372	89	8	outpatient	outpatient	NOUN
dpc-4372	89	9	clinic	clinic	NOUN
dpc-4372	89	10	was	be	AUX
dpc-4372	89	11	significantly	significantly	ADV
dpc-4372	89	12	lower	low	ADJ
dpc-4372	89	13	in	in	ADP
dpc-4372	89	14	patients	patient	NOUN
dpc-4372	89	15	with	with	ADP
dpc-4372	89	16	pre	pre	ADJ
dpc-4372	89	17	-	-	ADJ
dpc-4372	89	18	pd	pd	ADJ
dpc-4372	89	19	sd	sd	NOUN
dpc-4372	89	20	on	on	ADP
dpc-4372	89	21	the	the	DET
dpc-4372	89	22	scalp	scalp	NOUN
dpc-4372	89	23	than	than	ADP
dpc-4372	89	24	in	in	ADP
dpc-4372	89	25	patients	patient	NOUN
dpc-4372	89	26	without	without	ADP
dpc-4372	89	27	pre	pre	ADJ
dpc-4372	89	28	-	-	ADJ
dpc-4372	89	29	pd	pd	ADJ
dpc-4372	89	30	sd	sd	NOUN
dpc-4372	89	31	on	on	ADP
dpc-4372	89	32	the	the	DET
dpc-4372	89	33	scalp	scalp	NOUN
dpc-4372	89	34	(	(	PUNCT
dpc-4372	89	35	stage	stage	NOUN
dpc-4372	89	36	1	1	NUM
dpc-4372	89	37	:	:	PUNCT
dpc-4372	89	38	28.1	28.1	NUM
dpc-4372	89	39	%	%	NOUN
dpc-4372	89	40	vs.	vs.	ADP
dpc-4372	89	41	3.2	3.2	NUM
dpc-4372	89	42	%	%	NOUN
dpc-4372	89	43	,	,	PUNCT
dpc-4372	89	44	stage	stage	NOUN
dpc-4372	89	45	2	2	NUM
dpc-4372	89	46	:	:	PUNCT
dpc-4372	89	47	59.4	59.4	NUM
dpc-4372	89	48	%	%	NOUN
dpc-4372	89	49	vs.	vs.	ADP
dpc-4372	89	50	41.9	41.9	NUM
dpc-4372	89	51	%	%	NOUN
dpc-4372	89	52	,	,	PUNCT
dpc-4372	89	53	stage	stage	NOUN
dpc-4372	89	54	3	3	NUM
dpc-4372	89	55	:	:	PUNCT
dpc-4372	89	56	9.4	9.4	NUM
dpc-4372	89	57	%	%	NOUN
dpc-4372	89	58	vs.	vs.	ADP
dpc-4372	89	59	35.5	35.5	NUM
dpc-4372	89	60	%	%	NOUN
dpc-4372	89	61	,	,	PUNCT
dpc-4372	89	62	stage	stage	NOUN
dpc-4372	89	63	4	4	NUM
dpc-4372	89	64	:	:	SYM
dpc-4372	89	65	3.1	3.1	NUM
dpc-4372	89	66	%	%	NOUN
dpc-4372	89	67	vs.	vs.	ADP
dpc-4372	89	68	12.9	12.9	NUM
dpc-4372	89	69	%	%	NOUN
dpc-4372	89	70	,	,	PUNCT
dpc-4372	89	71	stage	stage	NOUN
dpc-4372	89	72	5	5	NUM
dpc-4372	89	73	:	:	SYM
dpc-4372	89	74	0	0	NUM
dpc-4372	89	75	%	%	NOUN
dpc-4372	89	76	vs.	vs.	ADP
dpc-4372	89	77	6.5	6.5	NUM
dpc-4372	89	78	%	%	NOUN
dpc-4372	89	79	;	;	PUNCT
dpc-4372	89	80	p	p	X
dpc-4372	89	81	<	<	X
dpc-4372	89	82	0.001	0.001	NUM
dpc-4372	89	83	)	)	PUNCT
dpc-4372	89	84	(	(	PUNCT
dpc-4372	89	85	table3	table3	PROPN
dpc-4372	89	86	)	)	PUNCT
dpc-4372	89	87	.	.	PUNCT
dpc-4372	90	1	actinic	actinic	ADJ
dpc-4372	90	2	keratosis	keratosis	NOUN
dpc-4372	90	3	was	be	AUX
dpc-4372	90	4	observed	observe	VERB
dpc-4372	90	5	on	on	ADP
dpc-4372	90	6	the	the	DET
dpc-4372	90	7	face	face	NOUN
dpc-4372	90	8	of	of	ADP
dpc-4372	90	9	9.8	9.8	NUM
dpc-4372	90	10	%	%	NOUN
dpc-4372	90	11	of	of	ADP
dpc-4372	90	12	the	the	DET
dpc-4372	90	13	pd	pd	PROPN
dpc-4372	90	14	patients	patient	NOUN
dpc-4372	90	15	and	and	CCONJ
dpc-4372	90	16	on	on	ADP
dpc-4372	90	17	the	the	DET
dpc-4372	90	18	scalp	scalp	NOUN
dpc-4372	90	19	of	of	ADP
dpc-4372	90	20	4.7	4.7	NUM
dpc-4372	90	21	%	%	NOUN
dpc-4372	90	22	.	.	PUNCT
dpc-4372	91	1	in	in	ADP
dpc-4372	91	2	patients	patient	NOUN
dpc-4372	91	3	with	with	ADP
dpc-4372	91	4	additional	additional	ADJ
dpc-4372	91	5	systemic	systemic	ADJ
dpc-4372	91	6	diseases	disease	NOUN
dpc-4372	91	7	other	other	ADJ
dpc-4372	91	8	than	than	ADP
dpc-4372	91	9	 	 	SPACE
dpc-4372	91	10	pd	pd	PROPN
dpc-4372	91	11	and	and	CCONJ
dpc-4372	91	12	drug	drug	NOUN
dpc-4372	91	13	use	use	NOUN
dpc-4372	91	14	other	other	ADJ
dpc-4372	91	15	than	than	ADP
dpc-4372	91	16	pd	pd	PROPN
dpc-4372	91	17	,	,	PUNCT
dpc-4372	91	18	there	there	PRON
dpc-4372	91	19	was	be	VERB
dpc-4372	91	20	no	no	DET
dpc-4372	91	21	statistically	statistically	ADV
dpc-4372	91	22	significant	significant	ADJ
dpc-4372	91	23	relationship	relationship	NOUN
dpc-4372	91	24	between	between	ADP
dpc-4372	91	25	skin	skin	NOUN
dpc-4372	91	26	findings	finding	NOUN
dpc-4372	91	27	(	(	PUNCT
dpc-4372	91	28	p	p	X
dpc-4372	91	29	>	>	X
dpc-4372	91	30	0.05	0.05	NUM
dpc-4372	91	31	)	)	PUNCT
dpc-4372	91	32	improvement	improvement	NOUN
dpc-4372	91	33	of	of	ADP
dpc-4372	91	34	dermatological	dermatological	ADJ
dpc-4372	91	35	findings	finding	NOUN
dpc-4372	91	36	after	after	ADP
dpc-4372	91	37	pd	pd	PROPN
dpc-4372	91	38	diagnosis	diagnosis	NOUN
dpc-4372	91	39	of	of	ADP
dpc-4372	91	40	the	the	DET
dpc-4372	91	41	patients	patient	NOUN
dpc-4372	91	42	with	with	ADP
dpc-4372	91	43	pre	pre	ADJ
dpc-4372	91	44	-	-	ADJ
dpc-4372	91	45	pd	pd	ADJ
dpc-4372	91	46	dermatological	dermatological	ADJ
dpc-4372	91	47	findings	finding	NOUN
dpc-4372	91	48	,	,	PUNCT
dpc-4372	91	49	92.4	92.4	NUM
dpc-4372	91	50	%	%	NOUN
dpc-4372	91	51	described	describe	VERB
dpc-4372	91	52	improvement	improvement	NOUN
dpc-4372	91	53	in	in	ADP
dpc-4372	91	54	these	these	DET
dpc-4372	91	55	findings	finding	NOUN
dpc-4372	91	56	after	after	ADP
dpc-4372	91	57	pd	pd	PROPN
dpc-4372	91	58	.	.	PROPN
dpc-4372	91	59	in	in	ADP
dpc-4372	91	60	cases	case	NOUN
dpc-4372	91	61	with	with	ADP
dpc-4372	91	62	skin	skin	NOUN
dpc-4372	91	63	findings	finding	NOUN
dpc-4372	91	64	detected	detect	VERB
dpc-4372	91	65	after	after	ADP
dpc-4372	91	66	dermatological	dermatological	ADJ
dpc-4372	91	67	examination	examination	NOUN
dpc-4372	91	68	,	,	PUNCT
dpc-4372	91	69	table	table	NOUN
dpc-4372	91	70	3	3	NUM
dpc-4372	91	71	.	.	PUNCT
dpc-4372	91	72	comparative	comparative	ADJ
dpc-4372	91	73	analysis	analysis	NOUN
dpc-4372	91	74	of	of	ADP
dpc-4372	91	75	dermatological	dermatological	ADJ
dpc-4372	91	76	conditions	condition	NOUN
dpc-4372	91	77	across	across	ADP
dpc-4372	91	78	parkinson	parkinson	NOUN
dpc-4372	91	79	’s	’s	PART
dpc-4372	91	80	disease	disease	NOUN
dpc-4372	91	81	stages	stage	NOUN
dpc-4372	91	82	.	.	PUNCT
dpc-4372	92	1	pd	pd	PROPN
dpc-4372	92	2	stage	stage	NOUN
dpc-4372	92	3	xerosis	xerosis	NOUN
dpc-4372	92	4	,	,	PUNCT
dpc-4372	92	5	freq	freq	ADJ
dpc-4372	92	6	%	%	NOUN
dpc-4372	92	7	sd	sd	NOUN
dpc-4372	92	8	,	,	PUNCT
dpc-4372	92	9	freq	freq	ADJ
dpc-4372	92	10	%	%	NOUN
dpc-4372	92	11	ssd	ssd	NOUN
dpc-4372	92	12	,	,	PUNCT
dpc-4372	92	13	freq	freq	ADJ
dpc-4372	92	14	%	%	NOUN
dpc-4372	92	15	rosacea	rosacea	NOUN
dpc-4372	92	16	,	,	PUNCT
dpc-4372	92	17	freq	freq	ADJ
dpc-4372	92	18	%	%	NOUN
dpc-4372	92	19	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	92	20	,	,	PUNCT
dpc-4372	92	21	freq	freq	ADJ
dpc-4372	92	22	%	%	NOUN
dpc-4372	92	23	pos	pos	NOUN
dpc-4372	92	24	neg	neg	NOUN
dpc-4372	92	25	p	p	PRON
dpc-4372	92	26	pos	pos	NOUN
dpc-4372	92	27	neg	neg	PROPN
dpc-4372	92	28	p	p	PRON
dpc-4372	92	29	pos	pos	NOUN
dpc-4372	92	30	neg	neg	PROPN
dpc-4372	92	31	p	p	PRON
dpc-4372	92	32	pos	pos	NOUN
dpc-4372	92	33	neg	neg	PROPN
dpc-4372	92	34	p	p	PRON
dpc-4372	92	35	pos	pos	NOUN
dpc-4372	92	36	neg	neg	PROPN
dpc-4372	92	37	p	p	NOUN
dpc-4372	92	38	1	1	NUM
dpc-4372	92	39	22.8	22.8	NUM
dpc-4372	92	40	7.2	7.2	NUM
dpc-4372	92	41	0.001	0.001	NUM
dpc-4372	92	42	22.2	22.2	NUM
dpc-4372	92	43	16.2	16.2	NUM
dpc-4372	92	44	0.011	0.011	NUM
dpc-4372	92	45	28.1	28.1	NUM
dpc-4372	92	46	3.2	3.2	NUM
dpc-4372	92	47	<	<	NOUN
dpc-4372	92	48	0.001	0.001	NUM
dpc-4372	92	49	16.6	16.6	NUM
dpc-4372	92	50	21.1	21.1	NUM
dpc-4372	92	51	0.67	0.67	NUM
dpc-4372	92	52	14.3	14.3	NUM
dpc-4372	92	53	29.5	29.5	NUM
dpc-4372	92	54	0.096	0.096	NUM
dpc-4372	92	55	2	2	NUM
dpc-4372	92	56	54.3	54.3	NUM
dpc-4372	92	57	44.7	44.7	NUM
dpc-4372	92	58	66.7	66.7	NUM
dpc-4372	92	59	48.6	48.6	NUM
dpc-4372	92	60	59.4	59.4	NUM
dpc-4372	92	61	41.9	41.9	NUM
dpc-4372	92	62	50.5	50.5	NUM
dpc-4372	92	63	57.6	57.6	NUM
dpc-4372	92	64	51.4	51.4	NUM
dpc-4372	92	65	40.9	40.9	NUM
dpc-4372	92	66	3	3	NUM
dpc-4372	92	67	17.4	17.4	NUM
dpc-4372	92	68	34,1	34,1	NUM
dpc-4372	92	69	8.3	8.3	NUM
dpc-4372	92	70	22.3	22.3	NUM
dpc-4372	92	71	9.4	9.4	NUM
dpc-4372	92	72	35.5	35.5	NUM
dpc-4372	92	73	20.9	20.9	NUM
dpc-4372	92	74	15.2	15.2	NUM
dpc-4372	92	75	14.3	14.3	NUM
dpc-4372	92	76	25	25	NUM
dpc-4372	92	77	4	4	NUM
dpc-4372	92	78	4.1	4.1	NUM
dpc-4372	92	79	12.5	12.5	NUM
dpc-4372	92	80	2.8	2.8	NUM
dpc-4372	92	81	10.1	10.1	NUM
dpc-4372	92	82	3.1	3.1	NUM
dpc-4372	92	83	12.9	12.9	NUM
dpc-4372	92	84	9.3	9.3	NUM
dpc-4372	92	85	6.1	6.1	NUM
dpc-4372	92	86	14.3	14.3	NUM
dpc-4372	92	87	2.3	2.3	NUM
dpc-4372	92	88	5	5	NUM
dpc-4372	92	89	1.4	1.4	NUM
dpc-4372	92	90	1.5	1.5	NUM
dpc-4372	92	91	0	0	NUM
dpc-4372	92	92	2.8	2.8	NUM
dpc-4372	92	93	0	0	NUM
dpc-4372	92	94	6.5	6.5	NUM
dpc-4372	92	95	2.7	2.7	NUM
dpc-4372	92	96	0	0	NUM
dpc-4372	92	97	5.7	5.7	NUM
dpc-4372	92	98	2.3	2.3	NUM
dpc-4372	92	99	this	this	DET
dpc-4372	92	100	table	table	NOUN
dpc-4372	92	101	presents	present	VERB
dpc-4372	92	102	a	a	DET
dpc-4372	92	103	comparative	comparative	ADJ
dpc-4372	92	104	analysis	analysis	NOUN
dpc-4372	92	105	of	of	ADP
dpc-4372	92	106	the	the	DET
dpc-4372	92	107	frequency	frequency	NOUN
dpc-4372	92	108	percentages	percentage	NOUN
dpc-4372	92	109	of	of	ADP
dpc-4372	92	110	various	various	ADJ
dpc-4372	92	111	dermatological	dermatological	ADJ
dpc-4372	92	112	conditions	condition	NOUN
dpc-4372	92	113	across	across	ADP
dpc-4372	92	114	different	different	ADJ
dpc-4372	92	115	stages	stage	NOUN
dpc-4372	92	116	of	of	ADP
dpc-4372	92	117	parkinson	parkinson	NOUN
dpc-4372	92	118	’s	’s	PART
dpc-4372	92	119	disease	disease	NOUN
dpc-4372	92	120	(	(	PUNCT
dpc-4372	92	121	pd	pd	NOUN
dpc-4372	92	122	)	)	PUNCT
dpc-4372	92	123	,	,	PUNCT
dpc-4372	92	124	ranging	range	VERB
dpc-4372	92	125	from	from	ADP
dpc-4372	92	126	stage	stage	NOUN
dpc-4372	92	127	1	1	NUM
dpc-4372	92	128	to	to	PART
dpc-4372	92	129	stage	stage	VERB
dpc-4372	92	130	5	5	NUM
dpc-4372	92	131	according	accord	VERB
dpc-4372	92	132	to	to	ADP
dpc-4372	92	133	the	the	DET
dpc-4372	92	134	hoehn	hoehn	NOUN
dpc-4372	92	135	and	and	CCONJ
dpc-4372	92	136	yahr	yahr	ADJ
dpc-4372	92	137	scale	scale	NOUN
dpc-4372	92	138	.	.	PUNCT
dpc-4372	93	1	“	"	PUNCT
dpc-4372	93	2	freq	freq	ADJ
dpc-4372	93	3	%	%	NOUN
dpc-4372	93	4	”	"	PUNCT
dpc-4372	93	5	columns	column	NOUN
dpc-4372	93	6	under	under	ADP
dpc-4372	93	7	each	each	DET
dpc-4372	93	8	condition	condition	NOUN
dpc-4372	93	9	(	(	PUNCT
dpc-4372	93	10	xerosis	xerosis	NOUN
dpc-4372	93	11	,	,	PUNCT
dpc-4372	93	12	seborrheic	seborrheic	PROPN
dpc-4372	93	13	dermatitis	dermatitis	NOUN
dpc-4372	93	14	(	(	PUNCT
dpc-4372	93	15	sd	sd	NOUN
dpc-4372	93	16	)	)	PUNCT
dpc-4372	93	17	,	,	PUNCT
dpc-4372	93	18	scalp	scalp	NOUN
dpc-4372	93	19	seborrheic	seborrheic	PROPN
dpc-4372	93	20	dermatitis	dermatitis	NOUN
dpc-4372	93	21	(	(	PUNCT
dpc-4372	93	22	ssd	ssd	NOUN
dpc-4372	93	23	)	)	PUNCT
dpc-4372	93	24	,	,	PUNCT
dpc-4372	93	25	rosacea	rosacea	NOUN
dpc-4372	93	26	,	,	PUNCT
dpc-4372	93	27	and	and	CCONJ
dpc-4372	93	28	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	93	29	)	)	PUNCT
dpc-4372	93	30	are	be	AUX
dpc-4372	93	31	divided	divide	VERB
dpc-4372	93	32	into	into	ADP
dpc-4372	93	33	“	"	PUNCT
dpc-4372	93	34	pos	pos	NOUN
dpc-4372	93	35	”	"	PUNCT
dpc-4372	93	36	for	for	ADP
dpc-4372	93	37	positive	positive	ADJ
dpc-4372	93	38	(	(	PUNCT
dpc-4372	93	39	presence	presence	NOUN
dpc-4372	93	40	of	of	ADP
dpc-4372	93	41	the	the	DET
dpc-4372	93	42	condition	condition	NOUN
dpc-4372	93	43	)	)	PUNCT
dpc-4372	93	44	and	and	CCONJ
dpc-4372	93	45	“	"	PUNCT
dpc-4372	93	46	neg	neg	PROPN
dpc-4372	93	47	”	"	PUNCT
dpc-4372	93	48	for	for	ADP
dpc-4372	93	49	negative	negative	ADJ
dpc-4372	93	50	(	(	PUNCT
dpc-4372	93	51	absence	absence	NOUN
dpc-4372	93	52	of	of	ADP
dpc-4372	93	53	the	the	DET
dpc-4372	93	54	condition	condition	NOUN
dpc-4372	93	55	)	)	PUNCT
dpc-4372	93	56	,	,	PUNCT
dpc-4372	93	57	indicating	indicate	VERB
dpc-4372	93	58	the	the	DET
dpc-4372	93	59	proportion	proportion	NOUN
dpc-4372	93	60	of	of	ADP
dpc-4372	93	61	patients	patient	NOUN
dpc-4372	93	62	at	at	ADP
dpc-4372	93	63	each	each	DET
dpc-4372	93	64	pd	pd	NOUN
dpc-4372	93	65	stage	stage	NOUN
dpc-4372	93	66	.	.	PUNCT
dpc-4372	94	1	p	p	X
dpc-4372	94	2	-	-	PUNCT
dpc-4372	94	3	values	value	NOUN
dpc-4372	94	4	indicate	indicate	VERB
dpc-4372	94	5	the	the	DET
dpc-4372	94	6	statistical	statistical	ADJ
dpc-4372	94	7	significance	significance	NOUN
dpc-4372	94	8	of	of	ADP
dpc-4372	94	9	the	the	DET
dpc-4372	94	10	differences	difference	NOUN
dpc-4372	94	11	observed	observe	VERB
dpc-4372	94	12	between	between	ADP
dpc-4372	94	13	the	the	DET
dpc-4372	94	14	presence	presence	NOUN
dpc-4372	94	15	and	and	CCONJ
dpc-4372	94	16	absence	absence	NOUN
dpc-4372	94	17	of	of	ADP
dpc-4372	94	18	each	each	DET
dpc-4372	94	19	condition	condition	NOUN
dpc-4372	94	20	at	at	ADP
dpc-4372	94	21	various	various	ADJ
dpc-4372	94	22	pd	pd	ADJ
dpc-4372	94	23	stages	stage	NOUN
dpc-4372	94	24	,	,	PUNCT
dpc-4372	94	25	with	with	ADP
dpc-4372	94	26	values	value	NOUN
dpc-4372	94	27	less	less	ADJ
dpc-4372	94	28	than	than	ADP
dpc-4372	94	29	0.05	0.05	NUM
dpc-4372	94	30	considered	consider	VERB
dpc-4372	94	31	statistically	statistically	ADV
dpc-4372	94	32	significant	significant	ADJ
dpc-4372	94	33	.	.	PUNCT
dpc-4372	95	1	the	the	DET
dpc-4372	95	2	absence	absence	NOUN
dpc-4372	95	3	of	of	ADP
dpc-4372	95	4	a	a	DET
dpc-4372	95	5	p	p	NOUN
dpc-4372	95	6	-	-	PUNCT
dpc-4372	95	7	value	value	NOUN
dpc-4372	95	8	indicates	indicate	VERB
dpc-4372	95	9	that	that	SCONJ
dpc-4372	95	10	statistical	statistical	ADJ
dpc-4372	95	11	analysis	analysis	NOUN
dpc-4372	95	12	data	datum	NOUN
dpc-4372	95	13	for	for	ADP
dpc-4372	95	14	those	those	DET
dpc-4372	95	15	stages	stage	NOUN
dpc-4372	95	16	are	be	AUX
dpc-4372	95	17	not	not	PART
dpc-4372	95	18	provided	provide	VERB
dpc-4372	95	19	.	.	PUNCT
dpc-4372	96	1	this	this	DET
dpc-4372	96	2	analysis	analysis	NOUN
dpc-4372	96	3	aimed	aim	VERB
dpc-4372	96	4	to	to	PART
dpc-4372	96	5	identify	identify	VERB
dpc-4372	96	6	potential	potential	ADJ
dpc-4372	96	7	correlations	correlation	NOUN
dpc-4372	96	8	between	between	ADP
dpc-4372	96	9	the	the	DET
dpc-4372	96	10	progression	progression	NOUN
dpc-4372	96	11	of	of	ADP
dpc-4372	96	12	pd	pd	PROPN
dpc-4372	96	13	and	and	CCONJ
dpc-4372	96	14	the	the	DET
dpc-4372	96	15	prevalence	prevalence	NOUN
dpc-4372	96	16	of	of	ADP
dpc-4372	96	17	specific	specific	ADJ
dpc-4372	96	18	dermatological	dermatological	ADJ
dpc-4372	96	19	conditions	condition	NOUN
dpc-4372	96	20	.	.	PUNCT
dpc-4372	97	1	chi	chi	ADJ
dpc-4372	97	2	-	-	PUNCT
dpc-4372	97	3	squared	square	VERB
dpc-4372	97	4	test	test	NOUN
dpc-4372	97	5	.	.	PUNCT
dpc-4372	98	1	6	6	NUM
dpc-4372	98	2	original	original	ADJ
dpc-4372	98	3	article	article	NOUN
dpc-4372	98	4	|	|	ADV
dpc-4372	98	5	dermatol	dermatol	ADJ
dpc-4372	98	6	pract	pract	NOUN
dpc-4372	98	7	concept	concept	NOUN
dpc-4372	98	8	.	.	PUNCT
dpc-4372	99	1	2024;14(4):e2024241	2024;14(4):e2024241	NUM
dpc-4372	99	2	alpha	alpha	NOUN
dpc-4372	99	3	-	-	PUNCT
dpc-4372	99	4	synuclein	synuclein	NOUN
dpc-4372	99	5	aggregates	aggregate	NOUN
dpc-4372	99	6	have	have	AUX
dpc-4372	99	7	been	be	AUX
dpc-4372	99	8	found	find	VERB
dpc-4372	99	9	in	in	ADP
dpc-4372	99	10	the	the	DET
dpc-4372	99	11	sebaceous	sebaceous	ADJ
dpc-4372	99	12	glands	gland	NOUN
dpc-4372	99	13	in	in	ADP
dpc-4372	99	14	skin	skin	NOUN
dpc-4372	99	15	biopsies	biopsy	NOUN
dpc-4372	99	16	of	of	ADP
dpc-4372	99	17	patients	patient	NOUN
dpc-4372	99	18	with	with	ADP
dpc-4372	99	19	pd	pd	PROPN
dpc-4372	99	20	[	[	X
dpc-4372	99	21	14	14	NUM
dpc-4372	99	22	]	]	PUNCT
dpc-4372	99	23	.	.	PUNCT
dpc-4372	100	1	alpha	alpha	PROPN
dpc-4372	100	2	synuclein	synuclein	PROPN
dpc-4372	100	3	deposits	deposit	NOUN
dpc-4372	100	4	may	may	AUX
dpc-4372	100	5	affect	affect	VERB
dpc-4372	100	6	sebum	sebum	NOUN
dpc-4372	100	7	production	production	NOUN
dpc-4372	100	8	and	and	CCONJ
dpc-4372	100	9	excretion	excretion	NOUN
dpc-4372	100	10	in	in	ADP
dpc-4372	100	11	the	the	DET
dpc-4372	100	12	sebaceous	sebaceous	ADJ
dpc-4372	100	13	glands	gland	NOUN
dpc-4372	100	14	,	,	PUNCT
dpc-4372	100	15	causing	cause	VERB
dpc-4372	100	16	skin	skin	NOUN
dpc-4372	100	17	oiliness	oiliness	NOUN
dpc-4372	100	18	or	or	CCONJ
dpc-4372	100	19	dryness	dryness	NOUN
dpc-4372	100	20	.	.	PUNCT
dpc-4372	101	1	in	in	ADP
dpc-4372	101	2	our	our	PRON
dpc-4372	101	3	study	study	NOUN
dpc-4372	101	4	,	,	PUNCT
dpc-4372	101	5	the	the	DET
dpc-4372	101	6	frequency	frequency	NOUN
dpc-4372	101	7	of	of	ADP
dpc-4372	101	8	sd	sd	NOUN
dpc-4372	101	9	in	in	ADP
dpc-4372	101	10	patients	patient	NOUN
dpc-4372	101	11	using	use	VERB
dpc-4372	101	12	levodopa	levodopa	NOUN
dpc-4372	101	13	/	/	SYM
dpc-4372	101	14	carbidopa	carbidopa	NOUN
dpc-4372	101	15	/	/	SYM
dpc-4372	101	16	entacapone	entacapone	ADJ
dpc-4372	101	17	and	and	CCONJ
dpc-4372	101	18	dopa	dopa	NOUN
dpc-4372	101	19	agonists	agonist	NOUN
dpc-4372	101	20	was	be	AUX
dpc-4372	101	21	statistically	statistically	ADV
dpc-4372	101	22	lower	low	ADJ
dpc-4372	101	23	than	than	ADP
dpc-4372	101	24	in	in	ADP
dpc-4372	101	25	patients	patient	NOUN
dpc-4372	101	26	not	not	PART
dpc-4372	101	27	using	use	VERB
dpc-4372	101	28	these	these	DET
dpc-4372	101	29	drugs	drug	NOUN
dpc-4372	101	30	.	.	PUNCT
dpc-4372	102	1	kohn	kohn	PROPN
dpc-4372	102	2	et	et	PROPN
dpc-4372	102	3	al	al	PROPN
dpc-4372	102	4	.	.	PROPN
dpc-4372	102	5	found	find	VERB
dpc-4372	102	6	a	a	DET
dpc-4372	102	7	significant	significant	ADJ
dpc-4372	102	8	decrease	decrease	NOUN
dpc-4372	102	9	in	in	ADP
dpc-4372	102	10	the	the	DET
dpc-4372	102	11	sebum	sebum	NOUN
dpc-4372	102	12	on	on	ADP
dpc-4372	102	13	the	the	DET
dpc-4372	102	14	foreheads	forehead	NOUN
dpc-4372	102	15	of	of	ADP
dpc-4372	102	16	patients	patient	NOUN
dpc-4372	102	17	receiving	receive	VERB
dpc-4372	102	18	l	l	NOUN
dpc-4372	102	19	-	-	PUNCT
dpc-4372	102	20	dopa	dopa	NOUN
dpc-4372	102	21	treatment	treatment	NOUN
dpc-4372	102	22	.	.	PUNCT
dpc-4372	103	1	they	they	PRON
dpc-4372	103	2	did	do	AUX
dpc-4372	103	3	not	not	PART
dpc-4372	103	4	find	find	VERB
dpc-4372	103	5	a	a	DET
dpc-4372	103	6	relationship	relationship	NOUN
dpc-4372	103	7	between	between	ADP
dpc-4372	103	8	dopa	dopa	NOUN
dpc-4372	103	9	dose	dose	NOUN
dpc-4372	103	10	,	,	PUNCT
dpc-4372	103	11	treatment	treatment	NOUN
dpc-4372	103	12	duration	duration	NOUN
dpc-4372	103	13	,	,	PUNCT
dpc-4372	103	14	and	and	CCONJ
dpc-4372	103	15	degree	degree	NOUN
dpc-4372	103	16	of	of	ADP
dpc-4372	103	17	sebaceous	sebaceous	ADJ
dpc-4372	103	18	gland	gland	NOUN
dpc-4372	103	19	inhibition	inhibition	NOUN
dpc-4372	103	20	[	[	X
dpc-4372	103	21	19	19	NUM
dpc-4372	103	22	]	]	PUNCT
dpc-4372	103	23	.	.	PUNCT
dpc-4372	104	1	martignoni	martignoni	AUX
dpc-4372	104	2	et	et	PROPN
dpc-4372	104	3	al	al	PROPN
dpc-4372	104	4	.	.	PROPN
dpc-4372	104	5	found	find	VERB
dpc-4372	104	6	no	no	DET
dpc-4372	104	7	correlation	correlation	NOUN
dpc-4372	104	8	between	between	ADP
dpc-4372	104	9	sebum	sebum	NOUN
dpc-4372	104	10	excretion	excretion	NOUN
dpc-4372	104	11	rates	rate	NOUN
dpc-4372	104	12	and	and	CCONJ
dpc-4372	104	13	duration	duration	NOUN
dpc-4372	104	14	of	of	ADP
dpc-4372	104	15	l	l	NOUN
dpc-4372	104	16	-	-	PUNCT
dpc-4372	104	17	dopa	dopa	NOUN
dpc-4372	104	18	treatment	treatment	NOUN
dpc-4372	104	19	[	[	X
dpc-4372	104	20	17	17	NUM
dpc-4372	104	21	]	]	PUNCT
dpc-4372	104	22	.	.	PUNCT
dpc-4372	105	1	tomic	tomic	PROPN
dpc-4372	105	2	et	et	PROPN
dpc-4372	105	3	al	al	PROPN
dpc-4372	105	4	.	.	PROPN
dpc-4372	105	5	found	find	VERB
dpc-4372	105	6	a	a	DET
dpc-4372	105	7	positive	positive	ADJ
dpc-4372	105	8	correlation	correlation	NOUN
dpc-4372	105	9	between	between	ADP
dpc-4372	105	10	age	age	NOUN
dpc-4372	105	11	,	,	PUNCT
dpc-4372	105	12	motor	motor	NOUN
dpc-4372	105	13	symptom	symptom	NOUN
dpc-4372	105	14	severity	severity	NOUN
dpc-4372	105	15	,	,	PUNCT
dpc-4372	105	16	and	and	CCONJ
dpc-4372	105	17	sd	sd	X
dpc-4372	105	18	in	in	ADP
dpc-4372	105	19	pd	pd	PROPN
dpc-4372	106	1	[	[	X
dpc-4372	106	2	4	4	NUM
dpc-4372	106	3	]	]	PUNCT
dpc-4372	106	4	.	.	PUNCT
dpc-4372	107	1	in	in	ADP
dpc-4372	107	2	contrast	contrast	NOUN
dpc-4372	107	3	,	,	PUNCT
dpc-4372	107	4	we	we	PRON
dpc-4372	107	5	did	do	AUX
dpc-4372	107	6	not	not	PART
dpc-4372	107	7	find	find	VERB
dpc-4372	107	8	any	any	DET
dpc-4372	107	9	significant	significant	ADJ
dpc-4372	107	10	relationship	relationship	NOUN
dpc-4372	107	11	between	between	ADP
dpc-4372	107	12	pd	pd	NOUN
dpc-4372	107	13	stage	stage	NOUN
dpc-4372	107	14	,	,	PUNCT
dpc-4372	107	15	age	age	NOUN
dpc-4372	107	16	,	,	PUNCT
dpc-4372	107	17	and	and	CCONJ
dpc-4372	107	18	sd	sd	NOUN
dpc-4372	107	19	.	.	PUNCT
dpc-4372	108	1	tomic	tomic	PROPN
dpc-4372	108	2	et	et	PROPN
dpc-4372	108	3	al	al	PROPN
dpc-4372	108	4	.	.	PROPN
dpc-4372	108	5	found	find	VERB
dpc-4372	108	6	that	that	SCONJ
dpc-4372	108	7	1/3	1/3	NUM
dpc-4372	108	8	of	of	ADP
dpc-4372	108	9	the	the	DET
dpc-4372	108	10	patients	patient	NOUN
dpc-4372	108	11	had	have	VERB
dpc-4372	108	12	symptoms	symptom	NOUN
dpc-4372	108	13	of	of	ADP
dpc-4372	108	14	sd	sd	NOUN
dpc-4372	108	15	before	before	ADP
dpc-4372	108	16	pd	pd	NOUN
dpc-4372	108	17	diagnosis	diagnosis	NOUN
dpc-4372	108	18	,	,	PUNCT
dpc-4372	108	19	and	and	CCONJ
dpc-4372	108	20	sd	sd	NOUN
dpc-4372	108	21	was	be	AUX
dpc-4372	108	22	1.8	1.8	NUM
dpc-4372	108	23	times	time	NOUN
dpc-4372	108	24	more	more	ADV
dpc-4372	108	25	common	common	ADJ
dpc-4372	108	26	in	in	ADP
dpc-4372	108	27	patients	patient	NOUN
dpc-4372	108	28	with	with	ADP
dpc-4372	108	29	moderate	moderate	ADJ
dpc-4372	108	30	and	and	CCONJ
dpc-4372	108	31	severe	severe	ADJ
dpc-4372	108	32	symptoms	symptom	NOUN
dpc-4372	108	33	than	than	ADP
dpc-4372	108	34	in	in	ADP
dpc-4372	108	35	patients	patient	NOUN
dpc-4372	108	36	with	with	ADP
dpc-4372	108	37	mild	mild	ADJ
dpc-4372	108	38	symptoms	symptom	NOUN
dpc-4372	108	39	[	[	X
dpc-4372	108	40	4	4	NUM
dpc-4372	108	41	]	]	PUNCT
dpc-4372	108	42	.	.	PUNCT
dpc-4372	109	1	in	in	ADP
dpc-4372	109	2	our	our	PRON
dpc-4372	109	3	study	study	NOUN
dpc-4372	109	4	,	,	PUNCT
dpc-4372	109	5	61	61	NUM
dpc-4372	109	6	%	%	NOUN
dpc-4372	109	7	of	of	ADP
dpc-4372	109	8	the	the	DET
dpc-4372	109	9	pd	pd	PROPN
dpc-4372	109	10	patients	patient	NOUN
dpc-4372	109	11	had	have	VERB
dpc-4372	109	12	sd	sd	NOUN
dpc-4372	109	13	before	before	SCONJ
dpc-4372	109	14	they	they	PRON
dpc-4372	109	15	were	be	AUX
dpc-4372	109	16	diagnosed	diagnose	VERB
dpc-4372	109	17	with	with	ADP
dpc-4372	109	18	pd	pd	PROPN
dpc-4372	109	19	.	.	PROPN
dpc-4372	110	1	unlike	unlike	ADP
dpc-4372	110	2	tomic	tomic	PROPN
dpc-4372	110	3	et	et	PROPN
dpc-4372	110	4	al	al	PROPN
dpc-4372	110	5	.	.	PROPN
dpc-4372	110	6	,	,	PUNCT
dpc-4372	110	7	we	we	PRON
dpc-4372	110	8	found	find	VERB
dpc-4372	110	9	the	the	DET
dpc-4372	110	10	pd	pd	PROPN
dpc-4372	110	11	stage	stage	NOUN
dpc-4372	110	12	at	at	ADP
dpc-4372	110	13	admission	admission	NOUN
dpc-4372	110	14	to	to	ADP
dpc-4372	110	15	our	our	PRON
dpc-4372	110	16	outpatient	outpatient	NOUN
dpc-4372	110	17	clinic	clinic	NOUN
dpc-4372	110	18	to	to	PART
dpc-4372	110	19	be	be	AUX
dpc-4372	110	20	significantly	significantly	ADV
dpc-4372	110	21	lower	low	ADJ
dpc-4372	110	22	in	in	ADP
dpc-4372	110	23	pd	pd	PROPN
dpc-4372	110	24	patients	patient	NOUN
dpc-4372	110	25	with	with	ADP
dpc-4372	110	26	sd	sd	NOUN
dpc-4372	110	27	than	than	ADP
dpc-4372	110	28	in	in	ADP
dpc-4372	110	29	those	those	PRON
dpc-4372	110	30	without	without	ADP
dpc-4372	110	31	sd	sd	NOUN
dpc-4372	110	32	.	.	PUNCT
dpc-4372	111	1	these	these	DET
dpc-4372	111	2	findings	finding	NOUN
dpc-4372	111	3	suggest	suggest	VERB
dpc-4372	111	4	that	that	SCONJ
dpc-4372	111	5	pd	pd	PROPN
dpc-4372	111	6	may	may	AUX
dpc-4372	111	7	be	be	AUX
dpc-4372	111	8	less	less	ADV
dpc-4372	111	9	severe	severe	ADJ
dpc-4372	111	10	in	in	ADP
dpc-4372	111	11	patients	patient	NOUN
dpc-4372	111	12	with	with	ADP
dpc-4372	111	13	sd	sd	NOUN
dpc-4372	111	14	.	.	PUNCT
dpc-4372	112	1	rosacea	rosacea	NOUN
dpc-4372	112	2	,	,	PUNCT
dpc-4372	112	3	whose	whose	DET
dpc-4372	112	4	prevalence	prevalence	NOUN
dpc-4372	112	5	in	in	ADP
dpc-4372	112	6	the	the	DET
dpc-4372	112	7	population	population	NOUN
dpc-4372	112	8	varies	vary	VERB
dpc-4372	112	9	between	between	ADP
dpc-4372	112	10	1	1	NUM
dpc-4372	112	11	%	%	NOUN
dpc-4372	112	12	and	and	CCONJ
dpc-4372	112	13	20	20	NUM
dpc-4372	112	14	%	%	NOUN
dpc-4372	113	1	[	[	X
dpc-4372	113	2	1	1	NUM
dpc-4372	113	3	]	]	PUNCT
dpc-4372	113	4	,	,	PUNCT
dpc-4372	113	5	was	be	AUX
dpc-4372	113	6	observed	observe	VERB
dpc-4372	113	7	at	at	ADP
dpc-4372	113	8	a	a	DET
dpc-4372	113	9	high	high	ADJ
dpc-4372	113	10	rate	rate	NOUN
dpc-4372	113	11	in	in	ADP
dpc-4372	113	12	patients	patient	NOUN
dpc-4372	113	13	with	with	ADP
dpc-4372	113	14	pd	pd	PROPN
dpc-4372	113	15	in	in	ADP
dpc-4372	113	16	our	our	PRON
dpc-4372	113	17	study	study	NOUN
dpc-4372	113	18	.	.	PUNCT
dpc-4372	114	1	a	a	DET
dpc-4372	114	2	few	few	ADJ
dpc-4372	114	3	studies	study	NOUN
dpc-4372	114	4	suggested	suggest	VERB
dpc-4372	114	5	a	a	DET
dpc-4372	114	6	relationship	relationship	NOUN
dpc-4372	114	7	between	between	ADP
dpc-4372	114	8	rosacea	rosacea	NOUN
dpc-4372	114	9	and	and	CCONJ
dpc-4372	114	10	pd	pd	NOUN
dpc-4372	115	1	[	[	X
dpc-4372	115	2	8,20,21	8,20,21	NUM
dpc-4372	115	3	]	]	PUNCT
dpc-4372	115	4	.	.	PUNCT
dpc-4372	116	1	the	the	DET
dpc-4372	116	2	relationship	relationship	NOUN
dpc-4372	116	3	between	between	ADP
dpc-4372	116	4	pd	pd	PROPN
dpc-4372	116	5	and	and	CCONJ
dpc-4372	116	6	rosacea	rosacea	NOUN
dpc-4372	116	7	is	be	AUX
dpc-4372	116	8	not	not	PART
dpc-4372	116	9	fully	fully	ADV
dpc-4372	116	10	known	know	VERB
dpc-4372	116	11	.	.	PUNCT
dpc-4372	117	1	however	however	ADV
dpc-4372	117	2	,	,	PUNCT
dpc-4372	117	3	common	common	ADJ
dpc-4372	117	4	mechanisms	mechanism	NOUN
dpc-4372	117	5	involving	involve	VERB
dpc-4372	117	6	increased	increase	VERB
dpc-4372	117	7	matrix	matrix	NOUN
dpc-4372	117	8	metalloproteinase	metalloproteinase	NOUN
dpc-4372	117	9	(	(	PUNCT
dpc-4372	117	10	mmp	mmp	PROPN
dpc-4372	117	11	)	)	PUNCT
dpc-4372	117	12	activity	activity	NOUN
dpc-4372	117	13	have	have	AUX
dpc-4372	117	14	been	be	AUX
dpc-4372	117	15	suggested	suggest	VERB
dpc-4372	117	16	to	to	PART
dpc-4372	117	17	play	play	VERB
dpc-4372	117	18	a	a	DET
dpc-4372	117	19	role	role	NOUN
dpc-4372	117	20	in	in	ADP
dpc-4372	117	21	the	the	DET
dpc-4372	117	22	relationship	relationship	NOUN
dpc-4372	117	23	between	between	ADP
dpc-4372	117	24	pd	pd	PROPN
dpc-4372	117	25	and	and	CCONJ
dpc-4372	117	26	rosacea	rosacea	NOUN
dpc-4372	117	27	.	.	PUNCT
dpc-4372	118	1	in	in	ADP
dpc-4372	118	2	addition	addition	NOUN
dpc-4372	118	3	,	,	PUNCT
dpc-4372	118	4	it	it	PRON
dpc-4372	118	5	has	have	AUX
dpc-4372	118	6	been	be	AUX
dpc-4372	118	7	stated	state	VERB
dpc-4372	118	8	that	that	SCONJ
dpc-4372	118	9	increased	increase	VERB
dpc-4372	118	10	levels	level	NOUN
dpc-4372	118	11	of	of	ADP
dpc-4372	118	12	mmp-3	mmp-3	NUM
dpc-4372	118	13	and	and	CCONJ
dpc-4372	118	14	mmp-9	mmp-9	NOUN
dpc-4372	118	15	in	in	ADP
dpc-4372	118	16	the	the	DET
dpc-4372	118	17	cerebrospinal	cerebrospinal	ADJ
dpc-4372	118	18	fluid	fluid	NOUN
dpc-4372	118	19	may	may	AUX
dpc-4372	118	20	lead	lead	VERB
dpc-4372	118	21	to	to	ADP
dpc-4372	118	22	the	the	DET
dpc-4372	118	23	death	death	NOUN
dpc-4372	118	24	of	of	ADP
dpc-4372	118	25	dopaminergic	dopaminergic	ADJ
dpc-4372	118	26	neurons	neuron	NOUN
dpc-4372	118	27	,	,	PUNCT
dpc-4372	118	28	and	and	CCONJ
dpc-4372	118	29	simultaneously	simultaneously	ADV
dpc-4372	118	30	,	,	PUNCT
dpc-4372	118	31	increased	increase	VERB
dpc-4372	118	32	levels	level	NOUN
dpc-4372	118	33	of	of	ADP
dpc-4372	118	34	mmp-1	mmp-1	NOUN
dpc-4372	118	35	,	,	PUNCT
dpc-4372	118	36	mmp-3	mmp-3	NOUN
dpc-4372	118	37	,	,	PUNCT
dpc-4372	118	38	and	and	CCONJ
dpc-4372	118	39	mmp-9	mmp-9	VERB
dpc-4372	118	40	in	in	ADP
dpc-4372	118	41	the	the	DET
dpc-4372	118	42	skin	skin	NOUN
dpc-4372	118	43	may	may	AUX
dpc-4372	118	44	lead	lead	VERB
dpc-4372	118	45	to	to	ADP
dpc-4372	118	46	tissue	tissue	NOUN
dpc-4372	118	47	damage	damage	NOUN
dpc-4372	118	48	[	[	X
dpc-4372	118	49	1,2,8	1,2,8	NUM
dpc-4372	118	50	]	]	X
dpc-4372	118	51	.	.	PUNCT
dpc-4372	119	1	additionally	additionally	ADV
dpc-4372	119	2	,	,	PUNCT
dpc-4372	119	3	sensory	sensory	ADJ
dpc-4372	119	4	nerve	nerve	NOUN
dpc-4372	119	5	fiber	fiber	NOUN
dpc-4372	119	6	dysfunction	dysfunction	NOUN
dpc-4372	119	7	is	be	AUX
dpc-4372	119	8	thought	think	VERB
dpc-4372	119	9	to	to	PART
dpc-4372	119	10	cause	cause	VERB
dpc-4372	119	11	immune	immune	ADJ
dpc-4372	119	12	destabilization	destabilization	NOUN
dpc-4372	119	13	and	and	CCONJ
dpc-4372	119	14	opportunistic	opportunistic	ADJ
dpc-4372	119	15	skin	skin	NOUN
dpc-4372	119	16	diseases	disease	NOUN
dpc-4372	119	17	in	in	ADP
dpc-4372	119	18	sensitive	sensitive	ADJ
dpc-4372	119	19	areas	area	NOUN
dpc-4372	119	20	of	of	ADP
dpc-4372	119	21	the	the	DET
dpc-4372	119	22	skin	skin	NOUN
dpc-4372	119	23	[	[	X
dpc-4372	119	24	1,8	1,8	NOUN
dpc-4372	119	25	]	]	X
dpc-4372	119	26	.	.	PUNCT
dpc-4372	120	1	pd	pd	PROPN
dpc-4372	120	2	also	also	ADV
dpc-4372	120	3	affects	affect	VERB
dpc-4372	120	4	the	the	DET
dpc-4372	120	5	entire	entire	ADJ
dpc-4372	120	6	gastrointestinal	gastrointestinal	ADJ
dpc-4372	120	7	system	system	NOUN
dpc-4372	120	8	.	.	PUNCT
dpc-4372	121	1	bacterial	bacterial	ADJ
dpc-4372	121	2	overgrowth	overgrowth	NOUN
dpc-4372	121	3	in	in	ADP
dpc-4372	121	4	the	the	DET
dpc-4372	121	5	small	small	ADJ
dpc-4372	121	6	intestine	intestine	NOUN
dpc-4372	121	7	and	and	CCONJ
dpc-4372	121	8	h.	h.	PROPN
dpc-4372	121	9	pylori	pylori	NOUN
dpc-4372	121	10	may	may	AUX
dpc-4372	121	11	contribute	contribute	VERB
dpc-4372	121	12	to	to	ADP
dpc-4372	121	13	the	the	DET
dpc-4372	121	14	pathogenesis	pathogenesis	NOUN
dpc-4372	121	15	of	of	ADP
dpc-4372	121	16	rosacea	rosacea	NOUN
dpc-4372	121	17	[	[	X
dpc-4372	121	18	1,2,22	1,2,22	NUM
dpc-4372	121	19	]	]	X
dpc-4372	121	20	.	.	PUNCT
dpc-4372	122	1	we	we	PRON
dpc-4372	122	2	found	find	VERB
dpc-4372	122	3	cherry	cherry	NOUN
dpc-4372	122	4	angioma	angioma	ADJ
dpc-4372	122	5	to	to	PART
dpc-4372	122	6	be	be	AUX
dpc-4372	122	7	more	more	ADV
dpc-4372	122	8	common	common	ADJ
dpc-4372	122	9	in	in	ADP
dpc-4372	122	10	patients	patient	NOUN
dpc-4372	122	11	with	with	ADP
dpc-4372	122	12	rosacea	rosacea	NOUN
dpc-4372	122	13	and	and	CCONJ
dpc-4372	122	14	rosacea	rosacea	NOUN
dpc-4372	122	15	to	to	PART
dpc-4372	122	16	be	be	AUX
dpc-4372	122	17	more	more	ADV
dpc-4372	122	18	common	common	ADJ
dpc-4372	122	19	in	in	ADP
dpc-4372	122	20	patients	patient	NOUN
dpc-4372	122	21	with	with	ADP
dpc-4372	122	22	cherry	cherry	NOUN
dpc-4372	122	23	angioma	angioma	PROPN
dpc-4372	122	24	.	.	PUNCT
dpc-4372	123	1	a	a	DET
dpc-4372	123	2	thorough	thorough	ADJ
dpc-4372	123	3	literature	literature	NOUN
dpc-4372	123	4	review	review	NOUN
dpc-4372	123	5	did	do	AUX
dpc-4372	123	6	not	not	PART
dpc-4372	123	7	reveal	reveal	VERB
dpc-4372	123	8	any	any	DET
dpc-4372	123	9	study	study	NOUN
dpc-4372	123	10	touching	touch	VERB
dpc-4372	123	11	on	on	ADP
dpc-4372	123	12	that	that	DET
dpc-4372	123	13	relationship	relationship	NOUN
dpc-4372	123	14	.	.	PUNCT
dpc-4372	124	1	the	the	DET
dpc-4372	124	2	fact	fact	NOUN
dpc-4372	124	3	that	that	SCONJ
dpc-4372	124	4	both	both	DET
dpc-4372	124	5	diseases	disease	NOUN
dpc-4372	124	6	were	be	AUX
dpc-4372	124	7	seen	see	VERB
dpc-4372	124	8	more	more	ADV
dpc-4372	124	9	frequently	frequently	ADV
dpc-4372	124	10	together	together	ADV
dpc-4372	124	11	may	may	AUX
dpc-4372	124	12	be	be	AUX
dpc-4372	124	13	attributed	attribute	VERB
dpc-4372	124	14	to	to	ADP
dpc-4372	124	15	their	their	PRON
dpc-4372	124	16	similar	similar	ADJ
dpc-4372	124	17	pathogenesis	pathogenesis	NOUN
dpc-4372	124	18	.	.	PUNCT
dpc-4372	125	1	the	the	DET
dpc-4372	125	2	prevalence	prevalence	NOUN
dpc-4372	125	3	of	of	ADP
dpc-4372	125	4	actinic	actinic	ADJ
dpc-4372	125	5	keratosis	keratosis	NOUN
dpc-4372	125	6	(	(	PUNCT
dpc-4372	125	7	ak	ak	PROPN
dpc-4372	125	8	)	)	PUNCT
dpc-4372	125	9	varies	vary	VERB
dpc-4372	125	10	from	from	ADP
dpc-4372	125	11	country	country	NOUN
dpc-4372	125	12	to	to	ADP
dpc-4372	125	13	country	country	NOUN
dpc-4372	125	14	,	,	PUNCT
dpc-4372	125	15	e.g.	e.g.	ADV
dpc-4372	125	16	,	,	PUNCT
dpc-4372	125	17	italy	italy	PROPN
dpc-4372	125	18	:	:	PUNCT
dpc-4372	125	19	1.4	1.4	NUM
dpc-4372	125	20	%	%	NOUN
dpc-4372	125	21	,	,	PUNCT
dpc-4372	125	22	south	south	PROPN
dpc-4372	125	23	korea	korea	PROPN
dpc-4372	125	24	:	:	PUNCT
dpc-4372	125	25	88	88	NUM
dpc-4372	125	26	%	%	NOUN
dpc-4372	125	27	[	[	X
dpc-4372	125	28	23	23	NUM
dpc-4372	125	29	]	]	PUNCT
dpc-4372	125	30	.	.	PUNCT
dpc-4372	126	1	in	in	ADP
dpc-4372	126	2	a	a	DET
dpc-4372	126	3	study	study	NOUN
dpc-4372	126	4	conducted	conduct	VERB
dpc-4372	126	5	in	in	ADP
dpc-4372	126	6	turkey	turkey	NOUN
dpc-4372	126	7	,	,	PUNCT
dpc-4372	126	8	yaldız	yaldız	PROPN
dpc-4372	126	9	et	et	PROPN
dpc-4372	126	10	al	al	PROPN
dpc-4372	126	11	.	.	PROPN
dpc-4372	126	12	reported	report	VERB
dpc-4372	126	13	the	the	DET
dpc-4372	126	14	prevalence	prevalence	NOUN
dpc-4372	126	15	of	of	ADP
dpc-4372	126	16	ak	ak	PROPN
dpc-4372	126	17	as	as	ADP
dpc-4372	126	18	4.61	4.61	NUM
dpc-4372	126	19	%	%	NOUN
dpc-4372	126	20	between	between	ADP
dpc-4372	126	21	the	the	DET
dpc-4372	126	22	ages	age	NOUN
dpc-4372	126	23	of	of	ADP
dpc-4372	126	24	60	60	NUM
dpc-4372	126	25	and	and	CCONJ
dpc-4372	126	26	69	69	NUM
dpc-4372	126	27	,	,	PUNCT
dpc-4372	126	28	in	in	ADP
dpc-4372	126	29	comparison	comparison	NOUN
dpc-4372	126	30	,	,	PUNCT
dpc-4372	126	31	in	in	ADP
dpc-4372	126	32	our	our	PRON
dpc-4372	126	33	study	study	NOUN
dpc-4372	126	34	,	,	PUNCT
dpc-4372	126	35	75.8	75.8	NUM
dpc-4372	126	36	%	%	NOUN
dpc-4372	126	37	of	of	ADP
dpc-4372	126	38	the	the	DET
dpc-4372	126	39	pd	pd	PROPN
dpc-4372	126	40	patients	patient	NOUN
dpc-4372	126	41	had	have	VERB
dpc-4372	126	42	no	no	DET
dpc-4372	126	43	dermatological	dermatological	ADJ
dpc-4372	126	44	complaint	complaint	NOUN
dpc-4372	126	45	.	.	PUNCT
dpc-4372	127	1	however	however	ADV
dpc-4372	127	2	,	,	PUNCT
dpc-4372	127	3	dermatological	dermatological	ADJ
dpc-4372	127	4	examination	examination	NOUN
dpc-4372	127	5	revealed	reveal	VERB
dpc-4372	127	6	at	at	ADP
dpc-4372	127	7	least	least	ADV
dpc-4372	127	8	one	one	NUM
dpc-4372	127	9	skin	skin	NOUN
dpc-4372	127	10	disease	disease	NOUN
dpc-4372	127	11	in	in	ADP
dpc-4372	127	12	92.1	92.1	NUM
dpc-4372	127	13	%	%	NOUN
dpc-4372	127	14	of	of	ADP
dpc-4372	127	15	the	the	DET
dpc-4372	127	16	patients	patient	NOUN
dpc-4372	127	17	,	,	PUNCT
dpc-4372	127	18	at	at	ADV
dpc-4372	127	19	least	least	ADV
dpc-4372	127	20	one	one	NUM
dpc-4372	127	21	scalp	scalp	NOUN
dpc-4372	127	22	disease	disease	NOUN
dpc-4372	127	23	in	in	ADP
dpc-4372	127	24	39.1	39.1	NUM
dpc-4372	127	25	%	%	NOUN
dpc-4372	127	26	,	,	PUNCT
dpc-4372	127	27	nail	nail	NOUN
dpc-4372	127	28	disease	disease	NOUN
dpc-4372	127	29	in	in	ADP
dpc-4372	127	30	27.4	27.4	NUM
dpc-4372	127	31	%	%	NOUN
dpc-4372	127	32	,	,	PUNCT
dpc-4372	127	33	and	and	CCONJ
dpc-4372	127	34	oral	oral	ADJ
dpc-4372	127	35	mucosa	mucosa	NOUN
dpc-4372	127	36	disease	disease	NOUN
dpc-4372	127	37	in	in	ADP
dpc-4372	127	38	1.4	1.4	NUM
dpc-4372	127	39	%	%	NOUN
dpc-4372	127	40	.	.	PUNCT
dpc-4372	128	1	the	the	DET
dpc-4372	128	2	most	most	ADV
dpc-4372	128	3	common	common	ADJ
dpc-4372	128	4	skin	skin	NOUN
dpc-4372	128	5	finding	finding	NOUN
dpc-4372	128	6	in	in	ADP
dpc-4372	128	7	our	our	PRON
dpc-4372	128	8	study	study	NOUN
dpc-4372	128	9	was	be	AUX
dpc-4372	128	10	xerosis	xerosis	NOUN
dpc-4372	128	11	,	,	PUNCT
dpc-4372	128	12	common	common	ADJ
dpc-4372	128	13	in	in	ADP
dpc-4372	128	14	the	the	DET
dpc-4372	128	15	geriatric	geriatric	ADJ
dpc-4372	128	16	population	population	NOUN
dpc-4372	128	17	.	.	PUNCT
dpc-4372	129	1	the	the	DET
dpc-4372	129	2	frequent	frequent	ADJ
dpc-4372	129	3	occurrence	occurrence	NOUN
dpc-4372	129	4	of	of	ADP
dpc-4372	129	5	xerosis	xerosis	NOUN
dpc-4372	129	6	in	in	ADP
dpc-4372	129	7	pd	pd	PROPN
dpc-4372	129	8	patients	patient	NOUN
dpc-4372	129	9	may	may	AUX
dpc-4372	129	10	be	be	AUX
dpc-4372	129	11	due	due	ADJ
dpc-4372	129	12	to	to	ADP
dpc-4372	129	13	age	age	NOUN
dpc-4372	129	14	or	or	CCONJ
dpc-4372	129	15	autonomic	autonomic	ADJ
dpc-4372	129	16	dysfunction	dysfunction	NOUN
dpc-4372	129	17	.	.	PUNCT
dpc-4372	130	1	in	in	ADP
dpc-4372	130	2	our	our	PRON
dpc-4372	130	3	study	study	NOUN
dpc-4372	130	4	,	,	PUNCT
dpc-4372	130	5	in	in	ADP
dpc-4372	130	6	most	most	ADJ
dpc-4372	130	7	pd	pd	NOUN
dpc-4372	130	8	patients	patient	NOUN
dpc-4372	130	9	with	with	ADP
dpc-4372	130	10	xerosis	xerosis	NOUN
dpc-4372	130	11	,	,	PUNCT
dpc-4372	130	12	xerosis	xerosis	NOUN
dpc-4372	130	13	occurred	occur	VERB
dpc-4372	130	14	before	before	ADP
dpc-4372	130	15	pd	pd	PROPN
dpc-4372	130	16	.	.	PROPN
dpc-4372	131	1	therefore	therefore	ADV
dpc-4372	131	2	,	,	PUNCT
dpc-4372	131	3	we	we	PRON
dpc-4372	131	4	think	think	VERB
dpc-4372	131	5	xerosis	xerosis	NOUN
dpc-4372	131	6	may	may	AUX
dpc-4372	131	7	be	be	AUX
dpc-4372	131	8	a	a	DET
dpc-4372	131	9	non	non	ADJ
dpc-4372	131	10	-	-	ADJ
dpc-4372	131	11	motor	motor	ADJ
dpc-4372	131	12	precursor	precursor	NOUN
dpc-4372	131	13	skin	skin	NOUN
dpc-4372	131	14	lesion	lesion	NOUN
dpc-4372	131	15	associated	associate	VERB
dpc-4372	131	16	with	with	ADP
dpc-4372	131	17	pd	pd	PROPN
dpc-4372	131	18	.	.	PROPN
dpc-4372	131	19	additionally	additionally	ADV
dpc-4372	131	20	,	,	PUNCT
dpc-4372	131	21	the	the	DET
dpc-4372	131	22	pd	pd	PROPN
dpc-4372	131	23	stage	stage	NOUN
dpc-4372	131	24	at	at	ADP
dpc-4372	131	25	admission	admission	NOUN
dpc-4372	131	26	to	to	ADP
dpc-4372	131	27	our	our	PRON
dpc-4372	131	28	outpatient	outpatient	NOUN
dpc-4372	131	29	clinic	clinic	NOUN
dpc-4372	131	30	was	be	AUX
dpc-4372	131	31	significantly	significantly	ADV
dpc-4372	131	32	lower	low	ADJ
dpc-4372	131	33	in	in	ADP
dpc-4372	131	34	patients	patient	NOUN
dpc-4372	131	35	with	with	ADP
dpc-4372	131	36	xerosis	xerosis	NOUN
dpc-4372	131	37	than	than	ADP
dpc-4372	131	38	those	those	PRON
dpc-4372	131	39	without	without	ADP
dpc-4372	131	40	xerosis	xerosis	NOUN
dpc-4372	131	41	,	,	PUNCT
dpc-4372	131	42	suggesting	suggest	VERB
dpc-4372	131	43	that	that	SCONJ
dpc-4372	131	44	xerosis	xerosis	NOUN
dpc-4372	131	45	is	be	AUX
dpc-4372	131	46	a	a	DET
dpc-4372	131	47	good	good	ADJ
dpc-4372	131	48	prognostic	prognostic	ADJ
dpc-4372	131	49	factor	factor	NOUN
dpc-4372	131	50	.	.	PUNCT
dpc-4372	132	1	a	a	DET
dpc-4372	132	2	thorough	thorough	ADJ
dpc-4372	132	3	literature	literature	NOUN
dpc-4372	132	4	review	review	NOUN
dpc-4372	132	5	did	do	AUX
dpc-4372	132	6	not	not	PART
dpc-4372	132	7	reveal	reveal	VERB
dpc-4372	132	8	any	any	DET
dpc-4372	132	9	study	study	NOUN
dpc-4372	132	10	on	on	ADP
dpc-4372	132	11	xerosis	xerosis	NOUN
dpc-4372	132	12	in	in	ADP
dpc-4372	132	13	patients	patient	NOUN
dpc-4372	132	14	with	with	ADP
dpc-4372	132	15	pd	pd	PROPN
dpc-4372	132	16	.	.	PROPN
dpc-4372	132	17	dyshidrosis	dyshidrosis	PROPN
dpc-4372	132	18	(	(	PUNCT
dpc-4372	132	19	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	132	20	and	and	CCONJ
dpc-4372	132	21	hypohidrosis	hypohidrosis	NOUN
dpc-4372	132	22	)	)	PUNCT
dpc-4372	132	23	,	,	PUNCT
dpc-4372	132	24	which	which	PRON
dpc-4372	132	25	is	be	AUX
dpc-4372	132	26	considered	consider	VERB
dpc-4372	132	27	a	a	DET
dpc-4372	132	28	part	part	NOUN
dpc-4372	132	29	of	of	ADP
dpc-4372	132	30	orthostatic	orthostatic	ADJ
dpc-4372	132	31	dysfunction	dysfunction	NOUN
dpc-4372	132	32	,	,	PUNCT
dpc-4372	132	33	is	be	AUX
dpc-4372	132	34	a	a	DET
dpc-4372	132	35	common	common	ADJ
dpc-4372	132	36	finding	finding	NOUN
dpc-4372	132	37	in	in	ADP
dpc-4372	132	38	pd	pd	PROPN
dpc-4372	132	39	.	.	PROPN
dpc-4372	133	1	in	in	ADP
dpc-4372	133	2	our	our	PRON
dpc-4372	133	3	study	study	NOUN
dpc-4372	133	4	,	,	PUNCT
dpc-4372	133	5	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	133	6	was	be	AUX
dpc-4372	133	7	observed	observe	VERB
dpc-4372	133	8	in	in	ADP
dpc-4372	133	9	37.2	37.2	NUM
dpc-4372	133	10	%	%	NOUN
dpc-4372	133	11	of	of	ADP
dpc-4372	133	12	the	the	DET
dpc-4372	133	13	patients	patient	NOUN
dpc-4372	133	14	.	.	PUNCT
dpc-4372	134	1	pont	pont	NOUN
dpc-4372	134	2	-	-	PUNCT
dpc-4372	134	3	sunyer	sunyer	PROPN
dpc-4372	134	4	et	et	PROPN
dpc-4372	134	5	al	al	PROPN
dpc-4372	134	6	.	.	PROPN
dpc-4372	134	7	reported	report	VERB
dpc-4372	134	8	that	that	SCONJ
dpc-4372	134	9	patients	patient	NOUN
dpc-4372	134	10	with	with	ADP
dpc-4372	134	11	pd	pd	PROPN
dpc-4372	134	12	had	have	VERB
dpc-4372	134	13	excessive	excessive	ADJ
dpc-4372	134	14	sweating	sweating	NOUN
dpc-4372	134	15	for	for	ADP
dpc-4372	134	16	2–10	2–10	NOUN
dpc-4372	134	17	years	year	NOUN
dpc-4372	134	18	before	before	ADP
dpc-4372	134	19	the	the	DET
dpc-4372	134	20	onset	onset	NOUN
dpc-4372	134	21	of	of	ADP
dpc-4372	134	22	typical	typical	ADJ
dpc-4372	134	23	motor	motor	NOUN
dpc-4372	134	24	symptoms	symptom	NOUN
dpc-4372	134	25	[	[	X
dpc-4372	134	26	16	16	NUM
dpc-4372	134	27	]	]	PUNCT
dpc-4372	134	28	.	.	PUNCT
dpc-4372	135	1	similarly	similarly	ADV
dpc-4372	135	2	,	,	PUNCT
dpc-4372	135	3	complaints	complaint	NOUN
dpc-4372	135	4	of	of	ADP
dpc-4372	135	5	the	the	DET
dpc-4372	135	6	majority	majority	NOUN
dpc-4372	135	7	of	of	ADP
dpc-4372	135	8	pd	pd	PROPN
dpc-4372	135	9	patients	patient	NOUN
dpc-4372	135	10	with	with	ADP
dpc-4372	135	11	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	135	12	in	in	ADP
dpc-4372	135	13	our	our	PRON
dpc-4372	135	14	study	study	NOUN
dpc-4372	135	15	had	have	AUX
dpc-4372	135	16	started	start	VERB
dpc-4372	135	17	before	before	ADP
dpc-4372	135	18	the	the	DET
dpc-4372	135	19	diagnosis	diagnosis	NOUN
dpc-4372	135	20	of	of	ADP
dpc-4372	135	21	pd	pd	PROPN
dpc-4372	135	22	.	.	PROPN
dpc-4372	135	23	wamelan	wamelan	PROPN
dpc-4372	135	24	et	et	PROPN
dpc-4372	135	25	al	al	PROPN
dpc-4372	135	26	.	.	PROPN
dpc-4372	135	27	reported	report	VERB
dpc-4372	135	28	that	that	SCONJ
dpc-4372	135	29	chronic	chronic	ADJ
dpc-4372	135	30	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	135	31	may	may	AUX
dpc-4372	135	32	be	be	AUX
dpc-4372	135	33	associated	associate	VERB
dpc-4372	135	34	with	with	ADP
dpc-4372	135	35	the	the	DET
dpc-4372	135	36	dysautonomic	dysautonomic	ADJ
dpc-4372	135	37	dominant	dominant	ADJ
dpc-4372	135	38	subtype	subtype	NOUN
dpc-4372	135	39	of	of	ADP
dpc-4372	135	40	pd	pd	PROPN
dpc-4372	135	41	and	and	CCONJ
dpc-4372	135	42	can	can	AUX
dpc-4372	135	43	thus	thus	ADV
dpc-4372	135	44	be	be	AUX
dpc-4372	135	45	used	use	VERB
dpc-4372	135	46	as	as	ADP
dpc-4372	135	47	a	a	DET
dpc-4372	135	48	simple	simple	ADJ
dpc-4372	135	49	clinical	clinical	ADJ
dpc-4372	135	50	screening	screening	NOUN
dpc-4372	135	51	tool	tool	NOUN
dpc-4372	135	52	.	.	PUNCT
dpc-4372	136	1	it	it	PRON
dpc-4372	136	2	has	have	AUX
dpc-4372	136	3	been	be	AUX
dpc-4372	136	4	suggested	suggest	VERB
dpc-4372	136	5	that	that	SCONJ
dpc-4372	136	6	sweating	sweat	VERB
dpc-4372	136	7	in	in	ADP
dpc-4372	136	8	pd	pd	PROPN
dpc-4372	136	9	patients	patient	NOUN
dpc-4372	136	10	occurs	occur	VERB
dpc-4372	136	11	mainly	mainly	ADV
dpc-4372	136	12	in	in	ADP
dpc-4372	136	13	the	the	DET
dpc-4372	136	14	head	head	NOUN
dpc-4372	136	15	and	and	CCONJ
dpc-4372	136	16	trunk	trunk	NOUN
dpc-4372	136	17	as	as	ADP
dpc-4372	136	18	part	part	NOUN
dpc-4372	136	19	of	of	ADP
dpc-4372	136	20	a	a	DET
dpc-4372	136	21	compensatory	compensatory	ADJ
dpc-4372	136	22	thermoregulation	thermoregulation	NOUN
dpc-4372	136	23	mechanism	mechanism	NOUN
dpc-4372	136	24	against	against	ADP
dpc-4372	136	25	the	the	DET
dpc-4372	136	26	loss	loss	NOUN
dpc-4372	136	27	of	of	ADP
dpc-4372	136	28	sweating	sweating	NOUN
dpc-4372	136	29	in	in	ADP
dpc-4372	136	30	the	the	DET
dpc-4372	136	31	extremities	extremity	NOUN
dpc-4372	136	32	[	[	X
dpc-4372	136	33	9	9	NUM
dpc-4372	136	34	]	]	PUNCT
dpc-4372	136	35	.	.	PUNCT
dpc-4372	137	1	in	in	ADP
dpc-4372	137	2	our	our	PRON
dpc-4372	137	3	study	study	NOUN
dpc-4372	137	4	,	,	PUNCT
dpc-4372	137	5	we	we	PRON
dpc-4372	137	6	detected	detect	VERB
dpc-4372	137	7	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	137	8	more	more	ADV
dpc-4372	137	9	frequently	frequently	ADV
dpc-4372	137	10	in	in	ADP
dpc-4372	137	11	female	female	ADJ
dpc-4372	137	12	pd	pd	NOUN
dpc-4372	137	13	patients	patient	NOUN
dpc-4372	137	14	.	.	PUNCT
dpc-4372	138	1	in	in	ADP
dpc-4372	138	2	contrast	contrast	NOUN
dpc-4372	138	3	,	,	PUNCT
dpc-4372	138	4	wamelan	wamelan	PROPN
dpc-4372	138	5	et	et	PROPN
dpc-4372	138	6	al	al	PROPN
dpc-4372	138	7	.	.	PROPN
dpc-4372	138	8	did	do	AUX
dpc-4372	138	9	not	not	PART
dpc-4372	138	10	report	report	VERB
dpc-4372	138	11	any	any	DET
dpc-4372	138	12	significant	significant	ADJ
dpc-4372	138	13	difference	difference	NOUN
dpc-4372	138	14	in	in	ADP
dpc-4372	138	15	the	the	DET
dpc-4372	138	16	rate	rate	NOUN
dpc-4372	138	17	of	of	ADP
dpc-4372	138	18	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	138	19	according	accord	VERB
dpc-4372	138	20	to	to	ADP
dpc-4372	138	21	sex	sex	NOUN
dpc-4372	138	22	[	[	X
dpc-4372	138	23	9	9	NUM
dpc-4372	138	24	]	]	PUNCT
dpc-4372	138	25	.	.	PUNCT
dpc-4372	139	1	in	in	ADP
dpc-4372	139	2	our	our	PRON
dpc-4372	139	3	study	study	NOUN
dpc-4372	139	4	,	,	PUNCT
dpc-4372	139	5	we	we	PRON
dpc-4372	139	6	detected	detect	VERB
dpc-4372	139	7	sd	sd	ADP
dpc-4372	139	8	in	in	ADP
dpc-4372	139	9	31.6	31.6	NUM
dpc-4372	139	10	%	%	NOUN
dpc-4372	139	11	of	of	ADP
dpc-4372	139	12	patients	patient	NOUN
dpc-4372	139	13	with	with	ADP
dpc-4372	139	14	pd	pd	PROPN
dpc-4372	139	15	on	on	ADP
dpc-4372	139	16	the	the	DET
dpc-4372	139	17	scalp	scalp	NOUN
dpc-4372	139	18	and	and	CCONJ
dpc-4372	139	19	27.4	27.4	NUM
dpc-4372	139	20	%	%	NOUN
dpc-4372	139	21	in	in	ADP
dpc-4372	139	22	the	the	DET
dpc-4372	139	23	skin	skin	NOUN
dpc-4372	139	24	on	on	ADP
dpc-4372	139	25	the	the	DET
dpc-4372	139	26	face	face	NOUN
dpc-4372	139	27	other	other	ADJ
dpc-4372	139	28	than	than	ADP
dpc-4372	139	29	the	the	DET
dpc-4372	139	30	scalp	scalp	NOUN
dpc-4372	139	31	and	and	CCONJ
dpc-4372	139	32	the	the	DET
dpc-4372	139	33	skin	skin	NOUN
dpc-4372	139	34	on	on	ADP
dpc-4372	139	35	the	the	DET
dpc-4372	139	36	chest	chest	NOUN
dpc-4372	139	37	and/or	and/or	CCONJ
dpc-4372	139	38	other	other	ADJ
dpc-4372	139	39	body	body	NOUN
dpc-4372	139	40	parts	part	NOUN
dpc-4372	139	41	.	.	PUNCT
dpc-4372	140	1	our	our	PRON
dpc-4372	140	2	finding	find	VERB
dpc-4372	140	3	that	that	SCONJ
dpc-4372	140	4	the	the	DET
dpc-4372	140	5	rate	rate	NOUN
dpc-4372	140	6	of	of	ADP
dpc-4372	140	7	sd	sd	NOUN
dpc-4372	140	8	,	,	PUNCT
dpc-4372	140	9	which	which	PRON
dpc-4372	140	10	is	be	AUX
dpc-4372	140	11	seen	see	VERB
dpc-4372	140	12	at	at	ADP
dpc-4372	140	13	1	1	NUM
dpc-4372	140	14	-	-	SYM
dpc-4372	140	15	3	3	NUM
dpc-4372	140	16	%	%	NOUN
dpc-4372	140	17	in	in	ADP
dpc-4372	140	18	the	the	DET
dpc-4372	140	19	general	general	ADJ
dpc-4372	140	20	population	population	NOUN
dpc-4372	140	21	,	,	PUNCT
dpc-4372	140	22	was	be	AUX
dpc-4372	140	23	higher	high	ADJ
dpc-4372	140	24	in	in	ADP
dpc-4372	140	25	pd	pd	PROPN
dpc-4372	140	26	patients	patient	NOUN
dpc-4372	140	27	is	be	AUX
dpc-4372	140	28	consistent	consistent	ADJ
dpc-4372	140	29	with	with	ADP
dpc-4372	140	30	other	other	ADJ
dpc-4372	140	31	studies	study	NOUN
dpc-4372	140	32	conducted	conduct	VERB
dpc-4372	140	33	to	to	ADP
dpc-4372	140	34	date	date	NOUN
dpc-4372	140	35	[	[	X
dpc-4372	140	36	1,2	1,2	NUM
dpc-4372	140	37	]	]	PUNCT
dpc-4372	140	38	.	.	PUNCT
dpc-4372	141	1	krestin	krestin	PROPN
dpc-4372	141	2	et	et	PROPN
dpc-4372	141	3	al	al	PROPN
dpc-4372	141	4	.	.	PROPN
dpc-4372	141	5	reported	report	VERB
dpc-4372	141	6	seborrheic	seborrheic	ADJ
dpc-4372	141	7	face	face	NOUN
dpc-4372	141	8	as	as	ADP
dpc-4372	141	9	a	a	DET
dpc-4372	141	10	skin	skin	NOUN
dpc-4372	141	11	finding	finding	NOUN
dpc-4372	141	12	in	in	ADP
dpc-4372	141	13	pd	pd	PROPN
dpc-4372	141	14	patients	patient	NOUN
dpc-4372	141	15	in	in	ADP
dpc-4372	141	16	1927	1927	NUM
dpc-4372	142	1	[	[	X
dpc-4372	142	2	1,7	1,7	NUM
dpc-4372	142	3	]	]	PUNCT
dpc-4372	142	4	.	.	PUNCT
dpc-4372	143	1	in	in	ADP
dpc-4372	143	2	a	a	DET
dpc-4372	143	3	retrospective	retrospective	ADJ
dpc-4372	143	4	study	study	NOUN
dpc-4372	143	5	,	,	PUNCT
dpc-4372	143	6	tanner	tanner	NOUN
dpc-4372	143	7	et	et	PROPN
dpc-4372	143	8	al	al	PROPN
dpc-4372	143	9	.	.	PROPN
dpc-4372	143	10	suggested	suggest	VERB
dpc-4372	143	11	that	that	SCONJ
dpc-4372	143	12	sd	sd	NOUN
dpc-4372	143	13	may	may	AUX
dpc-4372	143	14	be	be	AUX
dpc-4372	143	15	an	an	DET
dpc-4372	143	16	early	early	ADJ
dpc-4372	143	17	marker	marker	NOUN
dpc-4372	143	18	of	of	ADP
dpc-4372	143	19	pd	pd	NOUN
dpc-4372	144	1	[	[	X
dpc-4372	144	2	1	1	NUM
dpc-4372	144	3	]	]	PUNCT
dpc-4372	144	4	.	.	PUNCT
dpc-4372	145	1	in	in	ADP
dpc-4372	145	2	pd	pd	PROPN
dpc-4372	145	3	,	,	PUNCT
dpc-4372	145	4	dopamine	dopamine	NOUN
dpc-4372	145	5	deficiency	deficiency	NOUN
dpc-4372	145	6	causes	cause	VERB
dpc-4372	145	7	a	a	DET
dpc-4372	145	8	deficiency	deficiency	NOUN
dpc-4372	145	9	of	of	ADP
dpc-4372	145	10	melanocyte	melanocyte	NOUN
dpc-4372	145	11	-	-	PUNCT
dpc-4372	145	12	stimulating	stimulate	VERB
dpc-4372	145	13	hormone	hormone	NOUN
dpc-4372	145	14	(	(	PUNCT
dpc-4372	145	15	msh	msh	NOUN
dpc-4372	145	16	)	)	PUNCT
dpc-4372	145	17	inhibitory	inhibitory	ADJ
dpc-4372	145	18	factor	factor	NOUN
dpc-4372	145	19	,	,	PUNCT
dpc-4372	145	20	causing	cause	VERB
dpc-4372	145	21	an	an	DET
dpc-4372	145	22	increase	increase	NOUN
dpc-4372	145	23	in	in	ADP
dpc-4372	145	24	alpha	alpha	PROPN
dpc-4372	145	25	-	-	PUNCT
dpc-4372	145	26	msh	msh	PROPN
dpc-4372	145	27	and	and	CCONJ
dpc-4372	145	28	sebum	sebum	NOUN
dpc-4372	145	29	production	production	NOUN
dpc-4372	145	30	.	.	PUNCT
dpc-4372	146	1	in	in	ADP
dpc-4372	146	2	addition	addition	NOUN
dpc-4372	146	3	,	,	PUNCT
dpc-4372	146	4	decreased	decrease	VERB
dpc-4372	146	5	facial	facial	ADJ
dpc-4372	146	6	mobility	mobility	NOUN
dpc-4372	146	7	in	in	ADP
dpc-4372	146	8	pd	pd	PROPN
dpc-4372	146	9	contributes	contribute	VERB
dpc-4372	146	10	to	to	ADP
dpc-4372	146	11	a	a	DET
dpc-4372	146	12	greater	great	ADJ
dpc-4372	146	13	accumulation	accumulation	NOUN
dpc-4372	146	14	of	of	ADP
dpc-4372	146	15	sebum	sebum	NOUN
dpc-4372	146	16	.	.	PUNCT
dpc-4372	147	1	mortignoni	mortignoni	NOUN
dpc-4372	147	2	et	et	PROPN
dpc-4372	147	3	al	al	PROPN
dpc-4372	147	4	.	.	PROPN
dpc-4372	147	5	found	find	VERB
dpc-4372	147	6	sd	sd	PART
dpc-4372	147	7	to	to	PART
dpc-4372	147	8	be	be	AUX
dpc-4372	147	9	more	more	ADV
dpc-4372	147	10	common	common	ADJ
dpc-4372	147	11	in	in	ADP
dpc-4372	147	12	male	male	ADJ
dpc-4372	147	13	pd	pd	ADJ
dpc-4372	147	14	patients	patient	NOUN
dpc-4372	147	15	[	[	X
dpc-4372	147	16	17	17	NUM
dpc-4372	147	17	]	]	PUNCT
dpc-4372	147	18	.	.	PUNCT
dpc-4372	148	1	arsenijevic	arsenijevic	PROPN
dpc-4372	148	2	et	et	PROPN
dpc-4372	148	3	al	al	PROPN
dpc-4372	148	4	.	.	PROPN
dpc-4372	148	5	found	find	VERB
dpc-4372	148	6	a	a	DET
dpc-4372	148	7	positive	positive	ADJ
dpc-4372	148	8	correlation	correlation	NOUN
dpc-4372	148	9	between	between	ADP
dpc-4372	148	10	sd	sd	NOUN
dpc-4372	148	11	,	,	PUNCT
dpc-4372	148	12	pd	pd	PROPN
dpc-4372	148	13	,	,	PUNCT
dpc-4372	148	14	malassezia	malassezia	NOUN
dpc-4372	148	15	globosa	globosa	NOUN
dpc-4372	148	16	incidence	incidence	NOUN
dpc-4372	148	17	,	,	PUNCT
dpc-4372	148	18	high	high	ADJ
dpc-4372	148	19	yeast	yeast	NOUN
dpc-4372	148	20	density	density	NOUN
dpc-4372	148	21	,	,	PUNCT
dpc-4372	148	22	and	and	CCONJ
dpc-4372	148	23	high	high	ADJ
dpc-4372	148	24	skin	skin	NOUN
dpc-4372	148	25	phosphatase	phosphatase	NOUN
dpc-4372	148	26	and	and	CCONJ
dpc-4372	148	27	lipase	lipase	NOUN
dpc-4372	148	28	activity	activity	NOUN
dpc-4372	148	29	[	[	X
dpc-4372	148	30	18	18	NUM
dpc-4372	148	31	]	]	PUNCT
dpc-4372	148	32	.	.	PUNCT
dpc-4372	149	1	additionally	additionally	ADV
dpc-4372	149	2	,	,	PUNCT
dpc-4372	149	3	numerous	numerous	ADJ
dpc-4372	149	4	original	original	ADJ
dpc-4372	149	5	article	article	NOUN
dpc-4372	149	6	|	|	ADV
dpc-4372	149	7	dermatol	dermatol	ADJ
dpc-4372	149	8	pract	pract	NOUN
dpc-4372	149	9	concept	concept	NOUN
dpc-4372	149	10	.	.	PUNCT
dpc-4372	150	1	2024;14(4):e2024241	2024;14(4):e2024241	NUM
dpc-4372	150	2	7	7	NUM
dpc-4372	150	3	us	us	PROPN
dpc-4372	150	4	patient	patient	ADJ
dpc-4372	150	5	population	population	NOUN
dpc-4372	150	6	retrospective	retrospective	ADJ
dpc-4372	150	7	study	study	NOUN
dpc-4372	150	8	.	.	PUNCT
dpc-4372	151	1	j	j	PROPN
dpc-4372	151	2	eur	eur	PROPN
dpc-4372	151	3	acad	acad	PROPN
dpc-4372	151	4	dermatol	dermatol	NOUN
dpc-4372	151	5	venereol	venereol	NOUN
dpc-4372	151	6	.	.	PUNCT
dpc-4372	152	1	2018;32(4):e141	2018;32(4):e141	ADV
dpc-4372	152	2	-	-	PUNCT
dpc-4372	152	3	e144	e144	PROPN
dpc-4372	152	4	.	.	PUNCT
dpc-4372	152	5	doi:10.1111	doi:10.1111	PROPN
dpc-4372	152	6	/	/	SYM
dpc-4372	152	7	jdv.14638	jdv.14638	NOUN
dpc-4372	152	8	.	.	PUNCT
dpc-4372	153	1	9	9	X
dpc-4372	153	2	.	.	X
dpc-4372	153	3	van	van	PROPN
dpc-4372	153	4	wamelen	wamelen	PROPN
dpc-4372	153	5	dj	dj	PROPN
dpc-4372	153	6	,	,	PUNCT
dpc-4372	153	7	leta	leta	PROPN
dpc-4372	153	8	v	v	NOUN
dpc-4372	153	9	,	,	PUNCT
dpc-4372	153	10	podlewska	podlewska	NOUN
dpc-4372	153	11	am	be	AUX
dpc-4372	153	12	,	,	PUNCT
dpc-4372	153	13	et	et	PROPN
dpc-4372	153	14	al	al	PROPN
dpc-4372	153	15	.	.	PUNCT
dpc-4372	153	16	exploring	explore	VERB
dpc-4372	153	17	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	153	18	and	and	CCONJ
dpc-4372	153	19	related	relate	VERB
dpc-4372	153	20	thermoregulatory	thermoregulatory	ADJ
dpc-4372	153	21	symptoms	symptom	NOUN
dpc-4372	153	22	as	as	ADP
dpc-4372	153	23	a	a	DET
dpc-4372	153	24	possible	possible	ADJ
dpc-4372	153	25	clinical	clinical	ADJ
dpc-4372	153	26	identifier	identifier	NOUN
dpc-4372	153	27	for	for	ADP
dpc-4372	153	28	the	the	DET
dpc-4372	153	29	dysautonomic	dysautonomic	ADJ
dpc-4372	153	30	subtype	subtype	NOUN
dpc-4372	153	31	of	of	ADP
dpc-4372	153	32	parkinson	parkinson	NOUN
dpc-4372	153	33	’s	’s	PART
dpc-4372	153	34	disease	disease	NOUN
dpc-4372	153	35	.	.	PUNCT
dpc-4372	154	1	j	j	PROPN
dpc-4372	154	2	neurol	neurol	NOUN
dpc-4372	154	3	.	.	PUNCT
dpc-4372	155	1	2019;266(7):1736	2019;266(7):1736	NUM
dpc-4372	155	2	-	-	PUNCT
dpc-4372	155	3	1742	1742	NUM
dpc-4372	155	4	.	.	PUNCT
dpc-4372	156	1	doi:10.1007	doi:10.1007	VERB
dpc-4372	156	2	/	/	PUNCT
dpc-4372	157	1	s00415	s00415	NOUN
dpc-4372	157	2	-019	-019	PROPN
dpc-4372	157	3	-	-	PUNCT
dpc-4372	157	4	09325	09325	NUM
dpc-4372	157	5	-	-	PUNCT
dpc-4372	157	6	w.	w.	PROPN
dpc-4372	157	7	10	10	NUM
dpc-4372	157	8	.	.	PUNCT
dpc-4372	158	1	scott	scott	PROPN
dpc-4372	158	2	gd	gd	PROPN
dpc-4372	158	3	,	,	PUNCT
dpc-4372	158	4	lim	lim	PROPN
dpc-4372	158	5	mm	mm	PROPN
dpc-4372	158	6	,	,	PUNCT
dpc-4372	158	7	drake	drake	VERB
dpc-4372	158	8	mg	mg	PROPN
dpc-4372	158	9	,	,	PUNCT
dpc-4372	158	10	woltjer	woltjer	ADJ
dpc-4372	158	11	r	r	NOUN
dpc-4372	158	12	,	,	PUNCT
dpc-4372	158	13	quinn	quinn	PROPN
dpc-4372	158	14	jf	jf	PROPN
dpc-4372	158	15	.	.	PROPN
dpc-4372	158	16	onset	onset	PROPN
dpc-4372	158	17	of	of	ADP
dpc-4372	158	18	skin	skin	NOUN
dpc-4372	158	19	,	,	PUNCT
dpc-4372	158	20	gut	gut	NOUN
dpc-4372	158	21	,	,	PUNCT
dpc-4372	158	22	and	and	CCONJ
dpc-4372	158	23	genitourinary	genitourinary	ADJ
dpc-4372	158	24	prodromal	prodromal	ADJ
dpc-4372	158	25	parkinson	parkinson	NOUN
dpc-4372	158	26	’s	’s	PART
dpc-4372	158	27	disease	disease	NOUN
dpc-4372	158	28	:	:	PUNCT
dpc-4372	158	29	a	a	DET
dpc-4372	158	30	study	study	NOUN
dpc-4372	158	31	of	of	ADP
dpc-4372	158	32	1.5	1.5	NUM
dpc-4372	158	33	million	million	NUM
dpc-4372	158	34	veterans	veteran	NOUN
dpc-4372	158	35	.	.	PUNCT
dpc-4372	159	1	mov	mov	NOUN
dpc-4372	159	2	disord	disord	NOUN
dpc-4372	159	3	.	.	PUNCT
dpc-4372	160	1	2021;36(9	2021;36(9	NUM
dpc-4372	160	2	):	):	PUNCT
dpc-4372	160	3	2094	2094	NUM
dpc-4372	160	4	-	-	SYM
dpc-4372	160	5	2103	2103	NUM
dpc-4372	160	6	.	.	PUNCT
dpc-4372	161	1	doi:10.1002	doi:10.1002	NOUN
dpc-4372	161	2	/	/	SYM
dpc-4372	161	3	mds.28636	mds.28636	NOUN
dpc-4372	161	4	..	..	NOUN
dpc-4372	161	5	11	11	NUM
dpc-4372	161	6	.	.	PUNCT
dpc-4372	162	1	jucevičiūtė	jucevičiūtė	PROPN
dpc-4372	162	2	n	n	CCONJ
dpc-4372	162	3	,	,	PUNCT
dpc-4372	162	4	banaitytė	banaitytė	NOUN
dpc-4372	162	5	i	i	PRON
dpc-4372	162	6	,	,	PUNCT
dpc-4372	162	7	vaitkus	vaitkus	VERB
dpc-4372	162	8	a	a	NOUN
dpc-4372	162	9	,	,	PUNCT
dpc-4372	162	10	balnytė	balnytė	NOUN
dpc-4372	162	11	r.	r.	VERB
dpc-4372	162	12	preclinical	preclinical	ADJ
dpc-4372	162	13	signs	sign	NOUN
dpc-4372	162	14	of	of	ADP
dpc-4372	162	15	parkinson	parkinson	NOUN
dpc-4372	162	16	’s	’s	PART
dpc-4372	162	17	disease	disease	NOUN
dpc-4372	162	18	:	:	PUNCT
dpc-4372	162	19	a	a	DET
dpc-4372	162	20	possible	possible	ADJ
dpc-4372	162	21	association	association	NOUN
dpc-4372	162	22	of	of	ADP
dpc-4372	162	23	parkinson	parkinson	NOUN
dpc-4372	162	24	’s	’s	PART
dpc-4372	162	25	disease	disease	NOUN
dpc-4372	162	26	with	with	ADP
dpc-4372	162	27	skin	skin	NOUN
dpc-4372	162	28	and	and	CCONJ
dpc-4372	162	29	hair	hair	NOUN
dpc-4372	162	30	features	feature	NOUN
dpc-4372	162	31	.	.	PUNCT
dpc-4372	163	1	med	med	ADJ
dpc-4372	163	2	hypotheses	hypothesis	NOUN
dpc-4372	163	3	.	.	PUNCT
dpc-4372	164	1	2019;127	2019;127	NUM
dpc-4372	164	2	:	:	PUNCT
dpc-4372	164	3	100	100	NUM
dpc-4372	164	4	-	-	SYM
dpc-4372	164	5	104	104	NUM
dpc-4372	164	6	.	.	PUNCT
dpc-4372	165	1	doi:10.1016	doi:10.1016	PROPN
dpc-4372	165	2	/	/	SYM
dpc-4372	165	3	j.mehy.2019.04.013	j.mehy.2019.04.013	PROPN
dpc-4372	165	4	.	.	PROPN
dpc-4372	165	5	12	12	NUM
dpc-4372	165	6	.	.	PUNCT
dpc-4372	166	1	zhang	zhang	PROPN
dpc-4372	166	2	x	x	PROPN
dpc-4372	166	3	,	,	PUNCT
dpc-4372	166	4	guarin	guarin	NOUN
dpc-4372	166	5	d	d	NOUN
dpc-4372	166	6	,	,	PUNCT
dpc-4372	166	7	mohammadzadehhonarvar	mohammadzadehhonarvar	NOUN
dpc-4372	166	8	n	n	CCONJ
dpc-4372	166	9	,	,	PUNCT
dpc-4372	166	10	chen	chen	PROPN
dpc-4372	166	11	x	x	PROPN
dpc-4372	166	12	,	,	PUNCT
dpc-4372	166	13	gao	gao	PROPN
dpc-4372	166	14	x.	x.	PROPN
dpc-4372	166	15	parkinson	parkinson	PROPN
dpc-4372	166	16	’s	’s	PART
dpc-4372	166	17	disease	disease	NOUN
dpc-4372	166	18	and	and	CCONJ
dpc-4372	166	19	cancer	cancer	NOUN
dpc-4372	166	20	:	:	PUNCT
dpc-4372	166	21	a	a	DET
dpc-4372	166	22	systematic	systematic	ADJ
dpc-4372	166	23	review	review	NOUN
dpc-4372	166	24	and	and	CCONJ
dpc-4372	166	25	meta	meta	NOUN
dpc-4372	166	26	-	-	PUNCT
dpc-4372	166	27	analysis	analysis	NOUN
dpc-4372	166	28	of	of	ADP
dpc-4372	166	29	over	over	ADP
dpc-4372	166	30	17	17	NUM
dpc-4372	166	31	million	million	NUM
dpc-4372	166	32	participants	participant	NOUN
dpc-4372	166	33	.	.	PUNCT
dpc-4372	167	1	bmj	bmj	PROPN
dpc-4372	167	2	open	open	ADJ
dpc-4372	167	3	.	.	PUNCT
dpc-4372	168	1	2021;11(7):e046329	2021;11(7):e046329	NUM
dpc-4372	168	2	.	.	PUNCT
dpc-4372	169	1	doi:10.1136	doi:10.1136	NOUN
dpc-4372	169	2	/	/	SYM
dpc-4372	169	3	bmjopen-2020	bmjopen-2020	NOUN
dpc-4372	169	4	-	-	PUNCT
dpc-4372	169	5	046329	046329	NUM
dpc-4372	169	6	.	.	PUNCT
dpc-4372	170	1	13	13	NUM
dpc-4372	170	2	.	.	PUNCT
dpc-4372	170	3	han	han	PROPN
dpc-4372	170	4	y	y	PROPN
dpc-4372	170	5	,	,	PUNCT
dpc-4372	170	6	wu	wu	PROPN
dpc-4372	170	7	d	d	PROPN
dpc-4372	170	8	,	,	PUNCT
dpc-4372	170	9	wang	wang	PROPN
dpc-4372	170	10	y	y	PROPN
dpc-4372	170	11	,	,	PUNCT
dpc-4372	170	12	xie	xie	PROPN
dpc-4372	170	13	j	j	PROPN
dpc-4372	170	14	,	,	PUNCT
dpc-4372	170	15	zhang	zhang	PROPN
dpc-4372	170	16	z.	z.	PROPN
dpc-4372	170	17	skin	skin	PROPN
dpc-4372	170	18	alpha	alpha	PROPN
dpc-4372	170	19	-	-	PUNCT
dpc-4372	170	20	synuclein	synuclein	NOUN
dpc-4372	170	21	deposit	deposit	NOUN
dpc-4372	170	22	patterns	pattern	NOUN
dpc-4372	170	23	:	:	PUNCT
dpc-4372	170	24	a	a	DET
dpc-4372	170	25	predictor	predictor	NOUN
dpc-4372	170	26	of	of	ADP
dpc-4372	170	27	parkinson	parkinson	NOUN
dpc-4372	170	28	’s	’s	PART
dpc-4372	170	29	disease	disease	NOUN
dpc-4372	170	30	subtypes	subtype	NOUN
dpc-4372	170	31	.	.	PUNCT
dpc-4372	171	1	ebiomedicine	ebiomedicine	ADJ
dpc-4372	171	2	.	.	PUNCT
dpc-4372	172	1	2022;80:104076	2022;80:104076	NUM
dpc-4372	172	2	.	.	PUNCT
dpc-4372	172	3	doi:10.1016	doi:10.1016	PROPN
dpc-4372	172	4	/	/	SYM
dpc-4372	172	5	j.ebiom.2022	j.ebiom.2022	NOUN
dpc-4372	172	6	.104076	.104076	PROPN
dpc-4372	172	7	.	.	PUNCT
dpc-4372	173	1	14	14	NUM
dpc-4372	173	2	.	.	PUNCT
dpc-4372	174	1	rodríguez	rodríguez	NOUN
dpc-4372	174	2	-	-	PUNCT
dpc-4372	174	3	leyva	leyva	PROPN
dpc-4372	174	4	i	i	PRON
dpc-4372	174	5	,	,	PUNCT
dpc-4372	174	6	calderón	calderón	NOUN
dpc-4372	174	7	-	-	PUNCT
dpc-4372	174	8	garcidueñas	garcidueñas	NOUN
dpc-4372	174	9	al	al	PROPN
dpc-4372	174	10	,	,	PUNCT
dpc-4372	174	11	jiménez	jiménez	PROPN
dpc-4372	174	12	capdeville	capdeville	VERB
dpc-4372	174	13	me	i	PRON
dpc-4372	174	14	,	,	PUNCT
dpc-4372	174	15	et	et	PROPN
dpc-4372	174	16	al	al	PROPN
dpc-4372	174	17	.	.	PUNCT
dpc-4372	175	1	α	α	X
dpc-4372	175	2	-	-	PUNCT
dpc-4372	175	3	synuclein	synuclein	NOUN
dpc-4372	175	4	inclusions	inclusion	NOUN
dpc-4372	175	5	in	in	ADP
dpc-4372	175	6	the	the	DET
dpc-4372	175	7	skin	skin	NOUN
dpc-4372	175	8	of	of	ADP
dpc-4372	175	9	parkinson	parkinson	NOUN
dpc-4372	175	10	’s	’s	PART
dpc-4372	175	11	disease	disease	NOUN
dpc-4372	175	12	and	and	CCONJ
dpc-4372	175	13	parkinsonism	parkinsonism	NOUN
dpc-4372	175	14	.	.	PUNCT
dpc-4372	176	1	ann	ann	PROPN
dpc-4372	176	2	clin	clin	PROPN
dpc-4372	176	3	transl	transl	PROPN
dpc-4372	176	4	neurol	neurol	PROPN
dpc-4372	176	5	.	.	PUNCT
dpc-4372	177	1	2014;1(7):471	2014;1(7):471	NUM
dpc-4372	177	2	-	-	SYM
dpc-4372	177	3	478	478	NUM
dpc-4372	177	4	.	.	PUNCT
dpc-4372	177	5	doi:10.1002	doi:10.1002	NOUN
dpc-4372	177	6	/	/	SYM
dpc-4372	177	7	acn3.78	acn3.78	PROPN
dpc-4372	177	8	.	.	PUNCT
dpc-4372	178	1	15	15	NUM
dpc-4372	178	2	.	.	PUNCT
dpc-4372	179	1	wakabayashi	wakabayashi	PROPN
dpc-4372	179	2	k.	k.	PROPN
dpc-4372	179	3	where	where	SCONJ
dpc-4372	179	4	and	and	CCONJ
dpc-4372	179	5	how	how	SCONJ
dpc-4372	179	6	alpha	alpha	NOUN
dpc-4372	179	7	-	-	PUNCT
dpc-4372	179	8	synuclein	synuclein	NOUN
dpc-4372	179	9	pathology	pathology	NOUN
dpc-4372	179	10	spreads	spread	VERB
dpc-4372	179	11	in	in	ADP
dpc-4372	179	12	parkinson	parkinson	NOUN
dpc-4372	179	13	’s	’s	PART
dpc-4372	179	14	disease	disease	NOUN
dpc-4372	179	15	.	.	PUNCT
dpc-4372	180	1	neuropathology	neuropathology	NOUN
dpc-4372	180	2	.	.	PUNCT
dpc-4372	181	1	2020;40(5	2020;40(5	NUM
dpc-4372	181	2	):	):	PUNCT
dpc-4372	181	3	415	415	NUM
dpc-4372	181	4	-	-	SYM
dpc-4372	181	5	425	425	NUM
dpc-4372	181	6	.	.	PUNCT
dpc-4372	182	1	doi:10.1111	doi:10.1111	ADJ
dpc-4372	182	2	/	/	SYM
dpc-4372	182	3	neup.12691	neup.12691	PROPN
dpc-4372	182	4	.	.	PROPN
dpc-4372	183	1	16	16	NUM
dpc-4372	183	2	.	.	PUNCT
dpc-4372	184	1	pont	pont	NOUN
dpc-4372	184	2	-	-	PUNCT
dpc-4372	184	3	sunyer	sunyer	PROPN
dpc-4372	184	4	c	c	PROPN
dpc-4372	184	5	,	,	PUNCT
dpc-4372	184	6	hotter	hot	ADJ
dpc-4372	184	7	a	a	PRON
dpc-4372	184	8	,	,	PUNCT
dpc-4372	184	9	gaig	gaig	PROPN
dpc-4372	184	10	c	c	X
dpc-4372	184	11	,	,	PUNCT
dpc-4372	184	12	et	et	PROPN
dpc-4372	184	13	al	al	PROPN
dpc-4372	184	14	.	.	PUNCT
dpc-4372	185	1	the	the	DET
dpc-4372	185	2	onset	onset	NOUN
dpc-4372	185	3	of	of	ADP
dpc-4372	185	4	nonmotor	nonmotor	NOUN
dpc-4372	185	5	symptoms	symptom	NOUN
dpc-4372	185	6	in	in	ADP
dpc-4372	185	7	parkinson	parkinson	NOUN
dpc-4372	185	8	’s	’s	PART
dpc-4372	185	9	disease	disease	NOUN
dpc-4372	185	10	(	(	PUNCT
dpc-4372	185	11	the	the	DET
dpc-4372	185	12	onset	onset	ADJ
dpc-4372	185	13	pd	pd	PROPN
dpc-4372	185	14	study	study	PROPN
dpc-4372	185	15	)	)	PUNCT
dpc-4372	185	16	.	.	PUNCT
dpc-4372	186	1	mov	mov	NOUN
dpc-4372	186	2	disord	disord	NOUN
dpc-4372	186	3	.	.	PUNCT
dpc-4372	187	1	2015;30(2):229	2015;30(2):229	NUM
dpc-4372	187	2	-	-	PUNCT
dpc-4372	187	3	237	237	NUM
dpc-4372	187	4	.	.	PUNCT
dpc-4372	188	1	doi:10.1002	doi:10.1002	NOUN
dpc-4372	188	2	/	/	SYM
dpc-4372	188	3	mds.26077	mds.26077	PROPN
dpc-4372	188	4	.	.	PROPN
dpc-4372	188	5	17	17	NUM
dpc-4372	188	6	.	.	PUNCT
dpc-4372	189	1	martignoni	martignoni	PROPN
dpc-4372	189	2	e	e	PROPN
dpc-4372	189	3	,	,	PUNCT
dpc-4372	189	4	godi	godi	PROPN
dpc-4372	189	5	l	l	PROPN
dpc-4372	189	6	,	,	PUNCT
dpc-4372	189	7	pacchetti	pacchetti	PROPN
dpc-4372	189	8	c	c	NOUN
dpc-4372	189	9	,	,	PUNCT
dpc-4372	189	10	et	et	PROPN
dpc-4372	189	11	al	al	PROPN
dpc-4372	189	12	.	.	PROPN
dpc-4372	189	13	is	be	AUX
dpc-4372	189	14	seborrhea	seborrhea	ADJ
dpc-4372	189	15	a	a	DET
dpc-4372	189	16	sign	sign	NOUN
dpc-4372	189	17	of	of	ADP
dpc-4372	189	18	autonomic	autonomic	ADJ
dpc-4372	189	19	impairment	impairment	NOUN
dpc-4372	189	20	in	in	ADP
dpc-4372	189	21	parkinson	parkinson	NOUN
dpc-4372	189	22	’s	’s	PART
dpc-4372	189	23	disease	disease	NOUN
dpc-4372	189	24	?	?	PUNCT
dpc-4372	190	1	j	j	PROPN
dpc-4372	190	2	neural	neural	ADJ
dpc-4372	190	3	transm	transm	PROPN
dpc-4372	190	4	.	.	PUNCT
dpc-4372	191	1	1997;104(11	1997;104(11	NUM
dpc-4372	191	2	-	-	PUNCT
dpc-4372	191	3	12):1295	12):1295	NUM
dpc-4372	191	4	-	-	PUNCT
dpc-4372	191	5	1304	1304	NUM
dpc-4372	191	6	.	.	PUNCT
dpc-4372	192	1	doi:10.1007	doi:10.1007	PROPN
dpc-4372	192	2	/	/	SYM
dpc-4372	192	3	bf01294730	bf01294730	PROPN
dpc-4372	192	4	.	.	PUNCT
dpc-4372	193	1	18	18	NUM
dpc-4372	193	2	.	.	PUNCT
dpc-4372	193	3	arsic	arsic	PROPN
dpc-4372	193	4	arsenijevic	arsenijevic	PROPN
dpc-4372	193	5	vs	vs	ADP
dpc-4372	193	6	,	,	PUNCT
dpc-4372	193	7	milobratovic	milobratovic	ADJ
dpc-4372	193	8	d	d	PROPN
dpc-4372	193	9	,	,	PUNCT
dpc-4372	193	10	barac	barac	PROPN
dpc-4372	193	11	am	am	PROPN
dpc-4372	193	12	,	,	PUNCT
dpc-4372	193	13	vekic	vekic	PROPN
dpc-4372	193	14	b	b	PROPN
dpc-4372	193	15	,	,	PUNCT
dpc-4372	193	16	marinkovic	marinkovic	PROPN
dpc-4372	193	17	j	j	PROPN
dpc-4372	193	18	,	,	PUNCT
dpc-4372	193	19	kostic	kostic	PROPN
dpc-4372	193	20	vs.	vs.	ADP
dpc-4372	193	21	a	a	DET
dpc-4372	193	22	laboratory	laboratory	NOUN
dpc-4372	193	23	-	-	PUNCT
dpc-4372	193	24	based	base	VERB
dpc-4372	193	25	study	study	NOUN
dpc-4372	193	26	on	on	ADP
dpc-4372	193	27	patients	patient	NOUN
dpc-4372	193	28	with	with	ADP
dpc-4372	193	29	parkinson	parkinson	NOUN
dpc-4372	193	30	’s	’s	PART
dpc-4372	193	31	disease	disease	NOUN
dpc-4372	193	32	and	and	CCONJ
dpc-4372	193	33	seborrheic	seborrheic	PROPN
dpc-4372	193	34	dermatitis	dermatitis	NOUN
dpc-4372	193	35	:	:	PUNCT
dpc-4372	193	36	the	the	DET
dpc-4372	193	37	presence	presence	NOUN
dpc-4372	193	38	and	and	CCONJ
dpc-4372	193	39	density	density	NOUN
dpc-4372	193	40	of	of	ADP
dpc-4372	193	41	malassezia	malassezia	NOUN
dpc-4372	193	42	yeasts	yeast	NOUN
dpc-4372	193	43	,	,	PUNCT
dpc-4372	193	44	their	their	PRON
dpc-4372	193	45	different	different	ADJ
dpc-4372	193	46	species	specie	NOUN
dpc-4372	193	47	and	and	CCONJ
dpc-4372	193	48	enzymes	enzyme	NOUN
dpc-4372	193	49	production	production	NOUN
dpc-4372	193	50	.	.	PUNCT
dpc-4372	194	1	bmc	bmc	ADJ
dpc-4372	194	2	dermatol	dermatol	NOUN
dpc-4372	194	3	.	.	PUNCT
dpc-4372	195	1	2014;14:5	2014;14:5	NUM
dpc-4372	195	2	.	.	PUNCT
dpc-4372	195	3	doi:10.1186/1471	doi:10.1186/1471	NOUN
dpc-4372	195	4	-	-	PUNCT
dpc-4372	195	5	5945	5945	NUM
dpc-4372	195	6	-	-	SYM
dpc-4372	195	7	14	14	NUM
dpc-4372	195	8	-	-	SYM
dpc-4372	195	9	5	5	NUM
dpc-4372	195	10	.	.	NOUN
dpc-4372	195	11	19	19	NUM
dpc-4372	195	12	.	.	PUNCT
dpc-4372	196	1	kohn	kohn	PROPN
dpc-4372	196	2	sr	sr	PROPN
dpc-4372	196	3	,	,	PUNCT
dpc-4372	196	4	pochi	pochi	PROPN
dpc-4372	196	5	pe	pe	PROPN
dpc-4372	196	6	,	,	PUNCT
dpc-4372	196	7	strauss	strauss	PROPN
dpc-4372	196	8	js	js	PROPN
dpc-4372	196	9	,	,	PUNCT
dpc-4372	196	10	sax	sax	PROPN
dpc-4372	196	11	ds	ds	PROPN
dpc-4372	196	12	,	,	PUNCT
dpc-4372	196	13	feldman	feldman	PROPN
dpc-4372	196	14	rg	rg	PROPN
dpc-4372	196	15	,	,	PUNCT
dpc-4372	196	16	timberlake	timberlake	PROPN
dpc-4372	196	17	wh	wh	PROPN
dpc-4372	196	18	.	.	PUNCT
dpc-4372	196	19	sebaceous	sebaceous	ADJ
dpc-4372	196	20	gland	gland	NOUN
dpc-4372	196	21	secretion	secretion	NOUN
dpc-4372	196	22	in	in	ADP
dpc-4372	196	23	parkinson	parkinson	NOUN
dpc-4372	196	24	’s	’s	PART
dpc-4372	196	25	disease	disease	NOUN
dpc-4372	196	26	during	during	ADP
dpc-4372	196	27	l	l	NOUN
dpc-4372	196	28	-	-	PUNCT
dpc-4372	196	29	dopa	dopa	NOUN
dpc-4372	196	30	treatment	treatment	NOUN
dpc-4372	196	31	.	.	PUNCT
dpc-4372	197	1	j	j	PROPN
dpc-4372	197	2	invest	invest	VERB
dpc-4372	197	3	dermatol	dermatol	NOUN
dpc-4372	197	4	.	.	PUNCT
dpc-4372	198	1	1973;60(3	1973;60(3	NUM
dpc-4372	198	2	)	)	PUNCT
dpc-4372	198	3	.	.	PUNCT
dpc-4372	199	1	doi:10.1111/1523	doi:10.1111/1523	NOUN
dpc-4372	199	2	-	-	PUNCT
dpc-4372	199	3	1747.ep12682040	1747.ep12682040	NOUN
dpc-4372	199	4	..	..	PUNCT
dpc-4372	199	5	20	20	NUM
dpc-4372	199	6	.	.	PUNCT
dpc-4372	200	1	egeberg	egeberg	PROPN
dpc-4372	200	2	a	a	PROPN
dpc-4372	200	3	,	,	PUNCT
dpc-4372	200	4	hansen	hansen	PROPN
dpc-4372	200	5	pr	pr	PROPN
dpc-4372	200	6	,	,	PUNCT
dpc-4372	200	7	gislason	gislason	PROPN
dpc-4372	200	8	gh	gh	PROPN
dpc-4372	200	9	,	,	PUNCT
dpc-4372	200	10	thyssen	thyssen	PROPN
dpc-4372	200	11	jp	jp	PROPN
dpc-4372	200	12	.	.	PUNCT
dpc-4372	201	1	exploring	explore	VERB
dpc-4372	201	2	the	the	DET
dpc-4372	201	3	association	association	NOUN
dpc-4372	201	4	between	between	ADP
dpc-4372	201	5	rosacea	rosacea	NOUN
dpc-4372	201	6	and	and	CCONJ
dpc-4372	201	7	parkinson	parkinson	NOUN
dpc-4372	201	8	disease	disease	NOUN
dpc-4372	201	9	:	:	PUNCT
dpc-4372	201	10	a	a	DET
dpc-4372	201	11	danish	danish	ADJ
dpc-4372	201	12	nationwide	nationwide	ADJ
dpc-4372	201	13	cohort	cohort	NOUN
dpc-4372	201	14	study	study	NOUN
dpc-4372	201	15	.	.	PUNCT
dpc-4372	202	1	jama	jama	PROPN
dpc-4372	202	2	neurol	neurol	PROPN
dpc-4372	202	3	.	.	PUNCT
dpc-4372	203	1	2016;73(5):529	2016;73(5):529	NUM
dpc-4372	203	2	-	-	PUNCT
dpc-4372	203	3	534	534	NUM
dpc-4372	203	4	.	.	PUNCT
dpc-4372	204	1	doi:10.1001	doi:10.1001	PROPN
dpc-4372	204	2	/	/	SYM
dpc-4372	204	3	jamaneurol.2016.0022	jamaneurol.2016.0022	PROPN
dpc-4372	204	4	21	21	NUM
dpc-4372	204	5	.	.	PUNCT
dpc-4372	205	1	fischer	fischer	PROPN
dpc-4372	205	2	m	m	PROPN
dpc-4372	205	3	,	,	PUNCT
dpc-4372	205	4	gemende	gemende	VERB
dpc-4372	205	5	i	i	PRON
dpc-4372	205	6	,	,	PUNCT
dpc-4372	205	7	marsch	marsch	PROPN
dpc-4372	205	8	wc	wc	PROPN
dpc-4372	205	9	,	,	PUNCT
dpc-4372	205	10	fischer	fischer	PROPN
dpc-4372	205	11	pa	pa	PROPN
dpc-4372	205	12	.	.	PROPN
dpc-4372	205	13	skin	skin	NOUN
dpc-4372	205	14	function	function	NOUN
dpc-4372	205	15	and	and	CCONJ
dpc-4372	205	16	skin	skin	NOUN
dpc-4372	205	17	disorders	disorder	NOUN
dpc-4372	205	18	in	in	ADP
dpc-4372	205	19	parkinson	parkinson	NOUN
dpc-4372	205	20	’s	’s	PART
dpc-4372	205	21	disease	disease	NOUN
dpc-4372	205	22	.	.	PUNCT
dpc-4372	206	1	j	j	PROPN
dpc-4372	206	2	neural	neural	PROPN
dpc-4372	206	3	transm	transm	PROPN
dpc-4372	206	4	.	.	PUNCT
dpc-4372	207	1	2001;108(2):205	2001;108(2):205	X
dpc-4372	207	2	-	-	SYM
dpc-4372	207	3	213	213	NUM
dpc-4372	207	4	.	.	PUNCT
dpc-4372	207	5	doi:10.1007	doi:10.1007	PROPN
dpc-4372	207	6	/	/	SYM
dpc-4372	207	7	s007020170088	s007020170088	NOUN
dpc-4372	207	8	.	.	PUNCT
dpc-4372	208	1	22	22	NUM
dpc-4372	208	2	.	.	PUNCT
dpc-4372	209	1	fasano	fasano	PROPN
dpc-4372	209	2	a	a	X
dpc-4372	209	3	,	,	PUNCT
dpc-4372	209	4	visanji	visanji	PROPN
dpc-4372	209	5	np	np	PROPN
dpc-4372	209	6	,	,	PUNCT
dpc-4372	209	7	liu	liu	PROPN
dpc-4372	209	8	lwc	lwc	PROPN
dpc-4372	209	9	,	,	PUNCT
dpc-4372	209	10	lang	lang	PROPN
dpc-4372	209	11	ae	ae	PROPN
dpc-4372	209	12	,	,	PUNCT
dpc-4372	209	13	pfeiffer	pfeiffer	PROPN
dpc-4372	209	14	rf	rf	PROPN
dpc-4372	209	15	.	.	PUNCT
dpc-4372	209	16	gastrointestinal	gastrointestinal	ADJ
dpc-4372	209	17	dysfunction	dysfunction	NOUN
dpc-4372	209	18	in	in	ADP
dpc-4372	209	19	parkinson	parkinson	NOUN
dpc-4372	209	20	’s	’s	PART
dpc-4372	209	21	disease	disease	NOUN
dpc-4372	209	22	.	.	PUNCT
dpc-4372	210	1	lancet	lancet	PROPN
dpc-4372	210	2	neurol	neurol	PROPN
dpc-4372	210	3	.	.	PUNCT
dpc-4372	211	1	2015;14(6):625	2015;14(6):625	NUM
dpc-4372	211	2	-	-	SYM
dpc-4372	211	3	639	639	NUM
dpc-4372	211	4	.	.	PUNCT
dpc-4372	212	1	doi:10.1016	doi:10.1016	PROPN
dpc-4372	212	2	/	/	SYM
dpc-4372	212	3	s1474	s1474	PROPN
dpc-4372	212	4	-	-	PROPN
dpc-4372	212	5	4422(15)00007	4422(15)00007	PROPN
dpc-4372	212	6	-	-	PUNCT
dpc-4372	212	7	1	1	NUM
dpc-4372	212	8	.	.	NOUN
dpc-4372	212	9	23	23	NUM
dpc-4372	212	10	.	.	PUNCT
dpc-4372	213	1	ferreira	ferreira	PROPN
dpc-4372	213	2	j	j	PROPN
dpc-4372	213	3	,	,	PUNCT
dpc-4372	213	4	silva	silva	PROPN
dpc-4372	213	5	jm	jm	PROPN
dpc-4372	213	6	,	,	PUNCT
dpc-4372	213	7	freire	freire	PROPN
dpc-4372	213	8	r	r	NOUN
dpc-4372	213	9	,	,	PUNCT
dpc-4372	213	10	et	et	PROPN
dpc-4372	213	11	al	al	PROPN
dpc-4372	213	12	.	.	PROPN
dpc-4372	213	13	skin	skin	NOUN
dpc-4372	213	14	cancers	cancer	NOUN
dpc-4372	213	15	and	and	CCONJ
dpc-4372	213	16	precancerous	precancerous	ADJ
dpc-4372	213	17	lesions	lesion	NOUN
dpc-4372	213	18	in	in	ADP
dpc-4372	213	19	parkinson	parkinson	NOUN
dpc-4372	213	20	’s	’s	PART
dpc-4372	213	21	disease	disease	NOUN
dpc-4372	213	22	patients	patient	NOUN
dpc-4372	213	23	.	.	PUNCT
dpc-4372	214	1	mov	mov	NOUN
dpc-4372	214	2	disord	disord	NOUN
dpc-4372	214	3	.	.	PUNCT
dpc-4372	215	1	2007;22(10):1471	2007;22(10):1471	NUM
dpc-4372	215	2	-	-	SYM
dpc-4372	215	3	1475	1475	NUM
dpc-4372	215	4	.	.	PUNCT
dpc-4372	216	1	doi:10.1002	doi:10.1002	NOUN
dpc-4372	216	2	/	/	SYM
dpc-4372	217	1	mds.21575	mds.21575	X
dpc-4372	217	2	.	.	PUNCT
dpc-4372	218	1	24	24	NUM
dpc-4372	218	2	.	.	PUNCT
dpc-4372	219	1	yaldiz	yaldiz	PROPN
dpc-4372	219	2	m.	m.	NOUN
dpc-4372	219	3	prevalence	prevalence	NOUN
dpc-4372	219	4	of	of	ADP
dpc-4372	219	5	actinic	actinic	ADJ
dpc-4372	219	6	keratosis	keratosis	NOUN
dpc-4372	219	7	in	in	ADP
dpc-4372	219	8	patients	patient	NOUN
dpc-4372	219	9	attending	attend	VERB
dpc-4372	219	10	the	the	DET
dpc-4372	219	11	dermatology	dermatology	NOUN
dpc-4372	219	12	outpatient	outpatient	NOUN
dpc-4372	219	13	clinic	clinic	NOUN
dpc-4372	219	14	.	.	PUNCT
dpc-4372	220	1	medicine	medicine	NOUN
dpc-4372	220	2	(	(	PUNCT
dpc-4372	220	3	baltimore	baltimore	PROPN
dpc-4372	220	4	)	)	PUNCT
dpc-4372	220	5	.	.	PUNCT
dpc-4372	221	1	2019;98(28):e16465	2019;98(28):e16465	PROPN
dpc-4372	221	2	.	.	PUNCT
dpc-4372	222	1	doi:10.1097	doi:10.1097	PROPN
dpc-4372	222	2	/	/	PUNCT
dpc-4372	222	3	md.0000000000016465	md.0000000000016465	NUM
dpc-4372	222	4	.	.	PUNCT
dpc-4372	223	1	9.38	9.38	NUM
dpc-4372	223	2	%	%	NOUN
dpc-4372	223	3	between	between	ADP
dpc-4372	223	4	the	the	DET
dpc-4372	223	5	ages	age	NOUN
dpc-4372	223	6	of	of	ADP
dpc-4372	223	7	70	70	NUM
dpc-4372	223	8	and	and	CCONJ
dpc-4372	223	9	79	79	NUM
dpc-4372	223	10	,	,	PUNCT
dpc-4372	223	11	and	and	CCONJ
dpc-4372	223	12	14.5	14.5	NUM
dpc-4372	223	13	%	%	NOUN
dpc-4372	223	14	above	above	ADP
dpc-4372	223	15	the	the	DET
dpc-4372	223	16	age	age	NOUN
dpc-4372	223	17	of	of	ADP
dpc-4372	223	18	80	80	NUM
dpc-4372	224	1	[	[	NOUN
dpc-4372	224	2	24].we	24].we	NOUN
dpc-4372	224	3	did	do	AUX
dpc-4372	224	4	not	not	PART
dpc-4372	224	5	observe	observe	VERB
dpc-4372	224	6	an	an	DET
dpc-4372	224	7	increase	increase	NOUN
dpc-4372	224	8	in	in	ADP
dpc-4372	224	9	the	the	DET
dpc-4372	224	10	incidence	incidence	NOUN
dpc-4372	224	11	of	of	ADP
dpc-4372	224	12	ak	ak	PROPN
dpc-4372	224	13	in	in	ADP
dpc-4372	224	14	pd	pd	PROPN
dpc-4372	224	15	patients	patient	NOUN
dpc-4372	224	16	.	.	PUNCT
dpc-4372	225	1	there	there	PRON
dpc-4372	225	2	are	be	VERB
dpc-4372	225	3	conflicting	conflicting	ADJ
dpc-4372	225	4	results	result	NOUN
dpc-4372	225	5	in	in	ADP
dpc-4372	225	6	the	the	DET
dpc-4372	225	7	literature	literature	NOUN
dpc-4372	225	8	regarding	regard	VERB
dpc-4372	225	9	the	the	DET
dpc-4372	225	10	relationship	relationship	NOUN
dpc-4372	225	11	between	between	ADP
dpc-4372	225	12	precancerous	precancerous	ADJ
dpc-4372	225	13	skin	skin	NOUN
dpc-4372	225	14	lesions	lesion	NOUN
dpc-4372	225	15	and	and	CCONJ
dpc-4372	225	16	malignancies	malignancy	NOUN
dpc-4372	225	17	in	in	ADP
dpc-4372	225	18	pd	pd	PROPN
dpc-4372	226	1	[	[	X
dpc-4372	226	2	12,23	12,23	NUM
dpc-4372	226	3	]	]	X
dpc-4372	226	4	.	.	PUNCT
dpc-4372	227	1	ferreria	ferreria	PROPN
dpc-4372	227	2	et	et	PROPN
dpc-4372	227	3	al	al	PROPN
dpc-4372	227	4	.	.	PROPN
dpc-4372	227	5	reported	report	VERB
dpc-4372	227	6	an	an	DET
dpc-4372	227	7	increase	increase	NOUN
dpc-4372	227	8	in	in	ADP
dpc-4372	227	9	the	the	DET
dpc-4372	227	10	risk	risk	NOUN
dpc-4372	227	11	of	of	ADP
dpc-4372	227	12	skin	skin	NOUN
dpc-4372	227	13	cancer	cancer	NOUN
dpc-4372	227	14	with	with	ADP
dpc-4372	227	15	pd	pd	PROPN
dpc-4372	228	1	[	[	X
dpc-4372	228	2	23	23	NUM
dpc-4372	228	3	]	]	PUNCT
dpc-4372	228	4	.	.	PUNCT
dpc-4372	229	1	in	in	ADP
dpc-4372	229	2	a	a	DET
dpc-4372	229	3	meta	meta	ADJ
dpc-4372	229	4	-	-	PUNCT
dpc-4372	229	5	analysis	analysis	NOUN
dpc-4372	229	6	study	study	NOUN
dpc-4372	229	7	,	,	PUNCT
dpc-4372	229	8	zhang	zhang	PROPN
dpc-4372	229	9	et	et	PROPN
dpc-4372	229	10	al	al	PROPN
dpc-4372	229	11	.	.	PROPN
dpc-4372	229	12	reported	report	VERB
dpc-4372	229	13	an	an	DET
dpc-4372	229	14	inverse	inverse	NOUN
dpc-4372	229	15	relationship	relationship	NOUN
dpc-4372	229	16	between	between	ADP
dpc-4372	229	17	pd	pd	PROPN
dpc-4372	229	18	and	and	CCONJ
dpc-4372	229	19	total	total	ADJ
dpc-4372	229	20	cancer	cancer	NOUN
dpc-4372	229	21	risk	risk	NOUN
dpc-4372	229	22	,	,	PUNCT
dpc-4372	229	23	except	except	SCONJ
dpc-4372	229	24	for	for	ADP
dpc-4372	229	25	melanoma	melanoma	NOUN
dpc-4372	229	26	[	[	X
dpc-4372	229	27	12	12	NUM
dpc-4372	229	28	]	]	PUNCT
dpc-4372	229	29	.	.	PUNCT
dpc-4372	230	1	this	this	DET
dpc-4372	230	2	finding	finding	NOUN
dpc-4372	230	3	may	may	AUX
dpc-4372	230	4	be	be	AUX
dpc-4372	230	5	explained	explain	VERB
dpc-4372	230	6	by	by	ADP
dpc-4372	230	7	genes	gene	NOUN
dpc-4372	230	8	associated	associate	VERB
dpc-4372	230	9	with	with	ADP
dpc-4372	230	10	pd	pd	PROPN
dpc-4372	230	11	.	.	PROPN
dpc-4372	230	12	park2	park2	PROPN
dpc-4372	230	13	is	be	AUX
dpc-4372	230	14	a	a	DET
dpc-4372	230	15	tumor	tumor	NOUN
dpc-4372	230	16	suppressor	suppressor	NOUN
dpc-4372	230	17	gene	gene	NOUN
dpc-4372	230	18	,	,	PUNCT
dpc-4372	230	19	while	while	SCONJ
dpc-4372	230	20	lrrk2	lrrk2	PROPN
dpc-4372	230	21	mutations	mutation	NOUN
dpc-4372	230	22	are	be	AUX
dpc-4372	230	23	associated	associate	VERB
dpc-4372	230	24	with	with	ADP
dpc-4372	230	25	an	an	DET
dpc-4372	230	26	increased	increase	VERB
dpc-4372	230	27	risk	risk	NOUN
dpc-4372	230	28	of	of	ADP
dpc-4372	230	29	cancer	cancer	NOUN
dpc-4372	231	1	[	[	X
dpc-4372	231	2	12	12	NUM
dpc-4372	231	3	]	]	PUNCT
dpc-4372	231	4	.	.	PUNCT
dpc-4372	232	1	we	we	PRON
dpc-4372	232	2	did	do	AUX
dpc-4372	232	3	not	not	PART
dpc-4372	232	4	detect	detect	VERB
dpc-4372	232	5	skin	skin	NOUN
dpc-4372	232	6	cancer	cancer	NOUN
dpc-4372	232	7	in	in	ADP
dpc-4372	232	8	patients	patient	NOUN
dpc-4372	232	9	with	with	ADP
dpc-4372	232	10	pd	pd	PROPN
dpc-4372	232	11	in	in	ADP
dpc-4372	232	12	our	our	PRON
dpc-4372	232	13	study	study	NOUN
dpc-4372	232	14	.	.	PUNCT
dpc-4372	233	1	similarly	similarly	ADV
dpc-4372	233	2	,	,	PUNCT
dpc-4372	233	3	we	we	PRON
dpc-4372	233	4	did	do	AUX
dpc-4372	233	5	not	not	PART
dpc-4372	233	6	detect	detect	VERB
dpc-4372	233	7	a	a	DET
dpc-4372	233	8	significant	significant	ADJ
dpc-4372	233	9	increase	increase	NOUN
dpc-4372	233	10	in	in	ADP
dpc-4372	233	11	nail	nail	NOUN
dpc-4372	233	12	and	and	CCONJ
dpc-4372	233	13	oral	oral	ADJ
dpc-4372	233	14	mucosal	mucosal	NOUN
dpc-4372	233	15	diseases	disease	NOUN
dpc-4372	233	16	in	in	ADP
dpc-4372	233	17	patients	patient	NOUN
dpc-4372	233	18	with	with	ADP
dpc-4372	233	19	pd	pd	PROPN
dpc-4372	233	20	.	.	PUNCT
dpc-4372	234	1	the	the	DET
dpc-4372	234	2	most	most	ADV
dpc-4372	234	3	common	common	ADJ
dpc-4372	234	4	nail	nail	NOUN
dpc-4372	234	5	disease	disease	NOUN
dpc-4372	234	6	in	in	ADP
dpc-4372	234	7	patients	patient	NOUN
dpc-4372	234	8	with	with	ADP
dpc-4372	234	9	pd	pd	PROPN
dpc-4372	234	10	was	be	AUX
dpc-4372	234	11	onychomycosis	onychomycosis	NOUN
dpc-4372	234	12	.	.	PUNCT
dpc-4372	235	1	the	the	DET
dpc-4372	235	2	examining	examine	VERB
dpc-4372	235	3	neurologist	neurologist	NOUN
dpc-4372	235	4	detected	detect	VERB
dpc-4372	235	5	only	only	ADV
dpc-4372	235	6	4.5	4.5	NUM
dpc-4372	235	7	%	%	NOUN
dpc-4372	235	8	of	of	ADP
dpc-4372	235	9	the	the	DET
dpc-4372	235	10	skin	skin	NOUN
dpc-4372	235	11	findings	finding	NOUN
dpc-4372	235	12	in	in	ADP
dpc-4372	235	13	pd	pd	PROPN
dpc-4372	235	14	patients	patient	NOUN
dpc-4372	235	15	,	,	PUNCT
dpc-4372	235	16	indicating	indicate	VERB
dpc-4372	235	17	that	that	SCONJ
dpc-4372	235	18	the	the	DET
dpc-4372	235	19	skin	skin	NOUN
dpc-4372	235	20	findings	finding	NOUN
dpc-4372	235	21	of	of	ADP
dpc-4372	235	22	the	the	DET
dpc-4372	235	23	pd	pd	PROPN
dpc-4372	235	24	patients	patient	NOUN
dpc-4372	235	25	were	be	AUX
dpc-4372	235	26	ignored	ignore	VERB
dpc-4372	235	27	by	by	ADP
dpc-4372	235	28	both	both	CCONJ
dpc-4372	235	29	the	the	DET
dpc-4372	235	30	patient	patient	NOUN
dpc-4372	235	31	and	and	CCONJ
dpc-4372	235	32	the	the	DET
dpc-4372	235	33	neurologist	neurologist	NOUN
dpc-4372	235	34	.	.	PUNCT
dpc-4372	236	1	this	this	DET
dpc-4372	236	2	study	study	NOUN
dpc-4372	236	3	investigated	investigate	VERB
dpc-4372	236	4	the	the	DET
dpc-4372	236	5	skin	skin	NOUN
dpc-4372	236	6	findings	finding	NOUN
dpc-4372	236	7	in	in	ADP
dpc-4372	236	8	patients	patient	NOUN
dpc-4372	236	9	with	with	ADP
dpc-4372	236	10	pd	pd	PROPN
dpc-4372	236	11	.	.	PUNCT
dpc-4372	236	12	consequently	consequently	ADV
dpc-4372	236	13	,	,	PUNCT
dpc-4372	236	14	xerosis	xerosis	NOUN
dpc-4372	236	15	,	,	PUNCT
dpc-4372	236	16	hyperhidrosis	hyperhidrosis	NOUN
dpc-4372	236	17	,	,	PUNCT
dpc-4372	236	18	seborrheic	seborrheic	PROPN
dpc-4372	236	19	dermatitis	dermatitis	NOUN
dpc-4372	236	20	,	,	PUNCT
dpc-4372	236	21	rosacea	rosacea	NOUN
dpc-4372	236	22	,	,	PUNCT
dpc-4372	236	23	and	and	CCONJ
dpc-4372	236	24	cherry	cherry	NOUN
dpc-4372	236	25	angioma	angioma	PROPN
dpc-4372	236	26	were	be	AUX
dpc-4372	236	27	found	find	VERB
dpc-4372	236	28	to	to	PART
dpc-4372	236	29	be	be	AUX
dpc-4372	236	30	common	common	ADJ
dpc-4372	236	31	in	in	ADP
dpc-4372	236	32	patients	patient	NOUN
dpc-4372	236	33	with	with	ADP
dpc-4372	236	34	pd	pd	PROPN
dpc-4372	236	35	.	.	PROPN
dpc-4372	237	1	on	on	ADP
dpc-4372	237	2	the	the	DET
dpc-4372	237	3	other	other	ADJ
dpc-4372	237	4	hand	hand	NOUN
dpc-4372	237	5	,	,	PUNCT
dpc-4372	237	6	premalignant	premalignant	ADJ
dpc-4372	237	7	skin	skin	NOUN
dpc-4372	237	8	lesions	lesion	NOUN
dpc-4372	237	9	were	be	AUX
dpc-4372	237	10	rarely	rarely	ADV
dpc-4372	237	11	observed	observe	VERB
dpc-4372	237	12	in	in	ADP
dpc-4372	237	13	these	these	DET
dpc-4372	237	14	patients	patient	NOUN
dpc-4372	237	15	.	.	PUNCT
dpc-4372	238	1	the	the	DET
dpc-4372	238	2	pd	pd	PROPN
dpc-4372	238	3	stage	stage	NOUN
dpc-4372	238	4	was	be	AUX
dpc-4372	238	5	mostly	mostly	ADV
dpc-4372	238	6	lower	low	ADJ
dpc-4372	238	7	in	in	ADP
dpc-4372	238	8	patients	patient	NOUN
dpc-4372	238	9	with	with	ADP
dpc-4372	238	10	xerosis	xerosis	NOUN
dpc-4372	238	11	and	and	CCONJ
dpc-4372	238	12	pre	pre	ADJ
dpc-4372	238	13	-	-	ADJ
dpc-4372	238	14	pd	pd	ADJ
dpc-4372	238	15	sd	sd	NOUN
dpc-4372	238	16	.	.	PUNCT
dpc-4372	239	1	these	these	DET
dpc-4372	239	2	findings	finding	NOUN
dpc-4372	239	3	suggest	suggest	VERB
dpc-4372	239	4	that	that	SCONJ
dpc-4372	239	5	xerosis	xerosis	NOUN
dpc-4372	239	6	and	and	CCONJ
dpc-4372	239	7	sd	sd	NOUN
dpc-4372	239	8	can	can	AUX
dpc-4372	239	9	be	be	AUX
dpc-4372	239	10	used	use	VERB
dpc-4372	239	11	as	as	ADP
dpc-4372	239	12	effective	effective	ADJ
dpc-4372	239	13	prognostic	prognostic	ADJ
dpc-4372	239	14	markers	marker	NOUN
dpc-4372	239	15	in	in	ADP
dpc-4372	239	16	pd	pd	PROPN
dpc-4372	239	17	.	.	PUNCT
dpc-4372	240	1	however	however	ADV
dpc-4372	240	2	,	,	PUNCT
dpc-4372	240	3	further	further	ADJ
dpc-4372	240	4	large	large	ADJ
dpc-4372	240	5	-	-	PUNCT
dpc-4372	240	6	scale	scale	NOUN
dpc-4372	240	7	studies	study	NOUN
dpc-4372	240	8	are	be	AUX
dpc-4372	240	9	needed	need	VERB
dpc-4372	240	10	to	to	PART
dpc-4372	240	11	corroborate	corroborate	VERB
dpc-4372	240	12	the	the	DET
dpc-4372	240	13	findings	finding	NOUN
dpc-4372	240	14	of	of	ADP
dpc-4372	240	15	this	this	DET
dpc-4372	240	16	study	study	NOUN
dpc-4372	240	17	.	.	PUNCT
dpc-4372	241	1	references	reference	NOUN
dpc-4372	241	2	1	1	NUM
dpc-4372	241	3	.	.	PUNCT
dpc-4372	241	4	ravn	ravn	VERB
dpc-4372	241	5	a	a	DET
dpc-4372	241	6	-	-	PUNCT
dpc-4372	241	7	h	h	NOUN
dpc-4372	241	8	,	,	PUNCT
dpc-4372	241	9	thyssen	thyssen	PROPN
dpc-4372	241	10	jp	jp	PROPN
dpc-4372	241	11	,	,	PUNCT
dpc-4372	241	12	egeberg	egeberg	PROPN
dpc-4372	241	13	a.	a.	NOUN
dpc-4372	241	14	skin	skin	NOUN
dpc-4372	241	15	disorders	disorder	NOUN
dpc-4372	241	16	in	in	ADP
dpc-4372	241	17	parkinson	parkinson	NOUN
dpc-4372	241	18	’s	’s	PART
dpc-4372	241	19	disease	disease	NOUN
dpc-4372	241	20	:	:	PUNCT
dpc-4372	241	21	potential	potential	ADJ
dpc-4372	241	22	biomarkers	biomarker	NOUN
dpc-4372	241	23	and	and	CCONJ
dpc-4372	241	24	risk	risk	NOUN
dpc-4372	241	25	factors	factor	NOUN
dpc-4372	241	26	.	.	PUNCT
dpc-4372	242	1	clin	clin	PROPN
dpc-4372	242	2	cosmet	cosmet	PROPN
dpc-4372	242	3	investig	investig	NOUN
dpc-4372	242	4	dermatol	dermatol	NOUN
dpc-4372	242	5	.	.	PUNCT
dpc-4372	243	1	2017;10:87	2017;10:87	NUM
dpc-4372	243	2	-	-	SYM
dpc-4372	243	3	92	92	NUM
dpc-4372	243	4	.	.	PUNCT
dpc-4372	243	5	doi:10.2147	doi:10.2147	PROPN
dpc-4372	243	6	/	/	SYM
dpc-4372	243	7	ccid.s130319	ccid.s130319	PROPN
dpc-4372	243	8	.	.	PUNCT
dpc-4372	244	1	2	2	X
dpc-4372	244	2	.	.	X
dpc-4372	244	3	shah	shah	PROPN
dpc-4372	244	4	p	p	PROPN
dpc-4372	244	5	,	,	PUNCT
dpc-4372	244	6	sagar	sagar	PROPN
dpc-4372	244	7	pr	pr	PROPN
dpc-4372	244	8	,	,	PUNCT
dpc-4372	244	9	alhumaidi	alhumaidi	PROPN
dpc-4372	244	10	n	n	CCONJ
dpc-4372	244	11	,	,	PUNCT
dpc-4372	244	12	bollampally	bollampally	ADV
dpc-4372	244	13	vc	vc	PROPN
dpc-4372	244	14	,	,	PUNCT
dpc-4372	244	15	malik	malik	PROPN
dpc-4372	244	16	bh	bh	PROPN
dpc-4372	244	17	.	.	PROPN
dpc-4372	244	18	parkinson	parkinson	PROPN
dpc-4372	244	19	’s	’s	PART
dpc-4372	244	20	disease	disease	NOUN
dpc-4372	244	21	and	and	CCONJ
dpc-4372	244	22	its	its	PRON
dpc-4372	244	23	dermatological	dermatological	ADJ
dpc-4372	244	24	associations	association	NOUN
dpc-4372	244	25	:	:	PUNCT
dpc-4372	244	26	is	be	AUX
dpc-4372	244	27	your	your	PRON
dpc-4372	244	28	skin	skin	NOUN
dpc-4372	244	29	whispering	whisper	VERB
dpc-4372	244	30	you	you	PRON
dpc-4372	244	31	a	a	DET
dpc-4372	244	32	diagnosis	diagnosis	NOUN
dpc-4372	244	33	?	?	PUNCT
dpc-4372	245	1	cureus	cureus	NOUN
dpc-4372	245	2	.	.	PUNCT
dpc-4372	246	1	2020;12(8):e9933	2020;12(8):e9933	NUM
dpc-4372	246	2	.	.	PUNCT
dpc-4372	246	3	doi:10.7759	doi:10.7759	NOUN
dpc-4372	246	4	/	/	SYM
dpc-4372	246	5	cureus.9933	cureus.9933	NOUN
dpc-4372	246	6	.	.	NOUN
dpc-4372	246	7	3	3	X
dpc-4372	246	8	.	.	X
dpc-4372	246	9	shahid	shahid	PROPN
dpc-4372	246	10	w	w	PROPN
dpc-4372	246	11	,	,	PUNCT
dpc-4372	246	12	satyjeet	satyjeet	NOUN
dpc-4372	246	13	f	f	PROPN
dpc-4372	246	14	,	,	PUNCT
dpc-4372	246	15	kumari	kumari	PROPN
dpc-4372	246	16	r	r	PROPN
dpc-4372	246	17	,	,	PUNCT
dpc-4372	246	18	et	et	PROPN
dpc-4372	246	19	al	al	PROPN
dpc-4372	246	20	.	.	PUNCT
dpc-4372	247	1	dermatological	dermatological	ADJ
dpc-4372	247	2	manifestations	manifestation	NOUN
dpc-4372	247	3	of	of	ADP
dpc-4372	247	4	parkinson	parkinson	NOUN
dpc-4372	247	5	’s	’s	PART
dpc-4372	247	6	disease	disease	NOUN
dpc-4372	247	7	:	:	PUNCT
dpc-4372	247	8	clues	clue	NOUN
dpc-4372	247	9	for	for	ADP
dpc-4372	247	10	diagnosis	diagnosis	NOUN
dpc-4372	247	11	.	.	PUNCT
dpc-4372	248	1	cureus	cureus	NOUN
dpc-4372	248	2	.	.	PUNCT
dpc-4372	249	1	2020;12(10):e10836	2020;12(10):e10836	NOUN
dpc-4372	249	2	.	.	PUNCT
dpc-4372	250	1	doi:10.7759	doi:10.7759	NOUN
dpc-4372	250	2	/	/	SYM
dpc-4372	250	3	cureus.10836	cureus.10836	PROPN
dpc-4372	250	4	.	.	NOUN
dpc-4372	250	5	4	4	NUM
dpc-4372	250	6	.	.	X
dpc-4372	251	1	tomic	tomic	PROPN
dpc-4372	251	2	s	s	PROPN
dpc-4372	251	3	,	,	PUNCT
dpc-4372	251	4	kuric	kuric	ADJ
dpc-4372	251	5	i	i	PROPN
dpc-4372	251	6	,	,	PUNCT
dpc-4372	251	7	kuric	kuric	PROPN
dpc-4372	251	8	tg	tg	PROPN
dpc-4372	251	9	,	,	PUNCT
dpc-4372	251	10	et	et	PROPN
dpc-4372	251	11	al	al	PROPN
dpc-4372	251	12	.	.	PROPN
dpc-4372	252	1	seborrheic	seborrheic	PROPN
dpc-4372	252	2	dermatitis	dermatitis	NOUN
dpc-4372	252	3	is	be	AUX
dpc-4372	252	4	related	relate	VERB
dpc-4372	252	5	to	to	ADP
dpc-4372	252	6	motor	motor	NOUN
dpc-4372	252	7	symptoms	symptom	NOUN
dpc-4372	252	8	in	in	ADP
dpc-4372	252	9	parkinson	parkinson	NOUN
dpc-4372	252	10	’s	’s	PART
dpc-4372	252	11	disease	disease	NOUN
dpc-4372	252	12	.	.	PUNCT
dpc-4372	253	1	j	j	PROPN
dpc-4372	253	2	clin	clin	PROPN
dpc-4372	253	3	neurol	neurol	PROPN
dpc-4372	253	4	.	.	PUNCT
dpc-4372	254	1	2022;18(6):628	2022;18(6):628	NUM
dpc-4372	254	2	-	-	SYM
dpc-4372	254	3	634	634	NUM
dpc-4372	254	4	.	.	PUNCT
dpc-4372	255	1	doi:10.3988	doi:10.3988	PROPN
dpc-4372	255	2	/	/	PUNCT
dpc-4372	255	3	jcn.2022.18.6.628	jcn.2022.18.6.628	PROPN
dpc-4372	255	4	.	.	PROPN
dpc-4372	256	1	5	5	NUM
dpc-4372	256	2	.	.	PUNCT
dpc-4372	256	3	dinesh	dinesh	PROPN
dpc-4372	256	4	d	d	PROPN
dpc-4372	256	5	,	,	PUNCT
dpc-4372	256	6	lee	lee	PROPN
dpc-4372	256	7	js	js	PROPN
dpc-4372	256	8	,	,	PUNCT
dpc-4372	256	9	gao	gao	PROPN
dpc-4372	256	10	x	x	PRON
dpc-4372	256	11	,	,	PUNCT
dpc-4372	256	12	palacios	palacio	NOUN
dpc-4372	256	13	n.	n.	NOUN
dpc-4372	256	14	skin	skin	NOUN
dpc-4372	256	15	conditions	condition	NOUN
dpc-4372	256	16	in	in	ADP
dpc-4372	256	17	early	early	ADJ
dpc-4372	256	18	parkinson	parkinson	NOUN
dpc-4372	256	19	’s	’s	PART
dpc-4372	256	20	disease	disease	NOUN
dpc-4372	256	21	.	.	PUNCT
dpc-4372	257	1	parkinsonism	parkinsonism	PROPN
dpc-4372	257	2	relat	relat	PROPN
dpc-4372	257	3	disord	disord	PROPN
dpc-4372	257	4	.	.	PUNCT
dpc-4372	258	1	2021;84:40	2021;84:40	NUM
dpc-4372	258	2	-	-	SYM
dpc-4372	258	3	46	46	NUM
dpc-4372	258	4	.	.	PUNCT
dpc-4372	258	5	doi:10.1016	doi:10.1016	PROPN
dpc-4372	258	6	/	/	SYM
dpc-4372	258	7	j.parkreldis.2021.01.018	j.parkreldis.2021.01.018	PROPN
dpc-4372	258	8	.	.	PUNCT
dpc-4372	259	1	6	6	NUM
dpc-4372	259	2	.	.	X
dpc-4372	259	3	skorvanek	skorvanek	PROPN
dpc-4372	259	4	m	m	PROPN
dpc-4372	259	5	,	,	PUNCT
dpc-4372	259	6	bhatia	bhatia	PROPN
dpc-4372	259	7	kp	kp	PROPN
dpc-4372	259	8	.	.	PUNCT
dpc-4372	260	1	the	the	DET
dpc-4372	260	2	skin	skin	NOUN
dpc-4372	260	3	and	and	CCONJ
dpc-4372	260	4	parkinson	parkinson	NOUN
dpc-4372	260	5	’s	’s	PART
dpc-4372	260	6	disease	disease	NOUN
dpc-4372	260	7	:	:	PUNCT
dpc-4372	260	8	review	review	NOUN
dpc-4372	260	9	of	of	ADP
dpc-4372	260	10	clinical	clinical	ADJ
dpc-4372	260	11	,	,	PUNCT
dpc-4372	260	12	diagnostic	diagnostic	ADJ
dpc-4372	260	13	,	,	PUNCT
dpc-4372	260	14	and	and	CCONJ
dpc-4372	260	15	therapeutic	therapeutic	ADJ
dpc-4372	260	16	issues	issue	NOUN
dpc-4372	260	17	.	.	PUNCT
dpc-4372	261	1	mov	mov	NOUN
dpc-4372	261	2	disord	disord	PROPN
dpc-4372	261	3	clin	clin	PROPN
dpc-4372	261	4	pract	pract	PROPN
dpc-4372	261	5	.	.	PUNCT
dpc-4372	262	1	2017;4(1):21	2017;4(1):21	NUM
dpc-4372	262	2	-	-	SYM
dpc-4372	262	3	31	31	NUM
dpc-4372	262	4	.	.	PUNCT
dpc-4372	262	5	doi:10.1002	doi:10.1002	NOUN
dpc-4372	262	6	/	/	SYM
dpc-4372	262	7	mdc3.12425	mdc3.12425	NOUN
dpc-4372	262	8	.	.	NOUN
dpc-4372	263	1	7	7	X
dpc-4372	263	2	.	.	X
dpc-4372	263	3	niemann	niemann	PROPN
dpc-4372	263	4	n	n	CCONJ
dpc-4372	263	5	,	,	PUNCT
dpc-4372	263	6	billnitzer	billnitzer	NOUN
dpc-4372	263	7	a	a	NOUN
dpc-4372	263	8	,	,	PUNCT
dpc-4372	263	9	jankovic	jankovic	PROPN
dpc-4372	263	10	j.	j.	PROPN
dpc-4372	263	11	parkinson	parkinson	PROPN
dpc-4372	263	12	’s	’s	PART
dpc-4372	263	13	disease	disease	NOUN
dpc-4372	263	14	and	and	CCONJ
dpc-4372	263	15	skin	skin	NOUN
dpc-4372	263	16	.	.	PUNCT
dpc-4372	264	1	parkinsonism	parkinsonism	PROPN
dpc-4372	264	2	relat	relat	PROPN
dpc-4372	264	3	disord	disord	PROPN
dpc-4372	264	4	.	.	PUNCT
dpc-4372	265	1	2021;82:61	2021;82:61	NUM
dpc-4372	265	2	-	-	SYM
dpc-4372	265	3	76	76	NUM
dpc-4372	265	4	.	.	PUNCT
dpc-4372	265	5	doi:10.1016	doi:10.1016	PROPN
dpc-4372	265	6	/j.parkreldis.2020.11.017	/j.parkreldis.2020.11.017	PUNCT
dpc-4372	265	7	.	.	PUNCT
dpc-4372	266	1	8	8	X
dpc-4372	266	2	.	.	PUNCT
dpc-4372	266	3	mathieu	mathieu	PROPN
dpc-4372	266	4	rj	rj	PROPN
dpc-4372	266	5	,	,	PUNCT
dpc-4372	266	6	guido	guido	NOUN
dpc-4372	266	7	n	n	CCONJ
dpc-4372	266	8	,	,	PUNCT
dpc-4372	266	9	ibler	ibler	NOUN
dpc-4372	266	10	e	e	NOUN
dpc-4372	266	11	,	,	PUNCT
dpc-4372	266	12	et	et	PROPN
dpc-4372	266	13	al	al	PROPN
dpc-4372	266	14	.	.	PROPN
dpc-4372	266	15	rosacea	rosacea	PROPN
dpc-4372	266	16	and	and	CCONJ
dpc-4372	266	17	subsequent	subsequent	ADJ
dpc-4372	266	18	diagnosis	diagnosis	NOUN
dpc-4372	266	19	for	for	ADP
dpc-4372	266	20	parkinson	parkinson	NOUN
dpc-4372	266	21	’s	’s	PART
dpc-4372	266	22	disease	disease	NOUN
dpc-4372	266	23	:	:	PUNCT
dpc-4372	266	24	a	a	DET
dpc-4372	266	25	large	large	ADJ
dpc-4372	266	26	,	,	PUNCT
dpc-4372	266	27	urban	urban	ADJ
dpc-4372	266	28	,	,	PUNCT
dpc-4372	266	29	single	single	ADJ
dpc-4372	266	30	center	center	NOUN
dpc-4372	266	31	,	,	PUNCT